<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biomolecules</journal-id><journal-id journal-id-type="iso-abbrev">Biomolecules</journal-id><journal-id journal-id-type="publisher-id">biomolecules</journal-id><journal-title-group><journal-title>Biomolecules</journal-title></journal-title-group><issn pub-type="epub">2218-273X</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6920853</article-id><article-id pub-id-type="doi">10.3390/biom9110679</article-id><article-id pub-id-type="publisher-id">biomolecules-09-00679</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Natural Products and Synthetic Analogs as a Source of Antitumor Drugs</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7301-8151</contrib-id><name><surname>Sharifi-Rad</surname><given-names>Javad</given-names></name><xref ref-type="aff" rid="af1-biomolecules-09-00679">1</xref><xref rid="c1-biomolecules-09-00679" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0195-3383</contrib-id><name><surname>Ozleyen</surname><given-names>Adem</given-names></name><xref ref-type="aff" rid="af2-biomolecules-09-00679">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1740-4867</contrib-id><name><surname>Boyunegmez Tumer</surname><given-names>Tugba</given-names></name><xref ref-type="aff" rid="af3-biomolecules-09-00679">3</xref><xref rid="c1-biomolecules-09-00679" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Oluwaseun Adetunji</surname><given-names>Charles</given-names></name><xref ref-type="aff" rid="af4-biomolecules-09-00679">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0308-1155</contrib-id><name><surname>El Omari</surname><given-names>Nasreddine</given-names></name><xref ref-type="aff" rid="af5-biomolecules-09-00679">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9024-4898</contrib-id><name><surname>Balahbib</surname><given-names>Abdelaali</given-names></name><xref ref-type="aff" rid="af6-biomolecules-09-00679">6</xref></contrib><contrib contrib-type="author"><name><surname>Taheri</surname><given-names>Yasaman</given-names></name><xref ref-type="aff" rid="af7-biomolecules-09-00679">7</xref><xref ref-type="aff" rid="af8-biomolecules-09-00679">8</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9317-1631</contrib-id><name><surname>Bouyahya</surname><given-names>Abdelhakim</given-names></name><xref ref-type="aff" rid="af9-biomolecules-09-00679">9</xref><xref rid="c1-biomolecules-09-00679" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3183-7623</contrib-id><name><surname>Martorell</surname><given-names>Miquel</given-names></name><xref ref-type="aff" rid="af10-biomolecules-09-00679">10</xref><xref ref-type="aff" rid="af11-biomolecules-09-00679">11</xref><xref rid="c1-biomolecules-09-00679" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5934-5201</contrib-id><name><surname>Martins</surname><given-names>Nat&#x000e1;lia</given-names></name><xref ref-type="aff" rid="af12-biomolecules-09-00679">12</xref><xref ref-type="aff" rid="af13-biomolecules-09-00679">13</xref><xref rid="c1-biomolecules-09-00679" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4174-4586</contrib-id><name><surname>C. Cho</surname><given-names>William</given-names></name><xref ref-type="aff" rid="af14-biomolecules-09-00679">14</xref><xref rid="c1-biomolecules-09-00679" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-biomolecules-09-00679"><label>1</label>Zabol Medicinal Plants Research Center, Zabol University of Medical Sciences, Zabol 61615-585, Iran</aff><aff id="af2-biomolecules-09-00679"><label>2</label>Graduate Program of Biomolecular Sciences, Institute of Natural and Applied Sciences, Canakkale Onsekiz Mart University, Canakkale 17020, Turkey; <email>ademozleyen@gmail.com</email></aff><aff id="af3-biomolecules-09-00679"><label>3</label>Department of Molecular Biology and Genetics, Faculty of Arts and Science, Canakkale Onsekiz Mart University, Canakkale 17020, Turkey</aff><aff id="af4-biomolecules-09-00679"><label>4</label>Applied Microbiology, Biotechnology and Nanotechnology Laboratory, Department of Microbiology, Edo University, Iyamho, Edo State 300271, Nigeria; <email>adetunji.charles@edouniversity.edu.ng</email></aff><aff id="af5-biomolecules-09-00679"><label>5</label>Laboratory of Histology, Embryology and Cytogenetic, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat 10100, Morocco; <email>nasrelomari@gmail.com</email></aff><aff id="af6-biomolecules-09-00679"><label>6</label>Laboratory of Zoology and General Biology, Faculty of Sciences, Mohammed V University, Rabat 10106, Morocco; <email>balahbib.abdo@gmail.com</email></aff><aff id="af7-biomolecules-09-00679"><label>7</label>Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran 1991953381, Iran; <email>taaheri.yasaman@gmail.com</email></aff><aff id="af8-biomolecules-09-00679"><label>8</label>Department of Pharmacology and Toxicology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran 11369, Iran</aff><aff id="af9-biomolecules-09-00679"><label>9</label>Laboratory of Human Pathologies Biology, Department of Biology, Faculty of Sciences, and Genomic Center of Human Pathologies, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat 10106, Morocco</aff><aff id="af10-biomolecules-09-00679"><label>10</label>Department of Nutrition and Dietetics, Faculty of Pharmacy, University of Concepcion, Concepcion 4070386, Chile</aff><aff id="af11-biomolecules-09-00679"><label>11</label>Universidad de Concepci&#x000f3;n, Unidad de Desarrollo Tecnol&#x000f3;gico, UDT, Concepcion 4070386, Chile</aff><aff id="af12-biomolecules-09-00679"><label>12</label>Faculty of Medicine, University of Porto, Alameda Prof. Hern&#x000e2;ni Monteiro, 4200-319 Porto, Portugal</aff><aff id="af13-biomolecules-09-00679"><label>13</label>Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal</aff><aff id="af14-biomolecules-09-00679"><label>14</label>Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China</aff><author-notes><corresp id="c1-biomolecules-09-00679"><label>*</label>Correspondence: <email>javad.sharifirad@gmail.com</email> (J.S.-R.); <email>tumertb@gmail.com</email> (T.B.T.); <email>boyahyaa-90@hotmail.fr</email> (A.B.); <email>mmartorell@udec.cl</email> (M.M.); <email>ncmartins@med.up.pt</email> (N.M.); <email>chocs@ha.org.hk</email> (W.C.C.); Tel.: +98-21-8820-0104 (J.S.-R.); +90-2862180018 (ext. 1844) (T.B.T.); +212-601250878 (A.B.); +56-41-266-1671 (M.M.); +351-22-5512100 (N.M.); +852-3506-6284 (W.C.C.)</corresp></author-notes><pub-date pub-type="epub"><day>01</day><month>11</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>11</month><year>2019</year></pub-date><volume>9</volume><issue>11</issue><elocation-id>679</elocation-id><history><date date-type="received"><day>09</day><month>10</month><year>2019</year></date><date date-type="accepted"><day>27</day><month>10</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Cancer is a heterogeneous disease and one of the major issues of health concern, especially for the public health system globally. Nature is a source of anticancer drugs with abundant pool of diverse chemicals and pharmacologically active compounds. In recent decade, some natural products and synthetic analogs have been investigated for the cancer treatment. This article presents the utilization of natural products as a source of antitumor drugs.</p></abstract><kwd-group><kwd>phytochemical</kwd><kwd>phytomedicine</kwd><kwd>anticancer</kwd><kwd>natural products</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-biomolecules-09-00679"><title>1. Introduction</title><p>An abnormal development of cells that promulgates through the splitting of unrestricted cells is referred to as cancer. Cancer has been highlighted as one of the major issues of concern most especially for the public health system globally, and the US National Cancer Institute have forecasted with up rise of 50% in cancer cases, which will drastically increase to 21 million new cases in approximately two decades to this period [<xref rid="B1-biomolecules-09-00679" ref-type="bibr">1</xref>]. According to the projection, it is likely to record seven out of ten deaths as a result of cancer in Central and South America, Asia, and Africa. This is an alarm that most developing countries need to upgrade and develop more strategic planning that borders around the issues of surveillance, early detection, and operational treatment for cancer patients [<xref rid="B2-biomolecules-09-00679" ref-type="bibr">2</xref>]. Normally, individuals at a different time of their ages may be affected by cancer but there is a probability that the cancer diseases increases with increase in age [<xref rid="B3-biomolecules-09-00679" ref-type="bibr">3</xref>]. This might be due to the accumulated DNA damage and multi-stage carcinogenesis as one becomes older [<xref rid="B4-biomolecules-09-00679" ref-type="bibr">4</xref>,<xref rid="B5-biomolecules-09-00679" ref-type="bibr">5</xref>,<xref rid="B6-biomolecules-09-00679" ref-type="bibr">6</xref>].</p><p>The traditional approaches for cancer treatment include surgery, radiotherapy and chemotherapy [<xref rid="B7-biomolecules-09-00679" ref-type="bibr">7</xref>,<xref rid="B8-biomolecules-09-00679" ref-type="bibr">8</xref>]. Conversely, irrespective of the numerous type of synthetic drugs that have been utilized for the cancer chemotherapy and the healing accomplishment of various management schedules, the prevailing therapies have not yielded the level of expected result as tumor relapse and the beginning of metastasis often take place [<xref rid="B9-biomolecules-09-00679" ref-type="bibr">9</xref>,<xref rid="B10-biomolecules-09-00679" ref-type="bibr">10</xref>]. In light of this, there is a need to pursue more selective active compounds that have fewer side effects, are cost-effective, have more medicinal attributes, and have a minimum level of disease resistance have been enlisted as a major significant attribute necessary for cancer treatment most especially from biological and natural sources. Nevertheless, little information exists regarding the utilization of biological natural compounds and their cellular and molecular modes of action against cancer diseases. The late diagnosis and non-responsive therapy is a major reason of higher mortality among many cancer patients. This has instigated the need to search for an alternative cancer drug. The application of natural synthetic moieties is lead molecules that are preferable to some chemodrugs due to their various uncountable side effects [<xref rid="B11-biomolecules-09-00679" ref-type="bibr">11</xref>,<xref rid="B12-biomolecules-09-00679" ref-type="bibr">12</xref>].</p><p>The etiological process involved in the multiplying of a cancerous cell has been observed to be facilitated by some pathways or some mechanisms of action [<xref rid="B13-biomolecules-09-00679" ref-type="bibr">13</xref>,<xref rid="B14-biomolecules-09-00679" ref-type="bibr">14</xref>]. It has been stated that some active compounds derived from natural sources could be used effectively as a therapeutic technique for the treatment of these cancerous cells [<xref rid="B15-biomolecules-09-00679" ref-type="bibr">15</xref>]. To date, more than 60% of synthetic drugs are derived from natural sources, out of which natural active compound most especially from plant constitutes 75% of anticancer drugs [<xref rid="B16-biomolecules-09-00679" ref-type="bibr">16</xref>,<xref rid="B17-biomolecules-09-00679" ref-type="bibr">17</xref>]. The natural product obtained from different sources portends the capability to enhance numerous physiological pathways which are necessary for the treatment of stalwart diseases [<xref rid="B18-biomolecules-09-00679" ref-type="bibr">18</xref>] including cancer [<xref rid="B19-biomolecules-09-00679" ref-type="bibr">19</xref>]. Therefore, it has become imperative to apply various strategies for the management of these stubborn diseases using natural products, most especially phytochemicals from biological sources most especially from plants [<xref rid="B20-biomolecules-09-00679" ref-type="bibr">20</xref>,<xref rid="B21-biomolecules-09-00679" ref-type="bibr">21</xref>]. This might be linked to the involvement of some crucial phytochemicals that have the capability to inhibit many pathways and prevent some malignancies, as well as the crucial roles they play in the inhibition of these dangerous cancer cells [<xref rid="B22-biomolecules-09-00679" ref-type="bibr">22</xref>].</p><p>Nature is a rich source of anticancer drugs that are obtained from natural sources [<xref rid="B23-biomolecules-09-00679" ref-type="bibr">23</xref>]. This might be linked to their abundant pool of diverse chemotypes and pharmacologically active. Moreover only a small percentage from these biologically active compounds derived from natural products have been formulated into clinically active drugs but their active compounds could be a model that will be followed for the formulation of more effective analogs and prodrugs through the utilization of chemical techniques like metabolomics, total or combinatorial fabrication or alteration of their biosynthetic pathways.</p><p>Furthermore, recent advances in formulating consortium of novel biologically active compounds may lead to may result in more efficient administration of the drug to patients. This might also include the fusion of toxic natural molecules to monoclonal antibodies and polymeric carriers precisely directed towards epitopes on the targeted tumor cell, which could result in the discovery of more active antitumor drugs. This also requires the inputs of multidisciplinary collaborations among different scientists to optimize and standardized the most active biological compounds and their adequate effectiveness as antitumor drugs at the molecular level [<xref rid="B24-biomolecules-09-00679" ref-type="bibr">24</xref>,<xref rid="B25-biomolecules-09-00679" ref-type="bibr">25</xref>,<xref rid="B26-biomolecules-09-00679" ref-type="bibr">26</xref>,<xref rid="B27-biomolecules-09-00679" ref-type="bibr">27</xref>,<xref rid="B28-biomolecules-09-00679" ref-type="bibr">28</xref>].</p><p>For the past 10 years, some natural products have been discovered as a major source of drugs which have been utilized for the management of cancer chemotherapy, whereas almost 70% of them have been validated in various stages of clinical trials [<xref rid="B16-biomolecules-09-00679" ref-type="bibr">16</xref>,<xref rid="B17-biomolecules-09-00679" ref-type="bibr">17</xref>,<xref rid="B29-biomolecules-09-00679" ref-type="bibr">29</xref>,<xref rid="B30-biomolecules-09-00679" ref-type="bibr">30</xref>]. Some examples of antitumor drugs derived from plant compounds are Curcumin (diferuloylmethane) [<xref rid="B31-biomolecules-09-00679" ref-type="bibr">31</xref>,<xref rid="B32-biomolecules-09-00679" ref-type="bibr">32</xref>,<xref rid="B33-biomolecules-09-00679" ref-type="bibr">33</xref>,<xref rid="B34-biomolecules-09-00679" ref-type="bibr">34</xref>] and Paclitaxel (Taxol<sup>&#x000ae;</sup>), which is a taxane dipertene present in the crude extract obtained from the bark of <italic>Taxus brevifolia</italic> Nutt. (Western yew) [<xref rid="B35-biomolecules-09-00679" ref-type="bibr">35</xref>]. Another example is Taxol (essentially all taxanes), which hinders microtubule disassembly by joining the microtubules that have been polymerized [<xref rid="B35-biomolecules-09-00679" ref-type="bibr">35</xref>,<xref rid="B36-biomolecules-09-00679" ref-type="bibr">36</xref>,<xref rid="B37-biomolecules-09-00679" ref-type="bibr">37</xref>,<xref rid="B38-biomolecules-09-00679" ref-type="bibr">38</xref>,<xref rid="B39-biomolecules-09-00679" ref-type="bibr">39</xref>]. The bioavailability of these compounds is usually discussed, i.e., in the case of curcumin low bioavailability is addressed by using higher concentrations within nontoxic limits and its combination with other compounds or as formulations [<xref rid="B40-biomolecules-09-00679" ref-type="bibr">40</xref>].</p><p>Examples of antitumor synthetic analogs derived from plant, which have been validated scientifically, include paclitaxel (Taxols) and the analogs docetaxel (Taxoteres) and cabazitaxel (Jevtanas); camptothecin and analogs belotecan (Camptobells), topotecan (Hycamtins), and irinotecan (Camptosars); vinblastine (Velbans), vincristine (Oncovins), and their analogs vindesine (Eldisines) and vinorelbine (Navelbines); and podophyllotoxin and analogs etoposide (Etopophoss) and teniposide (Vumons). Moreover, bacterial derived from the soil have also shown a lot of potential as a great source of antitumor drugs like the glycopeptide bleomycin (Blenoxanes), the nonribosomal peptide dactinomycin (Cosmegens), anthracyclines doxorubicin (Doxils; Adriamycins) and daunorubicin (Cerubidines), and epirubicin (Ellences) (<xref rid="biomolecules-09-00679-t001" ref-type="table">Table 1</xref>) [<xref rid="B17-biomolecules-09-00679" ref-type="bibr">17</xref>,<xref rid="B24-biomolecules-09-00679" ref-type="bibr">24</xref>,<xref rid="B41-biomolecules-09-00679" ref-type="bibr">41</xref>].</p><p>The compact and unusual structural configuration of some of these natural compounds plays a crucial role in their joining together to specific targets or molecular interfaces. This might result in some level of phenotypic alteration, most especially in biological systems that involve fixing of natural molecules, entails structural requirements that allow their binding to specific targets or molecular interactions [<xref rid="B42-biomolecules-09-00679" ref-type="bibr">42</xref>,<xref rid="B43-biomolecules-09-00679" ref-type="bibr">43</xref>]. Some of these features shared the same similar medicinal attributes in the most different diseases. It has been validated that 64% of drugs derived from natural products are effectually used in the development of these drugs [<xref rid="B17-biomolecules-09-00679" ref-type="bibr">17</xref>,<xref rid="B44-biomolecules-09-00679" ref-type="bibr">44</xref>].</p><p>Moreover, due to the invaluable biological diversity of natural products, there is a need to still search for more effective antineoplastic activity active compounds from microorganisms, most especially from marine sources and from unexploited plants because some of these compounds might show exceptional activities when tested against new medicinal targets [<xref rid="B41-biomolecules-09-00679" ref-type="bibr">41</xref>,<xref rid="B45-biomolecules-09-00679" ref-type="bibr">45</xref>]. Examples of marine-derived anticancer drugs include the conjugated antibody brentuximab vedotin (Acentriss), cytarabine (Cytosars), eribulin mesylate (Halavens), and trabectedin (Yondeliss) [<xref rid="B46-biomolecules-09-00679" ref-type="bibr">46</xref>,<xref rid="B47-biomolecules-09-00679" ref-type="bibr">47</xref>,<xref rid="B48-biomolecules-09-00679" ref-type="bibr">48</xref>].</p><p>Therefore, this review presents a holistic view of the current trends towards the utilization of natural products and synthetic analogs as a source of new antitumor drugs that have been reported for the past decade. Moreover, recent information about antitumor drugs derived from various sources and their general bioactivity towards the management of different types of cancer is well elaborated in this review work.</p></sec><sec id="sec2-biomolecules-09-00679"><title>2. Antitumor Drugs: A Brief Medical History, Different Origins, and General Bioactivity</title><p>Cancer has been reported as the second most common cause of death with an estimated 9.6 million deaths in 2018 by the World Health Organization [<xref rid="B49-biomolecules-09-00679" ref-type="bibr">49</xref>]. It is not an emerging disease: people have been suffering from cancer throughout the world for centuries. Between 460 and 370 B.C, Hippocrates used the word cancer for the first time to describe carcinoma tumors [<xref rid="B50-biomolecules-09-00679" ref-type="bibr">50</xref>]. However, this disease is not discovered by Hippocrates. The pieces of evidence showed that bone cancer was reported in ancient Egypt mummies in approximately 1600 B.C. and breast cancer in 1500 B.C.; however, there was no recorded treatment for cancer [<xref rid="B51-biomolecules-09-00679" ref-type="bibr">51</xref>].</p><p>Considering the earliest reports on the nature of cancer, first findings dates back to 1761, when Giovanni Battista Morgagni, regarded as the father of modern anatomical pathology, did autopsies for the first time on dead bodies to elucidate the relation between patient&#x02019;s illness and pathologic observations. Giovanni&#x02019;s studies provided the basis of scientific cancer strategies [<xref rid="B52-biomolecules-09-00679" ref-type="bibr">52</xref>]. Additionally, John Hunter who introduced the idea that surgery could be a strategy for the patients whose tumors have not invasive and moveable characteristics to nearby sites, he said: &#x0201c;there is no impropriety in removing it.&#x0201d; [<xref rid="B53-biomolecules-09-00679" ref-type="bibr">53</xref>]. A century later, anesthesia was invented, and surgeons Bilroth, Handley, and Halsted carried out cancer operations by removing the entire tumor. Development of modern microscope accelerated the studies in the era of scientific oncology in the 19th century and Rudolf Virchow, the founder of cellular pathology, laid the foundation of the modern pathologic study of cancer [<xref rid="B54-biomolecules-09-00679" ref-type="bibr">54</xref>]. Thus, damages caused by cancer on the body could be detected. Moreover, the efficiency of operations could be examined by this method whether the cancerous tissue had been completely removed from the cancer site [<xref rid="B54-biomolecules-09-00679" ref-type="bibr">54</xref>].</p><p>Early in the 20th century, surgery and radiotherapy were the two most dominated modalities to cure cancer diseases [<xref rid="B55-biomolecules-09-00679" ref-type="bibr">55</xref>]. The term &#x02018;&#x02018;chemotherapy&#x02019;&#x02019; was provided into literature by the famous German chemist Paul Ehrlich in the early 1900s. It means the therapeutic use of chemicals to treat diseases [<xref rid="B56-biomolecules-09-00679" ref-type="bibr">56</xref>]. He was also the first scientist who evaluated the potential biological activities of a group of chemicals in animal models. He is a pioneer to overcome the major limitation in the cancer drug development process before clinical stages [<xref rid="B56-biomolecules-09-00679" ref-type="bibr">56</xref>,<xref rid="B57-biomolecules-09-00679" ref-type="bibr">57</xref>].</p><p>In the middle of the 20th century, during the World War II, breakthrough information emerged in the field of chemotherapy. It was reported that people exposed to mustard gas in the field of military action had toxic changes in the bone marrow cells [<xref rid="B57-biomolecules-09-00679" ref-type="bibr">57</xref>,<xref rid="B58-biomolecules-09-00679" ref-type="bibr">58</xref>]. As a result of these surprising findings, researchers focused on the mustard gas-related compounds to identify effective compounds to cure cancer. After much effort on their part, the first anticancer drug, called mechlorethamine (Mustargen<sup>&#x000ae;</sup>), was approved for the treatment of lymphoma and reached the markets in 1949 as a nitrogen mustard alkylating agent [<xref rid="B57-biomolecules-09-00679" ref-type="bibr">57</xref>,<xref rid="B59-biomolecules-09-00679" ref-type="bibr">59</xref>,<xref rid="B60-biomolecules-09-00679" ref-type="bibr">60</xref>]. The discovery of nitrogen mustard paved the way for the synthesis of other anticancer drugs. Sidney Farber, in 1948, showed the effectiveness of aminopterin, a folic acid antagonist, against childhood leukemia and it was the predecessor of the drug methotrexate that is still utilized in clinics [<xref rid="B58-biomolecules-09-00679" ref-type="bibr">58</xref>]. When the historical development of antitumor agents has been examined, it can be seen that drugs that were discovered in the second half of the 20th century have generally exerted their effects through direct binding to DNA thus creating cell toxicity (<xref ref-type="fig" rid="biomolecules-09-00679-f001">Figure 1</xref>). However, in the 21st century, with the advent of molecular biology techniques, the action mechanism of chemotherapeutic agents has become quite specific. The trend has been changing from small molecules to protein-based therapeutics as well as their small molecules conjugated forms (<xref ref-type="fig" rid="biomolecules-09-00679-f001">Figure 1</xref>).</p><p>These findings were significant milestones in anticancer drug developments which result in an increased number of drugs reaching to the markets [<xref rid="B60-biomolecules-09-00679" ref-type="bibr">60</xref>]. Between 1950 and 1980, on average, two new drugs were approved for their anticancer activities a year. Moreover, this number was doubled in the 1990s. An average of 10 novel oncologic drugs hit the markets in the years between 2011 and 2019 per year [<xref rid="B59-biomolecules-09-00679" ref-type="bibr">59</xref>]. Unlike the drug development process in the past, it takes ~13&#x02013;15 years for the validation of drugs in the preclinical and clinical phases. There are several stages in this workflow, including determination of molecular and phenotypic targets; design, in silico analysis, and synthesis of hit molecules; in vitro and animal studies for the elucidation of biological effects of test compounds; and optimization of a candidate compound for clinical studies. The efficacy, safety, and possible side effects of drugs are tested through clinical phases [<xref rid="B61-biomolecules-09-00679" ref-type="bibr">61</xref>]. In the following sections, the latest drugs approved by the Food and Drug Administration (FDA) USA in the last decade are summarized according to their mechanism of action. Nearly, 80% of FDA-approved drugs during the last three decades for cancer treatment are either natural products per se or derivatives [<xref rid="B62-biomolecules-09-00679" ref-type="bibr">62</xref>].</p><sec id="sec2dot1-biomolecules-09-00679"><title>2.1. FDA-Approved Small Molecules as Antitumor Drugs in the Last 10 Years</title><p>In the last decade, more than fifty small molecules as antitumor agents have been approved by the FDA (<xref rid="biomolecules-09-00679-t002" ref-type="table">Table 2</xref>).</p><p>Among these drugs, cabazitaxel (Jevtana) is a second-generation semisynthetic taxane derivative approved in 2010 by the FDA, especially for the treatment of metastatic hormone-refractory prostate cancer. Taxanes are a class of diterpenes, which were originally identified from plants of the genus Taxus (yews). Paclitaxel (Taxol) and docetaxel (Taxotere) are widely used progenitor of cabazitaxel (<xref ref-type="fig" rid="biomolecules-09-00679-f002">Figure 2</xref>). Their mechanism of action involves microtubule stabilization to induce cell death. In general, they bind to tubulin subunits and promote the assembly of microtubules while simultaneously inhibiting its disassembly. This leads to arrest in the cell cycle at the metaphase and triggers apoptosis in the cancerous cell. Although they have a similar mechanism of action, cabazitaxel has an advantage over paclitaxel and docetaxel, due to having extra methyl groups that mitigate constitutively and acquired antitumor drug resistance by inhibiting the P-glycoprotein (P-gp) efflux pump [<xref rid="B63-biomolecules-09-00679" ref-type="bibr">63</xref>,<xref rid="B64-biomolecules-09-00679" ref-type="bibr">64</xref>]. Besides, cabazitaxel is more effective in central nervous system (CNS) metastases because of its ability to pass through the blood&#x02013;brain barrier [<xref rid="B64-biomolecules-09-00679" ref-type="bibr">64</xref>].</p><p>Eribulin (Havalen) was isolated from the marine sponge <italic>Halichondria okadai</italic>. It is a non-taxane microtubule inhibitor with a novel mode of action and was approved by FDA in 2010 for the treatment of patients with metastatic breast cancer who have previously administered with at least two chemotherapeutic protocols. Although it is a fully synthetic organic molecule, its structure was inspired by halichondrin B, which is a polyether macrolide isolated from the rare marine sponge in 1986 by Hirata and Nemura [<xref rid="B65-biomolecules-09-00679" ref-type="bibr">65</xref>]. The studies with halichondrin B had reported a remarkable microtubule-associated in vivo and in vitro anticancer activity [<xref rid="B66-biomolecules-09-00679" ref-type="bibr">66</xref>]. As a result of these findings, in 1992, the total synthesis of halichondrin B was achieved by Kishi and colleagues [<xref rid="B67-biomolecules-09-00679" ref-type="bibr">67</xref>]. Several studies with this compound revealed that macrocyclic lactone C1&#x02013;C8 moiety on the right half of the molecule retains its cytotoxic activity [<xref rid="B67-biomolecules-09-00679" ref-type="bibr">67</xref>]. Although Eribulin is a structurally much simpler analog of halichondrin B, it retains a biologically active pharmacophore of the original molecule (<xref ref-type="fig" rid="biomolecules-09-00679-f003">Figure 3</xref>) [<xref rid="B68-biomolecules-09-00679" ref-type="bibr">68</xref>,<xref rid="B69-biomolecules-09-00679" ref-type="bibr">69</xref>,<xref rid="B70-biomolecules-09-00679" ref-type="bibr">70</xref>].</p><p>The cytotoxicity of eribulin is mediated through microtubules; however, its mode of action is different from other tubulin-binding agents such as taxanes and vinca alkaloids [<xref rid="B71-biomolecules-09-00679" ref-type="bibr">71</xref>,<xref rid="B72-biomolecules-09-00679" ref-type="bibr">72</xref>]. These agents bind along the sides of microtubules, specifically eribulin, and limitedly bind on the (+) ends of the structure, thus inhibiting polymerization but not depolymerization (shortening) of its growth. Therefore, eribulin results in the arrest of the cell cycle at the G<sub>2</sub>/M phase thus activation of the apoptotic processes and subsequently cell death [<xref rid="B66-biomolecules-09-00679" ref-type="bibr">66</xref>,<xref rid="B73-biomolecules-09-00679" ref-type="bibr">73</xref>,<xref rid="B74-biomolecules-09-00679" ref-type="bibr">74</xref>,<xref rid="B75-biomolecules-09-00679" ref-type="bibr">75</xref>].</p><p>Another potent and widely used chemotherapeutic agent representing its antitumor activity through microtubule inhibition is vinciristine&#x02014;a kind of plant alkaloid. It was first isolated from the extract of the periwinkle plant <italic>Catharanthus roseus</italic> (L.) G.Don (formerly known as <italic>Vinca rosea</italic> L.) in the scope of a screening program exploring the potential antidiabetic agents [<xref rid="B76-biomolecules-09-00679" ref-type="bibr">76</xref>,<xref rid="B77-biomolecules-09-00679" ref-type="bibr">77</xref>,<xref rid="B78-biomolecules-09-00679" ref-type="bibr">78</xref>]. The action mode of vincristine includes microtubule depolymerization through binding to tubulin subunits resulting in metaphase arrest and finally apoptotic cell death. Although vincristine has been effectively used for more than 50 years in the treatment of hematologic malignancies and solid tumors, it has important limitations due to its suboptimal pharmacokinetic profiles and dose-related neurotoxicity [<xref rid="B79-biomolecules-09-00679" ref-type="bibr">79</xref>]. VinCRIStine sulfate Liposome injection (Marqibo) is a novel and therapeutically improved formulation of vincristine encapsulated in sphingomyelin and cholesterol based nanoparticles. This liposome-remodeled form of the active compound is approved by FDA in 2013 for the treatment of relapsed Philadelphia chromosome-negative acute lymphoblastic leukemia (<xref ref-type="fig" rid="biomolecules-09-00679-f004">Figure 4</xref>).</p><p>In the last decade, poly(ADP-ribose) polymerases (PARPs), which are ubiquitous zinc finger DNA-binding enzymes, have been established as well-known targets of several oncologic drugs The cellular roles of PARP proteins include regulation of homologous recombination, transcription, and replication processes, as well as DNA repair mechanism under any stress conditions [<xref rid="B80-biomolecules-09-00679" ref-type="bibr">80</xref>]. Inhibition of the PARP proteins can bring about the stimulation of apoptotic pathways through NAD<sup>+</sup>/ATP depletion, loss of mitochondrial membrane dynamics, and the production of excess amount of apoptosis-inducing factor [<xref rid="B80-biomolecules-09-00679" ref-type="bibr">80</xref>]. Recently, the drug rucaparib (Rubraca, <xref ref-type="fig" rid="biomolecules-09-00679-f005">Figure 5</xref>), found in the class of piperidine type organic compounds, has been approved by FDA (2016) as a potent PARP-1, -2, and -3 inhibitor for the treatment of advanced ovarian cancer in women with deleterious germline or somatic BRCA mutation [<xref rid="B81-biomolecules-09-00679" ref-type="bibr">81</xref>]. Soon after, another piperidine compound, niraparib (Zejula, <xref ref-type="fig" rid="biomolecules-09-00679-f005">Figure 5</xref>), was approved by the FDA (2017) for its effectiveness on recurrent epithelial ovarian cancer [<xref rid="B82-biomolecules-09-00679" ref-type="bibr">82</xref>]. The drug exerts its effect by specifically inhibiting PARP-1 and PARP-2 activation resulting in niraparib-induced cytotoxicity in cancerous cells. Very recently, a kind of quinoline derivative talazoparib (Talzenna, <xref ref-type="fig" rid="biomolecules-09-00679-f005">Figure 5</xref>) has been approved by FDA (2018) for use in the treatment of germline BRCA mutated, HER2-negative, locally advanced, or metastatic breast cancer due to its inhibitory effect on PARP-1 and PARP-2 proteins [<xref rid="B83-biomolecules-09-00679" ref-type="bibr">83</xref>].</p><p>Chronic inflammation refers to the uncontrolled immune response of living organisms to initiate a defense mechanism against several endogenous and exogenous stimuli [<xref rid="B84-biomolecules-09-00679" ref-type="bibr">84</xref>,<xref rid="B85-biomolecules-09-00679" ref-type="bibr">85</xref>,<xref rid="B86-biomolecules-09-00679" ref-type="bibr">86</xref>]. However, a prolonged inflammatory response is associated with the production of an excess amount of reactive nitrogen/oxygen species, persistent cytokine release and sustained immune response [<xref rid="B85-biomolecules-09-00679" ref-type="bibr">85</xref>,<xref rid="B87-biomolecules-09-00679" ref-type="bibr">87</xref>]. This might lead to various inflammation-related pathological diseases including type II diabetes, coronary-neurologic disorders, as well as cancer [<xref rid="B88-biomolecules-09-00679" ref-type="bibr">88</xref>,<xref rid="B89-biomolecules-09-00679" ref-type="bibr">89</xref>]. The drug pomalidomide (Pomalyst; found in the family of organic compounds called phthalimides&#x02014;<xref ref-type="fig" rid="biomolecules-09-00679-f006">Figure 6</xref>) was approved in 2013 by the FDA to be used in the treatment of patients having relapsed and refractory multiple myeloma [<xref rid="B90-biomolecules-09-00679" ref-type="bibr">90</xref>]. It has been demonstrated that the drug is an immunomodulatory agent with multiple actions including the cytotoxic and apoptotic effects on tumor cells. As having immune modulatory effects, the drug is highly effective inhibitors of proinflammatory cytokines such as TNF-&#x003b1;, IL-6, and even transcription of COX2 [<xref rid="B90-biomolecules-09-00679" ref-type="bibr">90</xref>]. It is thought the primary biological target of the drug is the protein cereblon to suppress ubiquitin ligase activity. In the same year, another drug called lenalidomide (Revlimid; found in the family of organic compounds known as isoindolones&#x02014;<xref ref-type="fig" rid="biomolecules-09-00679-f006">Figure 6</xref>) was introduced into the markets for the treatment of mantle cell lymphoma. It has been shown that the drug inhibited the release of proinflammatory cytokines and increased the release of anti-inflammatory cytokines from peripheral blood mononuclear cells [<xref rid="B91-biomolecules-09-00679" ref-type="bibr">91</xref>]. In addition to these effects, the drug inhibited the expression of COX-2 selectively but not COX-1. Additionally, the drug stimulated the apoptosis of tumor cells by the inhibition of bone marrow stromal cell support and immunomodulatory activity [<xref rid="B92-biomolecules-09-00679" ref-type="bibr">92</xref>].</p><p>Receptor tyrosine kinases (RTKs) are a group of cell surface receptors that are responsible for the regulation of cell growth, motility, differentiation, and survival [<xref rid="B93-biomolecules-09-00679" ref-type="bibr">93</xref>]. The sustained activation and expression level of RTKs have been found to be correlated with the abnormalities in the downstream signaling pathways such as mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) and Janus kinase/signal transducers, and activators of transcription (JAK/STAT) pathways, which may finally result in cancer development and uncontrolled proliferation of the cells [<xref rid="B94-biomolecules-09-00679" ref-type="bibr">94</xref>,<xref rid="B95-biomolecules-09-00679" ref-type="bibr">95</xref>]. Therefore, during the past decade, different domains of RTKs including extracellular, transmembrane, and cytoplasmic domains have been studied extensively as therapeutic targets in the development of anticancer agents [<xref rid="B96-biomolecules-09-00679" ref-type="bibr">96</xref>]. The drug erdafitinib (Balversa; found in the class of organic compounds named alkyldiarylamines, <xref ref-type="fig" rid="biomolecules-09-00679-f007">Figure 7</xref>) is the latest FDA-approved (April 2019) oncologic drug as well as the first-ever fibroblast growth factor receptor (FGFR) kinase inhibitor for the treatment of patients who are suffering from advanced urothelial carcinoma [<xref rid="B97-biomolecules-09-00679" ref-type="bibr">97</xref>]. In normal tissues, FGFR proteins ubiquitously expressed for the regulation of various physiological processes such as phosphate and vitamin D homeostasis, as well as proliferation and antiapoptotic signaling of the cells [<xref rid="B98-biomolecules-09-00679" ref-type="bibr">98</xref>]. However, in the case of cancer, upon binding of FGF ligands to the receptor, the downstream signal transduction is stimulated leading to permanent activation of phosphoinositide phospholipase C (PLC&#x003b3;), MAPK, AKT, and STAT cascades [<xref rid="B98-biomolecules-09-00679" ref-type="bibr">98</xref>]. The drug erdafitinib is said to be a selective inhibitor for the tyrosine kinase enzymatic activities of expressed FGFR1, FGFR2, FGFR3, and FGFR4. The drug lenvatinib (Lenvima; an organic compound known as quinoline carboxamides, <xref ref-type="fig" rid="biomolecules-09-00679-f007">Figure 7</xref>) was approved by FDA in 2015 as a multipotent RTK inhibitor, which has been found to be effective in the treatment of patients with locally recurrent or metastatic, progressive thyroid cancer [<xref rid="B99-biomolecules-09-00679" ref-type="bibr">99</xref>]. Lenvatinib inhibits the activities of several vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). The production of endogenous VEGF is necessary for some physiological processes such as fetal development, menstruation, and wound healing in normal tissues [<xref rid="B100-biomolecules-09-00679" ref-type="bibr">100</xref>]. However, the overproduction of VEGF is associated with abnormal tumor growth and metastasis by stimulating the formation of new blood vessels from existing vasculature [<xref rid="B101-biomolecules-09-00679" ref-type="bibr">101</xref>]. Lenvatinib exerts its effect by binding to the adenosine 5&#x02032;-triphosphate site of VEGFR and to a neighboring region, leading to inhibition of tyrosine kinase activity as well as downstream cascades. Lenvatinib also inhibits other RTKs including fibroblast growth factor (FGF) receptors FGFR1, 2, 3, and 4; the platelet-derived growth factor receptor alpha (PDGFR&#x003b1;); KIT; and RET that have been implicated in the pathogenic angiogenesis, tumor growth, and cancer progression.</p></sec><sec id="sec2dot2-biomolecules-09-00679"><title>2.2. FDA-Approved Protein-Based Therapeutics in the Last 10 Years</title><p>Understanding the fundamental of proteins and novel techniques utilized in genetic engineering has made a great contribution to the field of the pharmaceutical industry. Unlike small molecule drugs, protein therapeutics cannot be produced via a sequence of chemical reactions, so natural sources, such as living cells or organisms, are essential hosts for the manufacture of a product [<xref rid="B103-biomolecules-09-00679" ref-type="bibr">103</xref>,<xref rid="B104-biomolecules-09-00679" ref-type="bibr">104</xref>]. Although protein-based drugs are highly target-specific and potent therapeutics, the characterization of final products is a highly challenging process because of their large molecular size, exhausting purification steps, as well as individual variations in cancer patients [<xref rid="B105-biomolecules-09-00679" ref-type="bibr">105</xref>].</p><p>Similar to numerous small molecules, a group of protein-based therapeutics has been approved for their inhibitory effect on RTKs and downstream signaling pathways. Human epidermal growth factor receptor 2 (HER2) is a significant prognostic and predictive biomarker commonly researched in oncological clinics. The overexpression of the HER2 is much higher in the breast and gastric/gastroesophageal cancer patients [<xref rid="B105-biomolecules-09-00679" ref-type="bibr">105</xref>]. Moreover, the HER2 positivity has been found to be associated with other cancer types such as ovary, endometrium, bladder, lung, as well as the colon [<xref rid="B105-biomolecules-09-00679" ref-type="bibr">105</xref>]. Binding of ligands to the receptor leads to the autophosphorylation of tyrosine residues within the cytoplasmic domain after that dimerization of receptors resulting in cell proliferation, angiogenesis, and invasion-related signaling pathway activations [<xref rid="B106-biomolecules-09-00679" ref-type="bibr">106</xref>]. Elucidation of the structure and other characteristics of HER2 have paved the way for a more effective personalized therapeutic strategy in HER2-positive patients. The drug trastuzumab (Herceptin; recombinant humanized IgG1 monoclonal antibody) has demonstrated high affinity against the extracellular domain of HER2, resulting in inhibition of cancer cells growth and proliferation, and increased survival in the breast and gastric cancer patients [<xref rid="B107-biomolecules-09-00679" ref-type="bibr">107</xref>]. Additionally, the biosimilar drugs to Herceptin, named trastuzumab-dkst (Ogivri), trastuzumab-pkrb, (Herzuma), and trastuzumab-anns (KANJINTI), have been approved for their therapeutic effects in the patients with metastatic breast and gastric cancer.</p><p>As an alternative to small molecules that are able to inhibit the function of VEGF receptor, the protein-based drugs bevacizumab (Avastin; recombinant humanized IgG1 monoclonal antibody) and ramucirumab (Cyramza; human IgG1 monoclonal antibody) have been introduced for their pharmacological actions against blood vessel proliferation and metastatic tumor growth in the patients with cervical cancer and gastric cancer respectively [<xref rid="B108-biomolecules-09-00679" ref-type="bibr">108</xref>,<xref rid="B109-biomolecules-09-00679" ref-type="bibr">109</xref>]. Bevacizumab exerts its effect by binding to VEGF and preventing the interaction between VEGF and its receptors, named Flt-1 and KDR, found on the surface of endothelial cells. On the other hand, ramucirumab shows high affinity against VEGFR2 and prevents the ligand-induced proliferation of endothelial cells by limiting the interaction between ligands (VEGF-A, VEGF-C, VEGF-D) and VEGF receptor [<xref rid="B108-biomolecules-09-00679" ref-type="bibr">108</xref>].</p><p>In 2018, the Nobel Assembly at Karolinska Institutet decided to award Tasuku Honjo jointly to James P. Allison in the category of Physiology or Medicine for their discovery of cancer therapy by inhibition of brake-like regulators found in the immune system [<xref rid="B110-biomolecules-09-00679" ref-type="bibr">110</xref>]. T cells are a group of white blood cells that play a significant role in the defense mechanism of a living organism by trigger the immune system [<xref rid="B111-biomolecules-09-00679" ref-type="bibr">111</xref>]. James P. Allison and other research teams have worked to elucidate the biological role of cytotoxic T lymphocyte-associated protein 4 (CTLA-4) in the treatment of several cancers and autoimmune diseases models [<xref rid="B112-biomolecules-09-00679" ref-type="bibr">112</xref>,<xref rid="B113-biomolecules-09-00679" ref-type="bibr">113</xref>,<xref rid="B114-biomolecules-09-00679" ref-type="bibr">114</xref>]. After the activation of T cells, the expression of CTLA-4 is stimulated, which downregulates immune responses by binding to the cluster of differentiation 28 receptors. James P. Allison proposed that the CTLA-4 blockade could encourage T cells to fight cancer cells [<xref rid="B113-biomolecules-09-00679" ref-type="bibr">113</xref>,<xref rid="B114-biomolecules-09-00679" ref-type="bibr">114</xref>]. The animal and clinical studies gave promising results for the treatment of advanced melanoma, a type of skin cancer [<xref rid="B115-biomolecules-09-00679" ref-type="bibr">115</xref>]. In line with these developments, the designed drug ipilimumab (Yervoy; humanized IgG1 monoclonal antibody) has been approved by FDA to be utilized for the 12 years and older patients with metastatic melanoma [<xref rid="B116-biomolecules-09-00679" ref-type="bibr">116</xref>]. Its action mechanism is based on inhibition of the activity of CTLA-4, thereby sustaining the activation of T cells to fight against tumor cells.</p><p>Additionally, Tasuku Honjo discovered the protein known as programmed cell death protein 1 (PD-1) that is localized in the T cell surfaces. PD-1 proteins behave like a brake in immune response results in inhibition of T cell activation [<xref rid="B117-biomolecules-09-00679" ref-type="bibr">117</xref>]. Interestingly, Honjo and his research group demonstrated that blockage of PD-1 could be an effective strategy for cancer treatment in the animal models. These promising results led to high attention on PD-1 as a biological target in pharmacological research [<xref rid="B117-biomolecules-09-00679" ref-type="bibr">117</xref>].</p><p>The drug pembrolizumab (Keytruda; humanized IgG4-kappa monoclonal antibody) has been approved by FDA in 2014 for the treatment of patients with lung cancer, advanced renal cell carcinoma, breast cancer, metastatic cervical cancer, primary mediastinal B-cell lymphoma, as well as hepatocellular carcinoma [<xref rid="B118-biomolecules-09-00679" ref-type="bibr">118</xref>]. It binds to PD-1 with high affinity, thus the interaction between its ligands (PD-L1 and PD-L2) and the receptor is prevented to maintain T cell proliferation and cytokine production. Moreover, another drug called nivolumab (Opdivo; human IgG4 monoclonal antibody) shows a higher affinity to immune checkpoint PD-1 to induce the natural tumor-specific T cell immune response of patients with metastatic colorectal cancer [<xref rid="B119-biomolecules-09-00679" ref-type="bibr">119</xref>]. On the other hand, a number of approved drugs have been designed to block directly the PD-L ligands for the sustained T cell activation. Recently, the drug durvalumab (Imfinzi; human IgG1 kappa monoclonal antibody) has been designed specifically for programmed death ligand 1 (PD-L1) to block the receptor&#x02013;ligand interaction. It exhibited a curative effect in patients with metastatic urothelial carcinoma and non-small cell lung cancer [<xref rid="B120-biomolecules-09-00679" ref-type="bibr">120</xref>]. With the same action mechanism, atezolizumab (Tecentriq; Fc-engineered, humanized, monoclonal antibody) has been introduced for the treatment of locally advanced or metastatic urothelial carcinoma [<xref rid="B121-biomolecules-09-00679" ref-type="bibr">121</xref>].</p></sec><sec id="sec2dot3-biomolecules-09-00679"><title>2.3. FDA-Approved Antibody&#x02013;Drug Conjugates in the Last 10 Years</title><p>One of the latest improvements in chemotherapeutic strategies is combining a FDA-approved cytotoxic small molecule with an antibody directed to a specific protein found on the tumor cells. This strategy acts like a double-edged sword, allowing the specific targeting of the tumor cells while simultaneously delivering two potent cytotoxic agents [<xref rid="B122-biomolecules-09-00679" ref-type="bibr">122</xref>,<xref rid="B123-biomolecules-09-00679" ref-type="bibr">123</xref>]. Moreover, it provides preferable efficacy and reduced risk of systemic toxicity compared to the existing chemotherapy strategies [<xref rid="B123-biomolecules-09-00679" ref-type="bibr">123</xref>]. Ado-trastuzumab emtansine (Kadcyla) is a kind of approved drug&#x02013;antibody conjugate that is utilized for the treatment of HER2-positive metastatic breast cancer [<xref rid="B124-biomolecules-09-00679" ref-type="bibr">124</xref>]. In this example, although the antibody compartment of the drug is HER2-specific humanized IgG1 (trastuzumab), which inhibits HER2 receptor signaling and leads to antibody-dependent cytotoxicity, the conjugated drug a maytansine derivative (DM-1) interferes with microtubules function, which results in cell cycle arrest and apoptosis [<xref rid="B125-biomolecules-09-00679" ref-type="bibr">125</xref>]. Another drug, brentuximab vedotin (Adcetris), was approved by the FDA in 2011 for the treatment of patients with Hodgkin&#x02019;s lymphoma and systemic anaplastic large cell lymphoma. However, one year later, it was revised with boxed warning due to post-treatment-based side effects and deaths. In March 2018, the FDA approved brentuximab vedotin to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma. The drug combines an anti-CD30 human-murine IgG1 with the drug monomethyl auristatin E (MMAE). Antibody provides the detection of cancer cells expressing CD30 whereas conjugated drug MMAE targets microtubules and distrupts their structure.</p><p>The strategy of protein-drug conjugate also provides design of therapeutic agents with improved half-life, qualified pharmocokinetics as well as stability. The drug calaspargase pegol-mknl (Asparlas) has been approved for the treatment of acute lymphoblastic leukemia in pediatrics and young adults by the FDA in 2018 [<xref rid="B126-biomolecules-09-00679" ref-type="bibr">126</xref>,<xref rid="B127-biomolecules-09-00679" ref-type="bibr">127</xref>]. The drug contains <italic>Escherichia coli</italic>-derived enzyme L-asparaginase II and monomethoxy polyethylene glycol (pegol) linked by succinimidyl carbonate in its structure. The enzyme L-asparaginase converts the L-asparagine to L-aspartic acid, resulting in a sharp drop in the present asparagine concentration. This decrease blocks protein synthesis and tumor cell proliferation in the cancer tissue. Moreover, the conjugated pegol group decreases enzyme antigenicity and increases the half-life of the drug [<xref rid="B127-biomolecules-09-00679" ref-type="bibr">127</xref>].</p></sec></sec><sec id="sec3-biomolecules-09-00679"><title>3. Plants and Related Bioactive Compounds as New Drug Sources for Different Cancers</title><sec id="sec3dot1-biomolecules-09-00679"><title>3.1. Oral, Gastrointestinal, and Pancreatic Cancers</title><p>Since ancient times, in East Asia, traditional medicinal plants have been used to treat many diseases, including cancer [<xref rid="B128-biomolecules-09-00679" ref-type="bibr">128</xref>,<xref rid="B129-biomolecules-09-00679" ref-type="bibr">129</xref>,<xref rid="B130-biomolecules-09-00679" ref-type="bibr">130</xref>]. In fact, in recent decades, despite the evolution of conventional treatments for oral cancer, morbidity and mortality rates have been steadily increasing. Indeed, the 5-year mortality rate is ~50% [<xref rid="B131-biomolecules-09-00679" ref-type="bibr">131</xref>,<xref rid="B132-biomolecules-09-00679" ref-type="bibr">132</xref>]. Recently, studies reported the anticancer effects of bioactive compounds from medicinal sources on oral cancer cell lines (<xref rid="biomolecules-09-00679-t003" ref-type="table">Table 3</xref>). Nam, et al. [<xref rid="B133-biomolecules-09-00679" ref-type="bibr">133</xref>] tested the anticancer activity of artemisinin and its various derivatives against oral cancer cell line (YD-10B) and they found as results an induction of apoptosis by the activation of caspase-3, which is the general mediator of apoptosis [<xref rid="B134-biomolecules-09-00679" ref-type="bibr">134</xref>,<xref rid="B135-biomolecules-09-00679" ref-type="bibr">135</xref>]. Several studies have evaluated the antitumor activity of eugenol in vitro against different oral cancer cells, and the results obtained showed that this compound had a good cytotoxic activity [<xref rid="B136-biomolecules-09-00679" ref-type="bibr">136</xref>,<xref rid="B137-biomolecules-09-00679" ref-type="bibr">137</xref>,<xref rid="B138-biomolecules-09-00679" ref-type="bibr">138</xref>]. On the other hand, it has been shown that polyphenols also have anticancer properties [<xref rid="B139-biomolecules-09-00679" ref-type="bibr">139</xref>]. Effectively, safrole, a polyphenolic compound of <italic>Piper betle</italic> L., has been tested in vitro on human buccal mucosal fibroblasts (BMFs) to prove its cytotoxic effect [<xref rid="B140-biomolecules-09-00679" ref-type="bibr">140</xref>]. Additionally, phytochemicals reduce the risk of cancer [<xref rid="B141-biomolecules-09-00679" ref-type="bibr">141</xref>]. Indeed, berberine, the main constituent of <italic>Coptis chinensis</italic> Franch., has been used in the treatment of gastrointestinal disorders including oral cancer cells (KB, OC2) [<xref rid="B142-biomolecules-09-00679" ref-type="bibr">142</xref>]. In addition, it proved effective against HSS3 oral cancer cells by inducing apoptosis [<xref rid="B143-biomolecules-09-00679" ref-type="bibr">143</xref>]. Thus, it has been reported that carvacrol possesses antitumor properties [<xref rid="B144-biomolecules-09-00679" ref-type="bibr">144</xref>]. Sertel et al. studied the antitumor activity of three medicinal plants on UMSCC1 cells and found a significant cytotoxic effect [<xref rid="B145-biomolecules-09-00679" ref-type="bibr">145</xref>,<xref rid="B146-biomolecules-09-00679" ref-type="bibr">146</xref>,<xref rid="B147-biomolecules-09-00679" ref-type="bibr">147</xref>]. While Manosroi et al. [<xref rid="B148-biomolecules-09-00679" ref-type="bibr">148</xref>] found the same effect regarding essential oils (EOs) from 17 Thai medicinal plants against KB cells, followed by Cha et al. [<xref rid="B149-biomolecules-09-00679" ref-type="bibr">149</xref>,<xref rid="B150-biomolecules-09-00679" ref-type="bibr">150</xref>] and Keawsa-ard et al. [<xref rid="B151-biomolecules-09-00679" ref-type="bibr">151</xref>], who evaluated the anticancer effect of <italic>Artemisia gmelinii</italic> Weber ex Stechm. (synonym of <italic>Artemisia iwayomogi</italic> Kitam.) and <italic>Solanum spirale</italic> Roxb., respectively, on human mouth epidermal carcinoma (KB). EOs of aromatic and medicinal plants have many biological activities [<xref rid="B152-biomolecules-09-00679" ref-type="bibr">152</xref>,<xref rid="B153-biomolecules-09-00679" ref-type="bibr">153</xref>]. Moreover, EOs derived from the herbal plant <italic>Pinus densiflora</italic> Siebold &#x00026; Zucc. can induce apoptotic cell death via reactive oxygen species (ROS) generation and activation of caspases in YD-8 human oral cancer cells. Note that the accumulation of ROS, under the conditions of oxidative stress, causes tissue toxicity by modifying cellular macromolecules such as proteins, lipids and DNA, which irreversibly alter cell viability and function [<xref rid="B154-biomolecules-09-00679" ref-type="bibr">154</xref>,<xref rid="B155-biomolecules-09-00679" ref-type="bibr">155</xref>]. In another study using the KB cell line, <italic>Artemisia capillaris</italic> Thunb. EOs had an anticancer effect related to the induction of apoptosis and activation of the MAPK signaling pathway [<xref rid="B149-biomolecules-09-00679" ref-type="bibr">149</xref>,<xref rid="B150-biomolecules-09-00679" ref-type="bibr">150</xref>]. The isolated limonoides of <italic>Azadirachta indica</italic> A.Juss. have been studied by Harish Kumar et al. [<xref rid="B156-biomolecules-09-00679" ref-type="bibr">156</xref>], who showed apoptosis on the hamster buccal pouch (HBP) carcinogenesis model. Finally, other compounds used in the treatment of oral cancer such as chalcone extracted from the medicinal plant <italic>Alpinia pricei</italic> Hayata [<xref rid="B157-biomolecules-09-00679" ref-type="bibr">157</xref>] and deoxyelephantopine (ESD) isolated from <italic>Elephantopus scaber</italic> L. [<xref rid="B158-biomolecules-09-00679" ref-type="bibr">158</xref>] have shown the ability to induce cell cycle arrest and apoptosis in human oral carcinoma HSC-3 cells and human nasopharyngeal carcinoma (CNE) cells, respectively.</p><p>On the other hand, several bioactive compounds found in medicinal and aromatic plants have shown antitumor properties against gastrointestinal cancer [<xref rid="B159-biomolecules-09-00679" ref-type="bibr">159</xref>,<xref rid="B160-biomolecules-09-00679" ref-type="bibr">160</xref>,<xref rid="B161-biomolecules-09-00679" ref-type="bibr">161</xref>,<xref rid="B162-biomolecules-09-00679" ref-type="bibr">162</xref>,<xref rid="B163-biomolecules-09-00679" ref-type="bibr">163</xref>,<xref rid="B164-biomolecules-09-00679" ref-type="bibr">164</xref>,<xref rid="B165-biomolecules-09-00679" ref-type="bibr">165</xref>,<xref rid="B166-biomolecules-09-00679" ref-type="bibr">166</xref>]. The results of these works are summarized in <xref rid="biomolecules-09-00679-t004" ref-type="table">Table 4</xref>. Liang et al, [<xref rid="B159-biomolecules-09-00679" ref-type="bibr">159</xref>] tested Ganoderma against HCT116 cell line and showed that this compound induced apoptosis in HCT116 and increased caspase-8, caspase-3, and Fas. Genistein exerted an important antiproliferative effect, proapoptotic effect in vitro HT-29 cell line by increasing the expression of Bax or p21 proteins, and inhibiting NF-kB and topoisomerase II expression [<xref rid="B162-biomolecules-09-00679" ref-type="bibr">162</xref>,<xref rid="B163-biomolecules-09-00679" ref-type="bibr">163</xref>]. The combination of this compound with cisplatin inhibited cell growth and induced apoptosis. On the other hand, the in vivo assay showed that some triterpenes are reported as antitumor drugs against HT-29 cell line via the suppression of proliferation and inhibition of tumor growth in the colon carcinoma xenograft model [<xref rid="B160-biomolecules-09-00679" ref-type="bibr">160</xref>]. Ginkgo biloba has also exhibited an in vitro anticancer effect on HT-29 cell line by the inhibition of tumor progression, the increasing caspase-3 activity, the elevating p53 expression, and decreasing of bcl-2 expression. In another in vivo study, Romano et al [<xref rid="B161-biomolecules-09-00679" ref-type="bibr">161</xref>] reported that cannabidiol exhibited an important anticancer activity on HCT116 mice xenograft through the reduction of the pre-neoplastic lesions and azoxymethane-induced polyps. Flavonoids compounds such as Apigenin, Isoliquiritigenin and Quercetin revealed important anticancer effects [<xref rid="B166-biomolecules-09-00679" ref-type="bibr">166</xref>,<xref rid="B167-biomolecules-09-00679" ref-type="bibr">167</xref>]. Their anticancer mechanisms are essentially related the inducing of apoptosis and/or arrest of cell cycle.</p><p>Pancreatic cancer (PC) is one of the most fatal of all cancers [<xref rid="B168-biomolecules-09-00679" ref-type="bibr">168</xref>]. It has been estimated that 458,918 new cases of PC diagnosed in 2018 [<xref rid="B169-biomolecules-09-00679" ref-type="bibr">169</xref>]. Like other types of cancer, several medicinal plants and plant-based products show effects against PC; indeed, several studies (<xref rid="biomolecules-09-00679-t005" ref-type="table">Table 5</xref>) have described antitumoral effects of medicinal plants [<xref rid="B170-biomolecules-09-00679" ref-type="bibr">170</xref>]. Berkovich, et al. [<xref rid="B171-biomolecules-09-00679" ref-type="bibr">171</xref>] revealed that the effect of <italic>Moringa oleifera</italic> Lam. leaf extracts on the survival of cultured human pancreatic cancer cells (Panc-1 cells) using flow cytometry analysis. They showed an inhibition of the growth of all pancreatic tested cell lines and inducing an elevation in the sub-G1 cell population of the cell cycle [<xref rid="B171-biomolecules-09-00679" ref-type="bibr">171</xref>]. Moreover, Win et al. [<xref rid="B172-biomolecules-09-00679" ref-type="bibr">172</xref>] reported that the chloroform extract of rhizomes of <italic>Boesenbergia rotunda</italic> (L.) Mansf exhibited important cytotoxic effects against PC cell lines. In addition, studies have identified some molecules with properties against PC [<xref rid="B173-biomolecules-09-00679" ref-type="bibr">173</xref>,<xref rid="B174-biomolecules-09-00679" ref-type="bibr">174</xref>,<xref rid="B175-biomolecules-09-00679" ref-type="bibr">175</xref>]. Indeed, plumbagin, a quinoid isolated from the roots of <italic>Plumbago zeylanica</italic> L., showed important anticancer effect by inducing an apoptosis action and decreasing therefore cell viability of PC cells (Panc-1, BxPC3, and ASPC1). Moreover, in vivo approach has revealed that this compound inhibited the both tumor weight and volume [<xref rid="B173-biomolecules-09-00679" ref-type="bibr">173</xref>]. The use of mimosine, a plant amino acid, subcutaneously growing human PC xenografts in immunosuppressed mice, resulted in significant tumor growth suppression and the sub-G1 fraction, and exerts an apoptotic activity assessed by flow cytometry [<xref rid="B174-biomolecules-09-00679" ref-type="bibr">174</xref>]. Another study, shown that epigallocatechin-3-gallate (EGCG), a polyphenolic compound from green tea, inhibits PC growth and induces apoptosis in human PC cells [<xref rid="B175-biomolecules-09-00679" ref-type="bibr">175</xref>]. A number of studies have shown that the medicinal plant present cytotoxicity towards a number of PC cell lines. The chittagonga extract showed a significant cytotoxic effect on HTB126, Panc-1, Mia-Paca2, and Capan-1 cancer cell lines [<xref rid="B176-biomolecules-09-00679" ref-type="bibr">176</xref>]. Moreover, the dichloromethane-soluble extract of <italic>Angelica pubescens</italic> Maxim. has significant effect against Panc-1 cancer cells [<xref rid="B177-biomolecules-09-00679" ref-type="bibr">177</xref>]. The glycoside (a flavonoid isolated from <italic>Acacia pennata</italic> (L.) Willd.) exhibited a selective cytotoxicity on human pancreatic (Panc-1) [<xref rid="B178-biomolecules-09-00679" ref-type="bibr">178</xref>]. Other volatile compounds such as Betulin and betulinic acid, which are naturally occurring pentacyclic triterpenes, revealed important anticancer effects [<xref rid="B179-biomolecules-09-00679" ref-type="bibr">179</xref>]. Several studies have investigated activity apoptosis in human PC cells induced by medicinal plant and the products of these plants. Inositol hexaphosphate (IP6) decreased cellular growth and increased apoptosis [<xref rid="B180-biomolecules-09-00679" ref-type="bibr">180</xref>]. Sorafenib induced an arrest of PC stem cells (CSC) [<xref rid="B181-biomolecules-09-00679" ref-type="bibr">181</xref>]. On the other hand, triptolide extracted from <italic>Tripterygium wilfordii</italic> Hook. f. significantly increased the apoptotic rates of human PC cells (SW199) [<xref rid="B182-biomolecules-09-00679" ref-type="bibr">182</xref>].</p></sec><sec id="sec3dot2-biomolecules-09-00679"><title>3.2. Skin Cancer</title><p>Skin cancer is a common disease that accounts for ~4.5% of human cancers, with an average rate of one million new cases each year. This prevalence is increasingly accelerated compared to other cancers. In, the different types of skin cancer cause today a significant morbidity rate, which shows the urgency to identify effective treatments; especially with side effects that are sometimes fatal, conventional treatments used. Today, the search for molecules that may have specific anticancer effects against skin cancer is a promising strategy. Indeed, a number of studies have shown that natural molecules containing in medicinal and aromatic plants have enormous capacity to inhibit tumor growth of skin cancer [<xref rid="B183-biomolecules-09-00679" ref-type="bibr">183</xref>,<xref rid="B184-biomolecules-09-00679" ref-type="bibr">184</xref>,<xref rid="B185-biomolecules-09-00679" ref-type="bibr">185</xref>,<xref rid="B186-biomolecules-09-00679" ref-type="bibr">186</xref>,<xref rid="B187-biomolecules-09-00679" ref-type="bibr">187</xref>,<xref rid="B188-biomolecules-09-00679" ref-type="bibr">188</xref>,<xref rid="B189-biomolecules-09-00679" ref-type="bibr">189</xref>,<xref rid="B190-biomolecules-09-00679" ref-type="bibr">190</xref>]. The cellular mechanisms involved in this anticancer action are numerous, including cell cycle arrest, the induction of apoptosis, and the inhibition of angiogenesis. The following table shows the anticancer properties of natural substances from medicinal and aromatic plants against skin cancer (<xref rid="biomolecules-09-00679-t006" ref-type="table">Table 6</xref>). Studies have reported that medicinal plant extracts rich in phenolic compounds showed important anticancer activities against several skin cancer cell lines [<xref rid="B187-biomolecules-09-00679" ref-type="bibr">187</xref>,<xref rid="B191-biomolecules-09-00679" ref-type="bibr">191</xref>]. The polyphenols of <italic>Euphorbia lagascae</italic> Spreng. also showed an important cytotoxicity on melanoma SK-MEL-28 by an arrest of cell cycle at G<sub>2</sub>/M through downregulating cyclins A, E, and B1 expression [<xref rid="B187-biomolecules-09-00679" ref-type="bibr">187</xref>]. Moreover, Tourino et al. [<xref rid="B191-biomolecules-09-00679" ref-type="bibr">191</xref>] reported that the procyanidins of <italic>Pinus pinaster</italic> Aiton induced a cytotoxic effect on the same line (Melanoma SK-MEL-28). Tran et al. [<xref rid="B192-biomolecules-09-00679" ref-type="bibr">192</xref>] demonstrated an antiproliferative activity of <italic>Dracaena angustifolia</italic> (Medik.) Roxb. saponins extracts. On the other hand, numerous isolated compounds from medicinal plants were reported to have antitumor effects on several skin cancer cell lines (<xref rid="biomolecules-09-00679-t006" ref-type="table">Table 6</xref>). Certain flavonoids, such as flavone glycoside, exhibited important anticancer effects [<xref rid="B183-biomolecules-09-00679" ref-type="bibr">183</xref>,<xref rid="B185-biomolecules-09-00679" ref-type="bibr">185</xref>,<xref rid="B190-biomolecules-09-00679" ref-type="bibr">190</xref>,<xref rid="B193-biomolecules-09-00679" ref-type="bibr">193</xref>,<xref rid="B194-biomolecules-09-00679" ref-type="bibr">194</xref>,<xref rid="B195-biomolecules-09-00679" ref-type="bibr">195</xref>]. Indeed, Balasubramanian, Narayanan, and Kedalgovindaram and Devarakonda Rama [<xref rid="B190-biomolecules-09-00679" ref-type="bibr">190</xref>] showed that flavone glycoside isolated from <italic>Indigofera aspalathoides</italic> DC. exhibited important cytotoxic effects on several melanoma cell lines (LOX IMVI, MALME-3M, SKMEL-2, SK-MEL-28, SK-MEL-5, UACC-257, and UACC-62). Anastyuk et al. [<xref rid="B183-biomolecules-09-00679" ref-type="bibr">183</xref>] reported that the fucoidans identified in <italic>Fucus evanescens</italic> C. Agardh inhibited colony formation and cell proliferation of SK-MEL-28 and SK-MEL-5 cell lines. Another flavonoid (Galangin) isolated from <italic>Alpinia officinarum</italic> Hance showed cytotoxic effects on B16F10 cell line (murine melanoma cell) via the reducing of the mitochondrial membrane potential. In a remarkable study, Das et al. [<xref rid="B195-biomolecules-09-00679" ref-type="bibr">195</xref>] reported that Apigenin isolated from <italic>Lycopodium clavatum</italic> L. showed an important in vitro cytotoxic effects on human keratinocyte cell line HaCaT. The anticancer activity of Apigenin involved the inhibition of the formation of ROS, and the interference with NF-kB and p38MAPK signaling pathways [<xref rid="B195-biomolecules-09-00679" ref-type="bibr">195</xref>]. The volatile compounds such as terpenes and terpenoids isolated from EOs have also reported as anticancer agents against skin cancer [<xref rid="B189-biomolecules-09-00679" ref-type="bibr">189</xref>,<xref rid="B196-biomolecules-09-00679" ref-type="bibr">196</xref>,<xref rid="B197-biomolecules-09-00679" ref-type="bibr">197</xref>,<xref rid="B198-biomolecules-09-00679" ref-type="bibr">198</xref>]. Linalool (phenolic volatile compound) extracted from the EO of <italic>Satureja thymbra</italic> L. showed cytotoxicity against amelanotic melanoma C32 cell line by inhibiting tumor cells growth [<xref rid="B196-biomolecules-09-00679" ref-type="bibr">196</xref>]. Fouche et al. [<xref rid="B197-biomolecules-09-00679" ref-type="bibr">197</xref>] reported that the Sesquiterpene lactones isolated from <italic>Schkuhria pinnata</italic> (Lam.) Kuntze ex Thell. exhibited remarkable in vitro cytotoxicity on Melanoma UACC-62 cell line. In another study, Darmanin et al. [<xref rid="B198-biomolecules-09-00679" ref-type="bibr">198</xref>] showed that some terpenoids extracted from <italic>Ricinus communis</italic> L. EO, such as 1,8-cineole, camphor and pinene, and caryophyllene, showed important in vitro antiproliferative effects on SK-MEL-28 cells via the inducing of an apoptotic action. Natural alkaloids showed also anticancer properties against skin cancer. This is isoquinoline isolated from <italic>Berberis aristata</italic> DC., which inhibited the growth of human epidermoids carcinoma cell (A-431). 4-Nerolidylcatechol is another natural drug isolated from <italic>Piper umbellatum</italic> L. (synonym of <italic>Pothomorphe umbellate</italic> (L.) Miq.) and has shown important antitumor activity on SK-MEL2, SK-MEL-103, and SK-MEL-147 cell lines. This activity is mediated by the G-1 phase arrest, the inhibition the effect of matrix metalloproteinase MMP-2 and MMP-9 activity, and the loss membrane integrity [<xref rid="B184-biomolecules-09-00679" ref-type="bibr">184</xref>]. Some authors, such as Aggarwal et al. [<xref rid="B199-biomolecules-09-00679" ref-type="bibr">199</xref>] and Niles et al. [<xref rid="B200-biomolecules-09-00679" ref-type="bibr">200</xref>], reported the anticancer activity of Resveratrol (natural compound isolated from <italic>Vitis vinifera</italic> L.) on melanoma (A-375, A-431, and SK-MEL-28). Resveratrol exhibited several anticancer mechanisms, such as the enhanced of the phosphorylation of ERK1/2; the inducing of cell cycle arrest at G1-phase; the inducing of the downregulating of the protein expression of cyclin D1, D2, and E; and also cdk2, cdk4, and cdk6 [<xref rid="B199-biomolecules-09-00679" ref-type="bibr">199</xref>,<xref rid="B200-biomolecules-09-00679" ref-type="bibr">200</xref>].</p></sec><sec id="sec3dot3-biomolecules-09-00679"><title>3.3. Brain Cancer</title><p>Brain cancer develops in the brain or spinal cord and is categorized into four grades [<xref rid="B169-biomolecules-09-00679" ref-type="bibr">169</xref>], with 296,851 new cases diagnosed in 2018 [<xref rid="B201-biomolecules-09-00679" ref-type="bibr">201</xref>]. The fatality rate due to brain cancer is the highest [<xref rid="B202-biomolecules-09-00679" ref-type="bibr">202</xref>]. Due to their chemical composition, recently, a number of studies have shown that medicinal plant products have anticancer properties against different types of brain cancers. Indeed, numerous compounds from medicinal species, such as <italic>Angelica sinensis</italic> (Oliv.) Diels, <italic>Annona glabra</italic> L., <italic>Bupleurum scorzonerifolium</italic> Wild., and <italic>Bursera microphylla</italic> A. Gray, have shown promising therapeutic effects on brain cancers. <xref rid="biomolecules-09-00679-t007" ref-type="table">Table 7</xref> summarizes the antitumor effects of these medicinal plants on brain cancer [<xref rid="B203-biomolecules-09-00679" ref-type="bibr">203</xref>] have investigated the anticancer property the EO of <italic>Croton regelianus</italic> M&#x000fc;ll. Arg. using in vitro and in vivo approaches. The in vitro assay showed that this oil displayed an important cytotoxicity in HL-60 and SF-295 cell lines Moreover, the in vivo study, using sarcoma 180 as a tumor model, demonstrated inhibitions rate of 28.1% and 31.8% for HL-60 and SF-295, respectively [<xref rid="B203-biomolecules-09-00679" ref-type="bibr">203</xref>,<xref rid="B204-biomolecules-09-00679" ref-type="bibr">204</xref>], which demonstrated that both extracts (Leaf oil and berry oil) of <italic>Juniperus phoenicea</italic> L. exhibited important activities against brain cancer human cell lines [<xref rid="B204-biomolecules-09-00679" ref-type="bibr">204</xref>]. However, the ethanolic extract of <italic>Scutellaria baicalensis</italic> Georgi inhibited the cellular growth in recurrent and drug resistant brain tumor cell lines [<xref rid="B205-biomolecules-09-00679" ref-type="bibr">205</xref>]. In another work, the treatment of GBM cells by chloroform extract of <italic>A. sinensis</italic> showed an anticancer effect by displaying the potency in suppressing growth of malignant brain tumor cells by cell cycle arrest and apoptosis. Moreover, the in vitro assay showed that <italic>A. sinensis</italic> triggered both p53-dependent and p53-independent pathways for apoptosis and shrink the volumes of in situ GBM [<xref rid="B206-biomolecules-09-00679" ref-type="bibr">206</xref>].</p><p>In addition, studies have identified some molecules with anticancer properties on brain cancer cell lines. Indeed, carvone (volatile compound extracted from several aromatic plants) exhibited remarkable anticancer effects on brain cancer. Its effects are essentially related to increasing in antioxidant level in cancer cells and a potential treatment of brain tumor in primary rat neuron and neuroblastoma (N2a) cells [<xref rid="B207-biomolecules-09-00679" ref-type="bibr">207</xref>]. &#x003b2;-elemene, another volatile compound, extracted from <italic>Curcuma aromatica</italic> Salisb. (synonym of <italic>Curcuma wenyujin</italic>) has shown important anticancer effects on brain cancer. Using an MTT assay and semiquantitative Western blot, the authors demonstrated that this compound inhibited brain carcinomas via the inhibition of U87 cell viability through the activation of the GMF&#x003b2; signaling pathway. It regulated also the cellular growth, fission, differentiation, and apoptosis [<xref rid="B208-biomolecules-09-00679" ref-type="bibr">208</xref>]. Some flavonoids (fisetin, quercetin, and luteolin) extracted from medicinal plants have reported to be the anticancer agents. Indeed, they inhibited the cancer cell lines growth through the inhibition of protein kinase C (PKC) in brain cancer. This inhibition is mainly effects dose dependent manner and also depending on flavonoid structure [<xref rid="B209-biomolecules-09-00679" ref-type="bibr">209</xref>]. Antioxidant flavonoid compounds, such as delphinidin, pelargonidin, and malvin, are cytotoxic natural agents [<xref rid="B210-biomolecules-09-00679" ref-type="bibr">210</xref>]. Another type of flavonoid (isoflavones), and also an isomer of flavone, was reported as antitumor drugs. Indeed, they decreased the phosphorylation of Akt and eIF4E proteins and rendered U87 cells more sensitive to rapamycin treatment [<xref rid="B211-biomolecules-09-00679" ref-type="bibr">211</xref>].</p><p>However, n-butylidenephthalide (BP), which is isolated from the chloroform triggered both p53-dependent and -independent pathways for apoptosis in vitro on glioblastoma multiforme (GBM) cells and suppressed growth of subcutaneous rat and human brain tumors and also, reduced the volume of GBM tumors in vivo [<xref rid="B212-biomolecules-09-00679" ref-type="bibr">212</xref>]. In another study, the authors reported that the effects of BRM270 on glioblastoma stem cells (GSCs) in vitro and GBM recurrence in vivo induced apoptotic cell death and inhibited cell growth [<xref rid="B213-biomolecules-09-00679" ref-type="bibr">213</xref>]. <italic>N</italic>-(4-Hydroxyphenyl) retinamide (4-HPR) has shown activity on two human glioblastoma, T98G and U87MG, cell lines, such as induction of both differentiation and apoptosis in human glioblastoma cells [<xref rid="B214-biomolecules-09-00679" ref-type="bibr">214</xref>]. Moreover, the use of epigallocatechin gallate (EGCG) (bioactive polyphenol in green tea) on GSLCs, which is enriched in human glioblastoma cell line U87, using neurosphere culture has revealed a remarkable inhibited cell viability, neurosphere formation, and also induced apoptosis [<xref rid="B215-biomolecules-09-00679" ref-type="bibr">215</xref>]. The administration of delta-9-tetrahydrocannabinol (&#x00394;9-THC) to GBM cell lines results in a significant decrease in cell viability via a mechanism that appears to elicit G1 arrest due to downregulation of E2F1, cyclin A. &#x00394;9-THC, and cannabidiol acted synergistically to inhibit cell proliferation on the U251 and SF126 glioblastoma cell lines as an essential mediator of cannabinoid antitumoral action [<xref rid="B216-biomolecules-09-00679" ref-type="bibr">216</xref>,<xref rid="B217-biomolecules-09-00679" ref-type="bibr">217</xref>].</p></sec><sec id="sec3dot4-biomolecules-09-00679"><title>3.4. Breast Cancer</title><p>Cancer is the second leading cause of mortality in developing countries [<xref rid="B49-biomolecules-09-00679" ref-type="bibr">49</xref>], where cancer risk is increasing due to population aging, smoking, and physical inactivity. Several studies have reported the anticancer activity of medicinal plants and their bioactive compounds (<xref rid="biomolecules-09-00679-t008" ref-type="table">Table 8</xref>). Liao et al. [<xref rid="B218-biomolecules-09-00679" ref-type="bibr">218</xref>] had reported that the evodiamine&#x02014;a main constituent of fructus Evodiae&#x02014;inhibited the proliferation of NCI/ADR-RES cells and caused significant apoptosis with arrest of G2/M cell cycle progression. A study on human breast cancer MDA-231 cells reported that treatment of Sanguinarine isolated from the root of <italic>Sanguinaria canadensis</italic> L. induces remarkable apoptosis [<xref rid="B219-biomolecules-09-00679" ref-type="bibr">219</xref>]. Indeed, this apoptosis may be due to effects on signaling pathways or changes in intracellular proteins [<xref rid="B220-biomolecules-09-00679" ref-type="bibr">220</xref>]. Li et al. [<xref rid="B221-biomolecules-09-00679" ref-type="bibr">221</xref>] studied the action of matrine&#x02014;a major component derived from <italic>Sophora flavescens</italic> Aiton&#x02014;on primary and metastatic breast cancer (MCF-7 and 4T1 cells) and they found that it induces cell death in breast cancer cells. Piperine, an alkaloid isolated from <italic>Piper nigrum</italic> L., has been shown to inhibit the growth of 4T1 cells and induce their apoptosis [<xref rid="B222-biomolecules-09-00679" ref-type="bibr">222</xref>].</p><p>The exploration of the EOs of different plants revealed that they had anticancer potency against breast cancer [<xref rid="B223-biomolecules-09-00679" ref-type="bibr">223</xref>]. Indeed, <italic>Boswellia sacra</italic> Flueck. EO was effective against T47D, MCF-7, and MDA-MB-231 cells with high cell mortality [<xref rid="B224-biomolecules-09-00679" ref-type="bibr">224</xref>]. Previous studies investigated EOs of several plants, such as <italic>Pulicaria jaubertii</italic> E.Gamal-Eldin [<xref rid="B225-biomolecules-09-00679" ref-type="bibr">225</xref>], <italic>Annona muricata</italic> L. [<xref rid="B226-biomolecules-09-00679" ref-type="bibr">226</xref>], <italic>Cedrelopsis grevei</italic> Baill. &#x00026; Courchet [<xref rid="B227-biomolecules-09-00679" ref-type="bibr">227</xref>], <italic>Seseli transcaucasicum</italic> Pimenov &#x00026; Sdobnina (synonym of <italic>Libanotis transcaucasica</italic> Schischk.) [<xref rid="B228-biomolecules-09-00679" ref-type="bibr">228</xref>], <italic>Melissa officinalis</italic> L. [<xref rid="B229-biomolecules-09-00679" ref-type="bibr">229</xref>], and <italic>Sal</italic>via <italic>officinalis</italic> L. [<xref rid="B230-biomolecules-09-00679" ref-type="bibr">230</xref>], have shown a cytotoxic effect on MCF-7 cells. By testing the same cell line, Chen et al. [<xref rid="B231-biomolecules-09-00679" ref-type="bibr">231</xref>] found that they have a high sensitivity towards <italic>Commiphora pyracanthoides</italic> Engl. and <italic>Boswellia carterii</italic> Balf.f. EOs. Also in 2013, [<xref rid="B232-biomolecules-09-00679" ref-type="bibr">232</xref>] have observed an antiproliferative activity of EOs of two species of Thymus against MCF-7 cells [<xref rid="B232-biomolecules-09-00679" ref-type="bibr">232</xref>], and in the same year, <italic>Porcelia macrocarpa</italic> R.E.Fr. EO resulted in viability of SKBr cells [<xref rid="B233-biomolecules-09-00679" ref-type="bibr">233</xref>]. In addition, several authors have investigated the anticancer properties of EOs components, such as carvacrol, which induces apoptosis in MDA-MB-231 cells [<xref rid="B234-biomolecules-09-00679" ref-type="bibr">234</xref>], and citral inducing apoptosis and cell cycle arrest in MCF-7 cells [<xref rid="B235-biomolecules-09-00679" ref-type="bibr">235</xref>]. Similar inhibiting of different phases of cell cycle has also been noted in MCF-7 and MDA-MB-231 cells in response to other phytochemicals [<xref rid="B236-biomolecules-09-00679" ref-type="bibr">236</xref>,<xref rid="B237-biomolecules-09-00679" ref-type="bibr">237</xref>]. This cell arrest is a therapeutic strategy widely used in the prevention of growth and cell division in cancer cells [<xref rid="B238-biomolecules-09-00679" ref-type="bibr">238</xref>]. Moreover, EOs, and their various constituents, present effective anticancer substances by acting on the evolution and expression of the cell cycle [<xref rid="B220-biomolecules-09-00679" ref-type="bibr">220</xref>]. Other studies have focused on evaluating the anticancer activity in vitro of EOs of several medicinal plants against MCF-7 cells by showing their antiproliferative activity [<xref rid="B239-biomolecules-09-00679" ref-type="bibr">239</xref>,<xref rid="B240-biomolecules-09-00679" ref-type="bibr">240</xref>,<xref rid="B241-biomolecules-09-00679" ref-type="bibr">241</xref>].</p></sec></sec><sec sec-type="conclusions" id="sec4-biomolecules-09-00679"><title>4. Conclusions and Future Remarks</title><p>Cancer is one of the leading causes of mortality worldwide and it is imperative to develop novel approaches to treat such diseases. The keystone in cancer combat has been conventional chemotherapy but it is associated with normal cell toxicities. Due to a lack of specificity, conventional cancer treatments often cause severe side effects and toxicities. Generally, natural agents are considered safe while treating or prevention diseases; however, some compounds as flavonoids have shown great potential in the combat against cancer [<xref rid="B294-biomolecules-09-00679" ref-type="bibr">294</xref>]. Plant-derived compounds have a high impact as cancer therapeutic agents both alone or in combination with conventional drugs [<xref rid="B295-biomolecules-09-00679" ref-type="bibr">295</xref>]. Current challenge against cancer is to develop new drugs that include the site specific delivery with low systemic toxicity [<xref rid="B296-biomolecules-09-00679" ref-type="bibr">296</xref>]. A tumor represents a dynamic environment with changes in cell mass, extracellular matrix composition, angiogenic status, among other factors. Promising technologies offer new opportunities to develop new drugs for cancer treatment with lower toxicity associated, but there are still challenges in cancer treatment research: One example is that the formulation of targeted therapies requires the identification of satisfactory molecular targets that have key functions in the growth and survival of cancer cells, and the design and creation of drugs that effectively hit the mark. However, some of the potential targets that have been identified apparently lack places to which an anticancer drug can bind and, therefore, are not susceptible to pharmacological effects. Unfortunately, most of the anticancer FDA-approved drugs and other regulatory agencies have no effect on the overall survival of the cancer patient. Cancer cell lines and animal models are a valuable tool for cancer research but reports indicate that these preclinical models are highly incomplete and not match with results obtained from clinical studies [<xref rid="B297-biomolecules-09-00679" ref-type="bibr">297</xref>]. Finding a way to design drugs that effectively hit the mark is a major challenge. Another example of challenge in cancer treatment is the drug resistance. More research is needed to discover the mechanisms of drug resistance and identify ways to overcome it.</p><p>This article focused on natural organic compounds and synthetic derivatives, but there are also natural inorganic compounds with potent anticancer activities. One example is arsenic trioxide (As<sub>2</sub>O<sub>3</sub>) which has been labeled as a poison for years, yet recently have gained importance in the therapy of leukemia and solid cancers [<xref rid="B298-biomolecules-09-00679" ref-type="bibr">298</xref>]. A role change has also been occurred in organic compounds such as artemisinin, a sesquiterpene lactone isolated from the <italic>Artemisia annua</italic> L. (Sweet Wormwood). This compound and its derivatives represent an efficacious antimalarial drug group with an excellent safety profile and, recently, have shown anticancer drug potential [<xref rid="B299-biomolecules-09-00679" ref-type="bibr">299</xref>]. These compounds represent two of the many examples of the power hidden in natural sources and, after many years of research, may become new promising drugs for cancer treatment.</p><p>Owing to the explosive rate of new anticancer drug development, there is an urgent need for a synergistic improvement of preclinical studies, clinical trials, pharmacovigilance, and post-marketing surveillance. Several pharmacological agents derived from natural compounds have shown anticancer activity via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through direct activation of intrinsic apoptotic pathway or modulation of diverse nonapoptotic pathways to upregulate death receptors [<xref rid="B300-biomolecules-09-00679" ref-type="bibr">300</xref>]. Unfortunately, a lack of robust clinical studies evidence exists to support the in vitro and in vivo results of the widespread use of natural products for chemoprevention and therapy of cancer. Modern technologies and research approaches will uncover the detailed mechanisms of action of the natural products and synthetic derivatives. The development of therapeutic modalities, such as chronotherapy, using natural products and synthetic analogs should be further studied to explore the new cancer treatment avenue.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by CONICYT PIA/APOYO CCTE AFB170007.</p></ack><notes><title>Author Contributions</title><p>All authors contributed to the manuscript. Conceptualization, J.S.-R.; validation investigation, resources, data curation, writing&#x02014;all authors; review and editing, T.B.T., J.S.-R., A.B., M.M., N.M. and W.C.C., All the authors read and approved the final manuscript.</p></notes><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-biomolecules-09-00679"><label>1.</label><element-citation publication-type="gov"><person-group person-group-type="author"><collab>National Cancer Institute</collab></person-group><article-title>Cancer Statistics</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.cancer.gov/about-cancer/understanding/">https://www.cancer.gov/about-cancer/understanding/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2017-12-31">(accessed on 31 December 2017)</date-in-citation></element-citation></ref><ref id="B2-biomolecules-09-00679"><label>2.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>World Health Organization (WHO)</collab></person-group><article-title>Cancer: Fact Sheet</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/factsheets/fs297/en">http://www.who.int/mediacentre/factsheets/fs297/en</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2017-12-31">(accessed on 31 December 2017)</date-in-citation></element-citation></ref><ref id="B3-biomolecules-09-00679"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>W.C.</given-names></name></person-group><article-title>Molecular connections of aging and cancer</article-title><source>Aging Dis.</source><year>2017</year><volume>8</volume><fpage>685</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.14336/AD.2017.0822</pub-id><?supplied-pmid 28966810?><pub-id pub-id-type="pmid">28966810</pub-id></element-citation></ref><ref id="B4-biomolecules-09-00679"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouvard</surname><given-names>V.</given-names></name><name><surname>Baan</surname><given-names>R.</given-names></name><name><surname>Straif</surname><given-names>K.</given-names></name><name><surname>Grosse</surname><given-names>Y.</given-names></name><name><surname>Secretan</surname><given-names>B.</given-names></name><name><surname>El Ghissassi</surname><given-names>F.</given-names></name><name><surname>Benbrahim-Tallaa</surname><given-names>L.</given-names></name><name><surname>Guha</surname><given-names>N.</given-names></name><name><surname>Freeman</surname><given-names>C.</given-names></name><name><surname>Galichet</surname><given-names>L.</given-names></name><etal/></person-group><article-title>A review of human carcinogens&#x02014;Part B: biological agents</article-title><source>Lancet Oncol.</source><year>2009</year><volume>10</volume><fpage>321</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(09)70096-8</pub-id><pub-id pub-id-type="pmid">19350698</pub-id></element-citation></ref><ref id="B5-biomolecules-09-00679"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soares</surname><given-names>J.P.</given-names></name><name><surname>Cortinhas</surname><given-names>A.</given-names></name><name><surname>Bento</surname><given-names>T.</given-names></name><name><surname>Leitao</surname><given-names>J.C.</given-names></name><name><surname>Collins</surname><given-names>A.R.</given-names></name><name><surname>Gaivao</surname><given-names>I.</given-names></name><name><surname>Mota</surname><given-names>M.P.</given-names></name></person-group><article-title>Aging and DNA damage in humans: a meta-analysis study</article-title><source>Aging</source><year>2014</year><volume>6</volume><fpage>432</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.18632/aging.100667</pub-id><?supplied-pmid 25140379?><pub-id pub-id-type="pmid">25140379</pub-id></element-citation></ref><ref id="B6-biomolecules-09-00679"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lombard</surname><given-names>D.B.</given-names></name><name><surname>Chua</surname><given-names>K.F.</given-names></name><name><surname>Mostoslavsky</surname><given-names>R.</given-names></name><name><surname>Franco</surname><given-names>S.</given-names></name><name><surname>Gostissa</surname><given-names>M.</given-names></name><name><surname>Alt</surname><given-names>F.W.</given-names></name></person-group><article-title>DNA repair, genome stability, and aging</article-title><source>Cell</source><year>2005</year><volume>120</volume><fpage>497</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.01.028</pub-id><pub-id pub-id-type="pmid">15734682</pub-id></element-citation></ref><ref id="B7-biomolecules-09-00679"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name></person-group><article-title>Anticancer drug discovery in the future: An evolutionary perspective</article-title><source>Drug Discov. Today</source><year>2009</year><volume>14</volume><fpage>1136</fpage><lpage>1142</lpage><pub-id pub-id-type="doi">10.1016/j.drudis.2009.09.006</pub-id><pub-id pub-id-type="pmid">19800414</pub-id></element-citation></ref><ref id="B8-biomolecules-09-00679"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Widmer</surname><given-names>N.</given-names></name><name><surname>Bardin</surname><given-names>C.</given-names></name><name><surname>Chatelut</surname><given-names>E.</given-names></name><name><surname>Paci</surname><given-names>A.</given-names></name><name><surname>Beijnen</surname><given-names>J.</given-names></name><name><surname>Leveque</surname><given-names>D.</given-names></name><name><surname>Veal</surname><given-names>G.</given-names></name><name><surname>Astier</surname><given-names>A.</given-names></name></person-group><article-title>Review of therapeutic drug monitoring of anticancer drugs part two&#x02014;targeted therapies</article-title><source>Eur. J. Cancer</source><year>2014</year><volume>50</volume><fpage>2020</fpage><lpage>2036</lpage><pub-id pub-id-type="doi">10.1016/j.ejca.2014.04.015</pub-id><pub-id pub-id-type="pmid">24928190</pub-id></element-citation></ref><ref id="B9-biomolecules-09-00679"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuczynski</surname><given-names>E.A.</given-names></name><name><surname>Sargent</surname><given-names>D.J.</given-names></name><name><surname>Grothey</surname><given-names>A.</given-names></name><name><surname>Kerbel</surname><given-names>R.S.</given-names></name></person-group><article-title>Drug rechallenge and treatment beyond progression&#x02014;implications for drug resistance</article-title><source>Nat. Rev. Clin. Oncol.</source><year>2013</year><volume>10</volume><fpage>571</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1038/nrclinonc.2013.158</pub-id><pub-id pub-id-type="pmid">23999218</pub-id></element-citation></ref><ref id="B10-biomolecules-09-00679"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Check Hayden</surname><given-names>E.</given-names></name></person-group><article-title>Cancer complexity slows quest for cure</article-title><source>Nature</source><year>2008</year><volume>455</volume><fpage>148</fpage><pub-id pub-id-type="doi">10.1038/455148a</pub-id><pub-id pub-id-type="pmid">18784686</pub-id></element-citation></ref><ref id="B11-biomolecules-09-00679"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>K.H.</given-names></name><name><surname>Noh</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>J.K.</given-names></name><name><surname>Eun</surname><given-names>J.W.</given-names></name><name><surname>Bae</surname><given-names>H.J.</given-names></name><name><surname>Chang</surname><given-names>Y.G.</given-names></name><name><surname>Kim</surname><given-names>M.G.</given-names></name><name><surname>Park</surname><given-names>W.S.</given-names></name><name><surname>Lee</surname><given-names>J.Y.</given-names></name><name><surname>Lee</surname><given-names>S.Y.</given-names></name><etal/></person-group><article-title>Histone deacetylase 6 functions as a tumor suppressor by activating c-Jun NH2-terminal kinase-mediated beclin 1-dependent autophagic cell death in liver cancer</article-title><source>Hepatology</source><year>2012</year><volume>56</volume><fpage>644</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1002/hep.25699</pub-id><pub-id pub-id-type="pmid">22392728</pub-id></element-citation></ref><ref id="B12-biomolecules-09-00679"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>B.</given-names></name><name><surname>Prasad</surname><given-names>S.</given-names></name><name><surname>Sung</surname><given-names>B.</given-names></name><name><surname>Krishnan</surname><given-names>S.</given-names></name><name><surname>Guha</surname><given-names>S.</given-names></name></person-group><article-title>Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature</article-title><source>Curr. Colorectal Cancer Rep.</source><year>2013</year><volume>9</volume><fpage>37</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1007/s11888-012-0154-1</pub-id><pub-id pub-id-type="pmid">23814530</pub-id></element-citation></ref><ref id="B13-biomolecules-09-00679"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pike</surname><given-names>M.C.</given-names></name><name><surname>Spicer</surname><given-names>D.V.</given-names></name><name><surname>Dahmoush</surname><given-names>L.</given-names></name><name><surname>Press</surname><given-names>M.F.</given-names></name></person-group><article-title>Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk</article-title><source>Epidemiol. Rev.</source><year>1993</year><volume>15</volume><fpage>17</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.epirev.a036102</pub-id><?supplied-pmid 8405201?><pub-id pub-id-type="pmid">8405201</pub-id></element-citation></ref><ref id="B14-biomolecules-09-00679"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamane</surname><given-names>K.</given-names></name><name><surname>Tateishi</surname><given-names>K.</given-names></name><name><surname>Klose</surname><given-names>R.J.</given-names></name><name><surname>Fang</surname><given-names>J.</given-names></name><name><surname>Fabrizio</surname><given-names>L.A.</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H.</given-names></name><name><surname>Taylor-Papadimitriou</surname><given-names>J.</given-names></name><name><surname>Tempst</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group><article-title>PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation</article-title><source>Mol. Cell</source><year>2007</year><volume>25</volume><fpage>801</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2007.03.001</pub-id><?supplied-pmid 17363312?><pub-id pub-id-type="pmid">17363312</pub-id></element-citation></ref><ref id="B15-biomolecules-09-00679"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoeb</surname><given-names>M.</given-names></name></person-group><article-title>Anticancer agents from medicinal plants</article-title><source>Bangladesh J. Pharmacol.</source><year>2008</year><volume>1</volume><fpage>35</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.3329/bjp.v1i2.486</pub-id></element-citation></ref><ref id="B16-biomolecules-09-00679"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name></person-group><article-title>Drugs and Drug Candidates from marine sources: An assessment of the current &#x0201c;state of play&#x0201d;</article-title><source>Planta Med.</source><year>2016</year><volume>82</volume><fpage>775</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1055/s-0042-101353</pub-id><pub-id pub-id-type="pmid">26891002</pub-id></element-citation></ref><ref id="B17-biomolecules-09-00679"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name></person-group><article-title>Natural products as sources of new drugs from 1981 to 2014</article-title><source>J. Nat. Prod.</source><year>2016</year><volume>79</volume><fpage>629</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.5b01055</pub-id><pub-id pub-id-type="pmid">26852623</pub-id></element-citation></ref><ref id="B18-biomolecules-09-00679"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balunas</surname><given-names>M.J.</given-names></name><name><surname>Kinghorn</surname><given-names>A.D.</given-names></name></person-group><article-title>Drug discovery from medicinal plants</article-title><source>Life Sci.</source><year>2005</year><volume>78</volume><fpage>431</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2005.09.012</pub-id><pub-id pub-id-type="pmid">16198377</pub-id></element-citation></ref><ref id="B19-biomolecules-09-00679"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cragg</surname><given-names>G.M.</given-names></name><name><surname>Newman</surname><given-names>D.J.</given-names></name></person-group><article-title>Plants as a source of anti-cancer agents</article-title><source>J. Ethnopharmacol.</source><year>2005</year><volume>100</volume><fpage>72</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2005.05.011</pub-id><pub-id pub-id-type="pmid">16009521</pub-id></element-citation></ref><ref id="B20-biomolecules-09-00679"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burns</surname><given-names>J.</given-names></name><name><surname>Yokota</surname><given-names>T.</given-names></name><name><surname>Ashihara</surname><given-names>H.</given-names></name><name><surname>Lean</surname><given-names>M.E.</given-names></name><name><surname>Crozier</surname><given-names>A.</given-names></name></person-group><article-title>Plant foods and herbal sources of resveratrol</article-title><source>J. Agric. Food Chem.</source><year>2002</year><volume>50</volume><fpage>3337</fpage><lpage>3340</lpage><pub-id pub-id-type="doi">10.1021/jf0112973</pub-id><pub-id pub-id-type="pmid">12010007</pub-id></element-citation></ref><ref id="B21-biomolecules-09-00679"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mans</surname><given-names>D.R.</given-names></name><name><surname>da Rocha</surname><given-names>A.B.</given-names></name><name><surname>Schwartsmann</surname><given-names>G.</given-names></name></person-group><article-title>Anti-cancer drug discovery and development in Brazil: Targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds</article-title><source>Oncologist</source><year>2000</year><volume>5</volume><fpage>185</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1634/theoncologist.5-3-185</pub-id><pub-id pub-id-type="pmid">10884497</pub-id></element-citation></ref><ref id="B22-biomolecules-09-00679"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somasundaram</surname><given-names>S.</given-names></name><name><surname>Edmund</surname><given-names>N.A.</given-names></name><name><surname>Moore</surname><given-names>D.T.</given-names></name><name><surname>Small</surname><given-names>G.W.</given-names></name><name><surname>Shi</surname><given-names>Y.Y.</given-names></name><name><surname>Orlowski</surname><given-names>R.Z.</given-names></name></person-group><article-title>Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer</article-title><source>Cancer Res.</source><year>2002</year><volume>62</volume><fpage>3868</fpage><lpage>3875</lpage><pub-id pub-id-type="pmid">12097302</pub-id></element-citation></ref><ref id="B23-biomolecules-09-00679"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name></person-group><article-title>Natural products as sources of new drugs over the 30 years from 1981 to 2010</article-title><source>J. Nat. Prod.</source><year>2012</year><volume>75</volume><fpage>311</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1021/np200906s</pub-id><?supplied-pmid 22316239?><pub-id pub-id-type="pmid">22316239</pub-id></element-citation></ref><ref id="B24-biomolecules-09-00679"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cragg</surname><given-names>G.M.</given-names></name><name><surname>Grothaus</surname><given-names>P.G.</given-names></name><name><surname>Newman</surname><given-names>D.J.</given-names></name></person-group><article-title>Impact of natural products on developing new anti-cancer agents</article-title><source>Chem. Rev.</source><year>2009</year><volume>109</volume><fpage>3012</fpage><lpage>3043</lpage><pub-id pub-id-type="doi">10.1021/cr900019j</pub-id><?supplied-pmid 19422222?><pub-id pub-id-type="pmid">19422222</pub-id></element-citation></ref><ref id="B25-biomolecules-09-00679"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grothaus</surname><given-names>P.G.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name><name><surname>Newman</surname><given-names>D.J.</given-names></name></person-group><article-title>Plant natural products in anticancer drug discovery</article-title><source>Curr. Org. Chem.</source><year>2010</year><volume>14</volume><fpage>1781</fpage><lpage>1791</lpage><pub-id pub-id-type="doi">10.2174/138527210792927708</pub-id></element-citation></ref><ref id="B26-biomolecules-09-00679"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demain</surname><given-names>A.L.</given-names></name><name><surname>Vaishnav</surname><given-names>P.</given-names></name></person-group><article-title>Natural products for cancer chemotherapy</article-title><source>Microb. Biotechnol.</source><year>2011</year><volume>4</volume><fpage>687</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1111/j.1751-7915.2010.00221.x</pub-id><pub-id pub-id-type="pmid">21375717</pub-id></element-citation></ref><ref id="B27-biomolecules-09-00679"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basmadjian</surname><given-names>C.</given-names></name><name><surname>Zhao</surname><given-names>Q.</given-names></name><name><surname>Bentouhami</surname><given-names>E.</given-names></name><name><surname>Djehal</surname><given-names>A.</given-names></name><name><surname>Nebigil</surname><given-names>C.G.</given-names></name><name><surname>Johnson</surname><given-names>R.A.</given-names></name><name><surname>Serova</surname><given-names>M.</given-names></name><name><surname>de Gramont</surname><given-names>A.</given-names></name><name><surname>Faivre</surname><given-names>S.</given-names></name><name><surname>Raymond</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Cancer wars: Natural products strike back</article-title><source>Front. Chem.</source><year>2014</year><volume>2</volume><fpage>20</fpage><pub-id pub-id-type="doi">10.3389/fchem.2014.00020</pub-id><pub-id pub-id-type="pmid">24822174</pub-id></element-citation></ref><ref id="B28-biomolecules-09-00679"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cragg</surname><given-names>G.M.</given-names></name><name><surname>Newman</surname><given-names>D.J.</given-names></name></person-group><article-title>Nature: A vital source of leads for anticancer drug development</article-title><source>Phytochem. Rev.</source><year>2009</year><volume>8</volume><fpage>313</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1007/s11101-009-9123-y</pub-id></element-citation></ref><ref id="B29-biomolecules-09-00679"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sithranga Boopathy</surname><given-names>N.</given-names></name><name><surname>Kathiresan</surname><given-names>K.</given-names></name></person-group><article-title>Anticancer drugs from marine flora: An overview</article-title><source>J. Oncol.</source><year>2010</year><volume>2010</volume><elocation-id>214186</elocation-id><pub-id pub-id-type="doi">10.1155/2010/214186</pub-id><pub-id pub-id-type="pmid">21461373</pub-id></element-citation></ref><ref id="B30-biomolecules-09-00679"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kingston</surname><given-names>D.G.I.</given-names></name></person-group><article-title>Modern natural products drug discovery and its relevance to biodiversity conservation</article-title><source>J. Nat. Prod.</source><year>2011</year><volume>74</volume><fpage>496</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1021/np100550t</pub-id><?supplied-pmid 21138324?><pub-id pub-id-type="pmid">21138324</pub-id></element-citation></ref><ref id="B31-biomolecules-09-00679"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>S.J.</given-names></name><name><surname>Murphy</surname><given-names>L.L.</given-names></name><name><surname>Venema</surname><given-names>R.C.</given-names></name><name><surname>Singletary</surname><given-names>K.W.</given-names></name><name><surname>Young</surname><given-names>A.J.</given-names></name></person-group><article-title>Curcumin binds tubulin, induces mitotic catastrophe, and impedes normal endothelial cell proliferation</article-title><source>Food Chem. Toxicol.</source><year>2013</year><volume>60</volume><fpage>431</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2013.08.008</pub-id><pub-id pub-id-type="pmid">23939039</pub-id></element-citation></ref><ref id="B32-biomolecules-09-00679"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thangapazham</surname><given-names>R.L.</given-names></name><name><surname>Sharad</surname><given-names>S.</given-names></name><name><surname>Maheshwari</surname><given-names>R.K.</given-names></name></person-group><article-title>Skin regenerative potentials of curcumin</article-title><source>Biofactors</source><year>2013</year><volume>39</volume><fpage>141</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1002/biof.1078</pub-id><pub-id pub-id-type="pmid">23315856</pub-id></element-citation></ref><ref id="B33-biomolecules-09-00679"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name><name><surname>Harikumar</surname><given-names>K.B.</given-names></name></person-group><article-title>Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases</article-title><source>Int. J. Biochem. Cell Biol.</source><year>2009</year><volume>41</volume><fpage>40</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2008.06.010</pub-id><?supplied-pmid 18662800?><pub-id pub-id-type="pmid">18662800</pub-id></element-citation></ref><ref id="B34-biomolecules-09-00679"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>S.J.</given-names></name><name><surname>Pandey</surname><given-names>S.</given-names></name></person-group><article-title>Chemo-resistant melanoma sensitized by tamoxifen to low dose curcumin treatment through induction of apoptosis and autophagy</article-title><source>Cancer Biol.</source><year>2011</year><volume>11</volume><fpage>216</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.4161/cbt.11.2.13798</pub-id></element-citation></ref><ref id="B35-biomolecules-09-00679"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname><given-names>S.</given-names></name><name><surname>Cusid&#x000f3;</surname><given-names>R.M.</given-names></name><name><surname>Mirjalili</surname><given-names>M.H.</given-names></name><name><surname>Moyano</surname><given-names>E.</given-names></name><name><surname>Palaz&#x000f3;n</surname><given-names>J.</given-names></name><name><surname>Bonfill</surname><given-names>M.</given-names></name></person-group><article-title>Production of the anticancer drug taxol in Taxus baccata suspension cultures: A review</article-title><source>Process Biochem.</source><year>2011</year><volume>46</volume><fpage>23</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.procbio.2010.09.004</pub-id></element-citation></ref><ref id="B36-biomolecules-09-00679"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prota</surname><given-names>A.E.</given-names></name><name><surname>Bargsten</surname><given-names>K.</given-names></name><name><surname>Zurwerra</surname><given-names>D.</given-names></name><name><surname>Field</surname><given-names>J.J.</given-names></name><name><surname>Diaz</surname><given-names>J.F.</given-names></name><name><surname>Altmann</surname><given-names>K.H.</given-names></name><name><surname>Steinmetz</surname><given-names>M.O.</given-names></name></person-group><article-title>Molecular mechanism of action of microtubule-stabilizing anticancer agents</article-title><source>Science</source><year>2013</year><volume>339</volume><fpage>587</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1126/science.1230582</pub-id><?supplied-pmid 23287720?><pub-id pub-id-type="pmid">23287720</pub-id></element-citation></ref><ref id="B37-biomolecules-09-00679"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganguly</surname><given-names>A.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Cabral</surname><given-names>F.</given-names></name></person-group><article-title>Paclitaxel-dependent cell lines reveal a novel drug activity</article-title><source>Mol. Cancer Ther.</source><year>2010</year><volume>9</volume><fpage>2914</fpage><lpage>2923</lpage><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-10-0552</pub-id><?supplied-pmid 20978163?><pub-id pub-id-type="pmid">20978163</pub-id></element-citation></ref><ref id="B38-biomolecules-09-00679"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priyadarshini</surname><given-names>K.</given-names></name><name><surname>Aparajitha</surname><given-names>U.K.</given-names></name></person-group><article-title>Paclitaxel against cancer: A short review</article-title><source>Med. Chem.</source><year>2012</year><volume>2</volume><fpage>139</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.4172/2161-0444.1000130</pub-id></element-citation></ref><ref id="B39-biomolecules-09-00679"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales-Cano</surname><given-names>D.</given-names></name><name><surname>Calvino</surname><given-names>E.</given-names></name><name><surname>Rubio</surname><given-names>V.</given-names></name><name><surname>Herraez</surname><given-names>A.</given-names></name><name><surname>Sancho</surname><given-names>P.</given-names></name><name><surname>Tejedor</surname><given-names>M.C.</given-names></name><name><surname>Diez</surname><given-names>J.C.</given-names></name></person-group><article-title>Apoptosis induced by paclitaxel via Bcl-2, Bax and caspases 3 and 9 activation in NB4 human leukaemia cells is not modulated by ERK inhibition</article-title><source>Exp. Toxicol. Pathol.</source><year>2013</year><volume>65</volume><fpage>1101</fpage><lpage>1108</lpage><pub-id pub-id-type="doi">10.1016/j.etp.2013.04.006</pub-id><?supplied-pmid 23735541?><pub-id pub-id-type="pmid">23735541</pub-id></element-citation></ref><ref id="B40-biomolecules-09-00679"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Harsha</surname><given-names>C.</given-names></name><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Vikkurthi</surname><given-names>R.</given-names></name><name><surname>Sailo</surname><given-names>B.L.</given-names></name><name><surname>Bordoloi</surname><given-names>D.</given-names></name><name><surname>Gupta</surname><given-names>S.C.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Is curcumin bioavailability a problem in humans: Lessons from clinical trials</article-title><source>Expert Opin. Drug Metab. Toxicol.</source><year>2019</year><volume>15</volume><fpage>705</fpage><lpage>733</lpage><pub-id pub-id-type="doi">10.1080/17425255.2019.1650914</pub-id><pub-id pub-id-type="pmid">31361978</pub-id></element-citation></ref><ref id="B41-biomolecules-09-00679"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa-Lotufo</surname><given-names>L.V.</given-names></name><name><surname>Wilke</surname><given-names>D.V.</given-names></name><name><surname>Jimenez</surname><given-names>P.C.</given-names></name><name><surname>Epifanio</surname><given-names>R.d.A.</given-names></name></person-group><article-title>Organismos marinhos como fonte de novos f&#x000e1;rmacos: Hist&#x000f3;rico &#x00026; perspectivas</article-title><source>Qu&#x000ed;mica Nova</source><year>2009</year><volume>32</volume><fpage>703</fpage><lpage>716</lpage></element-citation></ref><ref id="B42-biomolecules-09-00679"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La Clair</surname><given-names>J.J.</given-names></name></person-group><article-title>Natural product mode of action (MOA) studies: A link between natural and synthetic worlds</article-title><source>Nat. Prod. Rep.</source><year>2010</year><volume>27</volume><fpage>969</fpage><lpage>995</lpage><pub-id pub-id-type="doi">10.1039/b909989c</pub-id><pub-id pub-id-type="pmid">20422068</pub-id></element-citation></ref><ref id="B43-biomolecules-09-00679"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>E.E.</given-names></name></person-group><article-title>Natural products as chemical probes</article-title><source>Acs Chem. Biol.</source><year>2010</year><volume>5</volume><fpage>639</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1021/cb100105c</pub-id><?supplied-pmid 20509672?><pub-id pub-id-type="pmid">20509672</pub-id></element-citation></ref><ref id="B44-biomolecules-09-00679"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valli</surname><given-names>M.</given-names></name><name><surname>dos Santos</surname><given-names>R.N.</given-names></name><name><surname>Figueira</surname><given-names>L.D.</given-names></name><name><surname>Nakajima</surname><given-names>C.H.</given-names></name><name><surname>Castro-Gamboa</surname><given-names>I.</given-names></name><name><surname>Andricopulo</surname><given-names>A.D.</given-names></name><name><surname>Bolzani</surname><given-names>V.S.</given-names></name></person-group><article-title>Development of a natural products database from the biodiversity of Brazil</article-title><source>J. Nat. Prod.</source><year>2013</year><volume>76</volume><fpage>439</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.1021/np3006875</pub-id><?supplied-pmid 23330984?><pub-id pub-id-type="pmid">23330984</pub-id></element-citation></ref><ref id="B45-biomolecules-09-00679"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cragg</surname><given-names>G.M.</given-names></name><name><surname>Grothaus</surname><given-names>P.G.</given-names></name><name><surname>Newman</surname><given-names>D.J.</given-names></name></person-group><article-title>New horizons for old drugs and drug leads</article-title><source>J. Nat. Prod.</source><year>2014</year><volume>77</volume><fpage>703</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1021/np5000796</pub-id><?supplied-pmid 24499205?><pub-id pub-id-type="pmid">24499205</pub-id></element-citation></ref><ref id="B46-biomolecules-09-00679"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerwick</surname><given-names>W.H.</given-names></name><name><surname>Moore</surname><given-names>B.S.</given-names></name></person-group><article-title>Lessons from the past and charting the future of marine natural products drug discovery and chemical biology</article-title><source>Chem. Biol.</source><year>2012</year><volume>19</volume><fpage>85</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2011.12.014</pub-id><?supplied-pmid 22284357?><pub-id pub-id-type="pmid">22284357</pub-id></element-citation></ref><ref id="B47-biomolecules-09-00679"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montaser</surname><given-names>R.</given-names></name><name><surname>Luesch</surname><given-names>H.</given-names></name></person-group><article-title>Marine natural products: A new wave of drugs?</article-title><source>Future Med. Chem.</source><year>2011</year><volume>3</volume><fpage>1475</fpage><lpage>1489</lpage><pub-id pub-id-type="doi">10.4155/fmc.11.118</pub-id><?supplied-pmid 21882941?><pub-id pub-id-type="pmid">21882941</pub-id></element-citation></ref><ref id="B48-biomolecules-09-00679"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imhoff</surname><given-names>J.F.</given-names></name><name><surname>Labes</surname><given-names>A.</given-names></name><name><surname>Wiese</surname><given-names>J.</given-names></name></person-group><article-title>Bio-mining the microbial treasures of the ocean: New natural products</article-title><source>Biotechnol. Adv.</source><year>2011</year><volume>29</volume><fpage>468</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2011.03.001</pub-id><pub-id pub-id-type="pmid">21419836</pub-id></element-citation></ref><ref id="B49-biomolecules-09-00679"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>World Health Organization (WHO)</collab></person-group><article-title>Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018</article-title><source>Int. Agency Res. Cancer</source><year>2018</year><volume>263</volume></element-citation></ref><ref id="B50-biomolecules-09-00679"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>S.-H.</given-names></name></person-group><article-title>An early history of human breast cancer: West meets East</article-title><source>Chin. J. Cancer</source><year>2013</year><volume>32</volume><fpage>475</fpage><pub-id pub-id-type="doi">10.5732/cjc.013.10097</pub-id><pub-id pub-id-type="pmid">23958056</pub-id></element-citation></ref><ref id="B51-biomolecules-09-00679"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudhakar</surname><given-names>A.</given-names></name></person-group><article-title>History of cancer, ancient and modern treatment methods</article-title><source>J. Cancer Sci.</source><year>2009</year><volume>1</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.4172/1948-5956.100000e2</pub-id></element-citation></ref><ref id="B52-biomolecules-09-00679"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>S.K.</given-names></name></person-group><article-title>Giovanni Battista Morgagni (1682&#x02013;1771): Father of pathologic anatomy and pioneer of modern medicine</article-title><source>Anat. Sci. Int.</source><year>2017</year><volume>92</volume><fpage>305</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1007/s12565-016-0373-7</pub-id><pub-id pub-id-type="pmid">27629485</pub-id></element-citation></ref><ref id="B53-biomolecules-09-00679"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobson</surname><given-names>J.</given-names></name></person-group><article-title>John Hunter&#x02019;s views on cancer</article-title><source>Ann. R. Coll. Surg. Engl.</source><year>1959</year><volume>25</volume><fpage>176</fpage><?supplied-pmid 13817098?><pub-id pub-id-type="pmid">13817098</pub-id></element-citation></ref><ref id="B54-biomolecules-09-00679"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>E.</given-names></name><name><surname>Scott</surname><given-names>M.</given-names></name></person-group><article-title>The life and work of Rudolf Virchow 1821&#x02013;1902: &#x0201c;Cell theory, thrombosis and the sausage duel&#x0201d;</article-title><source>J. Intensive Care Soc.</source><year>2017</year><volume>18</volume><fpage>234</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1177/1751143716663967</pub-id><?supplied-pmid 29118836?><pub-id pub-id-type="pmid">29118836</pub-id></element-citation></ref><ref id="B55-biomolecules-09-00679"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papac</surname><given-names>R.J.</given-names></name></person-group><article-title>Origins of cancer therapy</article-title><source>Yale J. Biol. Med.</source><year>2001</year><volume>74</volume><fpage>391</fpage><?supplied-pmid 11922186?><pub-id pub-id-type="pmid">11922186</pub-id></element-citation></ref><ref id="B56-biomolecules-09-00679"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>S.H.</given-names></name></person-group><article-title>Paul Ehrlich: Founder of chemotherapy</article-title><source>Nat. Rev. Drug Discov.</source><year>2008</year><volume>7</volume><fpage>373</fpage><pub-id pub-id-type="doi">10.1038/nrd2582</pub-id><?supplied-pmid 18456958?><pub-id pub-id-type="pmid">18456958</pub-id></element-citation></ref><ref id="B57-biomolecules-09-00679"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeVita</surname><given-names>V.T.</given-names></name><name><surname>Chu</surname><given-names>E.</given-names></name></person-group><article-title>A history of cancer chemotherapy</article-title><source>Cancer Res.</source><year>2008</year><volume>68</volume><fpage>8643</fpage><lpage>8653</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-6611</pub-id><?supplied-pmid 18974103?><pub-id pub-id-type="pmid">18974103</pub-id></element-citation></ref><ref id="B58-biomolecules-09-00679"><label>58.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Avenda&#x000f1;o</surname><given-names>C.</given-names></name><name><surname>Menendez</surname><given-names>J.C.</given-names></name></person-group><source>Medicinal chemistry of anticancer drugs</source><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2015</year></element-citation></ref><ref id="B59-biomolecules-09-00679"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinch</surname><given-names>M.S.</given-names></name></person-group><article-title>An analysis of FDA-approved drugs for oncology</article-title><source>Drug Discov. Today</source><year>2014</year><volume>19</volume><fpage>1831</fpage><lpage>1835</lpage><pub-id pub-id-type="doi">10.1016/j.drudis.2014.08.007</pub-id><?supplied-pmid 25172803?><pub-id pub-id-type="pmid">25172803</pub-id></element-citation></ref><ref id="B60-biomolecules-09-00679"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magalh&#x000e3;es</surname><given-names>L.G.</given-names></name><name><surname>Ferreira</surname><given-names>L.L.</given-names></name><name><surname>Andricopulo</surname><given-names>A.D.</given-names></name></person-group><article-title>Recent advances and perspectives in cancer drug design</article-title><source>Da Acad. Bras. De Ci&#x000ea;ncias</source><year>2018</year><volume>90</volume><fpage>1233</fpage><lpage>1250</lpage></element-citation></ref><ref id="B61-biomolecules-09-00679"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>C.T.</given-names></name></person-group><article-title>Food and Drug Administration drug approval process: a history and overview</article-title><source>Nurs. Clin.</source><year>2016</year><volume>51</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.cnur.2015.10.007</pub-id></element-citation></ref><ref id="B62-biomolecules-09-00679"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bishayee</surname><given-names>A.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name></person-group><article-title>Bioactive natural products in cancer prevention and therapy: Progress and promise</article-title><source>Semin. Cancer Biol.</source><year>2016</year><volume>40&#x02013;41</volume><fpage>1</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1016/j.semcancer.2016.08.006</pub-id></element-citation></ref><ref id="B63-biomolecules-09-00679"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nightingale</surname><given-names>G.</given-names></name><name><surname>Ryu</surname><given-names>J.</given-names></name></person-group><article-title>Cabazitaxel (jevtana): A novel agent for metastatic castration-resistant prostate cancer</article-title><source>Pharm. Ther.</source><year>2012</year><volume>37</volume><fpage>440</fpage></element-citation></ref><ref id="B64-biomolecules-09-00679"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pal</surname><given-names>S.K.</given-names></name><name><surname>Twardowski</surname><given-names>P.</given-names></name><name><surname>Sartor</surname><given-names>O.</given-names></name></person-group><article-title>Critical appraisal of cabazitaxel in the management of advanced prostate cancer</article-title><source>Clin. Interv. Aging</source><year>2010</year><volume>5</volume><fpage>395</fpage><pub-id pub-id-type="doi">10.2147/CIA.S14570</pub-id><?supplied-pmid 21152241?><pub-id pub-id-type="pmid">21152241</pub-id></element-citation></ref><ref id="B65-biomolecules-09-00679"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirata</surname><given-names>Y.</given-names></name><name><surname>Uemura</surname><given-names>D.</given-names></name></person-group><article-title>Halichondrins-antitumor polyether macrolides from a marine sponge</article-title><source>Pure Appl. Chem.</source><year>1986</year><volume>58</volume><fpage>701</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1351/pac198658050701</pub-id></element-citation></ref><ref id="B66-biomolecules-09-00679"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Towle</surname><given-names>M.J.</given-names></name><name><surname>Salvato</surname><given-names>K.A.</given-names></name><name><surname>Budrow</surname><given-names>J.</given-names></name><name><surname>Wels</surname><given-names>B.F.</given-names></name><name><surname>Kuznetsov</surname><given-names>G.</given-names></name><name><surname>Aalfs</surname><given-names>K.K.</given-names></name><name><surname>Welsh</surname><given-names>S.</given-names></name><name><surname>Zheng</surname><given-names>W.</given-names></name><name><surname>Seletsky</surname><given-names>B.M.</given-names></name><name><surname>Palme</surname><given-names>M.H.</given-names></name></person-group><article-title>In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B</article-title><source>Cancer Res.</source><year>2001</year><volume>61</volume><fpage>1013</fpage><lpage>1021</lpage><?supplied-pmid 11221827?><pub-id pub-id-type="pmid">11221827</pub-id></element-citation></ref><ref id="B67-biomolecules-09-00679"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aicher</surname><given-names>T.D.</given-names></name><name><surname>Buszek</surname><given-names>K.R.</given-names></name><name><surname>Fang</surname><given-names>F.G.</given-names></name><name><surname>Forsyth</surname><given-names>C.J.</given-names></name><name><surname>Jung</surname><given-names>S.H.</given-names></name><name><surname>Kishi</surname><given-names>Y.</given-names></name><name><surname>Matelich</surname><given-names>M.C.</given-names></name><name><surname>Scola</surname><given-names>P.M.</given-names></name><name><surname>Spero</surname><given-names>D.M.</given-names></name><name><surname>Yoon</surname><given-names>S.K.</given-names></name></person-group><article-title>Total synthesis of halichondrin B and norhalichondrin B</article-title><source>J. Am. Chem. Soc.</source><year>1992</year><volume>114</volume><fpage>3162</fpage><lpage>3164</lpage><pub-id pub-id-type="doi">10.1021/ja00034a086</pub-id></element-citation></ref><ref id="B68-biomolecules-09-00679"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Habgood</surname><given-names>G.J.</given-names></name><name><surname>Christ</surname><given-names>W.J.</given-names></name><name><surname>Kishi</surname><given-names>Y.</given-names></name><name><surname>Littlefield</surname><given-names>B.A.</given-names></name><name><surname>Melvin</surname><given-names>J.Y.</given-names></name></person-group><article-title>Structure&#x02013;activity relationships of halichondrin B analogues: modifications at C. 30&#x02013;C. 38</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2000</year><volume>10</volume><fpage>1029</fpage><lpage>2032</lpage><pub-id pub-id-type="doi">10.1016/S0960-894X(00)00150-5</pub-id><pub-id pub-id-type="pmid">10843209</pub-id></element-citation></ref><ref id="B69-biomolecules-09-00679"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>R.</given-names></name><name><surname>Paull</surname><given-names>K.D.</given-names></name><name><surname>Herald</surname><given-names>C.L.</given-names></name><name><surname>Malspeis</surname><given-names>L.</given-names></name><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Hamel</surname><given-names>E.</given-names></name></person-group><article-title>Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data</article-title><source>J. Biol. Chem.</source><year>1991</year><volume>266</volume><fpage>15882</fpage><lpage>15889</lpage><pub-id pub-id-type="pmid">1874739</pub-id></element-citation></ref><ref id="B70-biomolecules-09-00679"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamos</surname><given-names>D.P.</given-names></name><name><surname>Chen</surname><given-names>S.S.</given-names></name><name><surname>Kishi</surname><given-names>Y.</given-names></name></person-group><article-title>New Synthetic Route to the C. 14&#x02212; C. 38 Segment of Halichondrins</article-title><source>J. Org. Chem.</source><year>1997</year><volume>62</volume><fpage>7552</fpage><lpage>7553</lpage><pub-id pub-id-type="doi">10.1021/jo971713b</pub-id></element-citation></ref><ref id="B71-biomolecules-09-00679"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jordan</surname><given-names>M.A.</given-names></name><name><surname>Kamath</surname><given-names>K.</given-names></name><name><surname>Manna</surname><given-names>T.</given-names></name><name><surname>Okouneva</surname><given-names>T.</given-names></name><name><surname>Miller</surname><given-names>H.P.</given-names></name><name><surname>Davis</surname><given-names>C.</given-names></name><name><surname>Littlefield</surname><given-names>B.A.</given-names></name><name><surname>Wilson</surname><given-names>L.</given-names></name></person-group><article-title>The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth</article-title><source>Mol. Cancer. Ther.</source><year>2005</year><volume>4</volume><fpage>1086</fpage><lpage>1095</lpage><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-04-0345</pub-id><pub-id pub-id-type="pmid">16020666</pub-id></element-citation></ref><ref id="B72-biomolecules-09-00679"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dabydeen</surname><given-names>D.A.</given-names></name><name><surname>Burnett</surname><given-names>J.C.</given-names></name><name><surname>Bai</surname><given-names>R.</given-names></name><name><surname>Verdier-Pinard</surname><given-names>P.</given-names></name><name><surname>Hickford</surname><given-names>S.J.</given-names></name><name><surname>Pettit</surname><given-names>G.R.</given-names></name><name><surname>Blunt</surname><given-names>J.W.</given-names></name><name><surname>Munro</surname><given-names>M.H.</given-names></name><name><surname>Gussio</surname><given-names>R.</given-names></name><name><surname>Hamel</surname><given-names>E.</given-names></name></person-group><article-title>Comparison of the activities of the truncated halichondrin B analog NSC 707389 (E7389) with those of the parent compound and a proposed binding site on tubulin</article-title><source>Mol. Pharm.</source><year>2006</year><volume>70</volume><fpage>1866</fpage><lpage>1875</lpage><pub-id pub-id-type="doi">10.1124/mol.106.026641</pub-id></element-citation></ref><ref id="B73-biomolecules-09-00679"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alday</surname><given-names>P.H.</given-names></name><name><surname>Correia</surname><given-names>J.J.</given-names></name></person-group><article-title>Macromolecular interaction of halichondrin B analogues eribulin (E7389) and ER-076349 with tubulin by analytical ultracentrifugation</article-title><source>Biochemistry</source><year>2009</year><volume>48</volume><fpage>7927</fpage><lpage>7938</lpage><pub-id pub-id-type="doi">10.1021/bi900776u</pub-id><pub-id pub-id-type="pmid">19586046</pub-id></element-citation></ref><ref id="B74-biomolecules-09-00679"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okouneva</surname><given-names>T.</given-names></name><name><surname>Azarenko</surname><given-names>O.</given-names></name><name><surname>Wilson</surname><given-names>L.</given-names></name><name><surname>Littlefield</surname><given-names>B.A.</given-names></name><name><surname>Jordan</surname><given-names>M.A.</given-names></name></person-group><article-title>Inhibition of centromere dynamics by eribulin (E7389) during mitotic metaphase</article-title><source>Mol. Cancer Ther.</source><year>2008</year><volume>7</volume><fpage>2003</fpage><lpage>2011</lpage><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-08-0095</pub-id><?supplied-pmid 18645010?><pub-id pub-id-type="pmid">18645010</pub-id></element-citation></ref><ref id="B75-biomolecules-09-00679"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuznetsov</surname><given-names>G.</given-names></name><name><surname>Towle</surname><given-names>M.J.</given-names></name><name><surname>Cheng</surname><given-names>H.</given-names></name><name><surname>Kawamura</surname><given-names>T.</given-names></name><name><surname>TenDyke</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Kishi</surname><given-names>Y.</given-names></name><name><surname>Melvin</surname><given-names>J.Y.</given-names></name><name><surname>Littlefield</surname><given-names>B.A.</given-names></name></person-group><article-title>Induction of morphological and biochemical apoptosis following prolonged mitotic blockage by halichondrin B macrocyclic ketone analog E7389</article-title><source>Cancer Res.</source><year>2004</year><volume>64</volume><fpage>5760</fpage><lpage>5766</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-1169</pub-id><?supplied-pmid 15313917?><pub-id pub-id-type="pmid">15313917</pub-id></element-citation></ref><ref id="B76-biomolecules-09-00679"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>I.S.</given-names></name><name><surname>Armstrong</surname><given-names>J.G.</given-names></name><name><surname>Gorman</surname><given-names>M.</given-names></name><name><surname>Burnett</surname><given-names>J.P.</given-names></name></person-group><article-title>The vinca alkaloids: A new class of oncolytic agents</article-title><source>Cancer Res.</source><year>1963</year><volume>23</volume></element-citation></ref><ref id="B77-biomolecules-09-00679"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noble</surname><given-names>R.L.</given-names></name></person-group><article-title>The discovery of the vinca alkaloids&#x02014;chemotherapeutic agents against cancer</article-title><source>Biochem. Cell Biol.</source><year>1990</year><volume>68</volume><fpage>1344</fpage><lpage>1351</lpage><pub-id pub-id-type="doi">10.1139/o90-197</pub-id><pub-id pub-id-type="pmid">2085431</pub-id></element-citation></ref><ref id="B78-biomolecules-09-00679"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noble</surname><given-names>R.</given-names></name><name><surname>Beer</surname><given-names>C.</given-names></name><name><surname>Cutts</surname><given-names>J.</given-names></name></person-group><article-title>Role of chance observations in chemotherapy: Vinca rosea</article-title><source>Ann. N. Y. Acad. Sci.</source><year>1958</year><volume>76</volume><fpage>882</fpage><lpage>894</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.1958.tb54906.x</pub-id><?supplied-pmid 13627916?><pub-id pub-id-type="pmid">13627916</pub-id></element-citation></ref><ref id="B79-biomolecules-09-00679"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silverman</surname><given-names>J.A.</given-names></name><name><surname>Deitcher</surname><given-names>S.R.</given-names></name></person-group><article-title>Marqibo<sup>&#x000ae;</sup> (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine</article-title><source>Cancer Chemother. Pharm.</source><year>2013</year><volume>71</volume><fpage>555</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1007/s00280-012-2042-4</pub-id></element-citation></ref><ref id="B80-biomolecules-09-00679"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Fattah</surname><given-names>F.J.</given-names></name><name><surname>Dong</surname><given-names>Y.</given-names></name><name><surname>Bey</surname><given-names>E.A.</given-names></name><name><surname>Patel</surname><given-names>M.</given-names></name><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Boothman</surname><given-names>D.A.</given-names></name></person-group><article-title>Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases</article-title><source>Crit. Rev. <sup>TM</sup> Eukaryot. Gene Expr.</source><year>2014</year><volume>24</volume><pub-id pub-id-type="doi">10.1615/CritRevEukaryotGeneExpr.2013006875</pub-id></element-citation></ref><ref id="B81-biomolecules-09-00679"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenner</surname><given-names>Z.B.</given-names></name><name><surname>Sood</surname><given-names>A.K.</given-names></name><name><surname>Coleman</surname><given-names>R.L.</given-names></name></person-group><article-title>Evaluation of rucaparib and companion diagnostics in the PARP inhibitor landscape for recurrent ovarian cancer therapy</article-title><source>Future Oncol.</source><year>2016</year><volume>12</volume><fpage>1439</fpage><lpage>1456</lpage><pub-id pub-id-type="doi">10.2217/fon-2016-0002</pub-id><pub-id pub-id-type="pmid">27087632</pub-id></element-citation></ref><ref id="B82-biomolecules-09-00679"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirza</surname><given-names>M.R.</given-names></name><name><surname>Monk</surname><given-names>B.J.</given-names></name><name><surname>Herrstedt</surname><given-names>J.</given-names></name><name><surname>Oza</surname><given-names>A.M.</given-names></name><name><surname>Mahner</surname><given-names>S.</given-names></name><name><surname>Redondo</surname><given-names>A.</given-names></name><name><surname>Fabbro</surname><given-names>M.</given-names></name><name><surname>Ledermann</surname><given-names>J.A.</given-names></name><name><surname>Lorusso</surname><given-names>D.</given-names></name><name><surname>Vergote</surname><given-names>I.</given-names></name></person-group><article-title>Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer</article-title><source>N. Engl. J. Med.</source><year>2016</year><volume>375</volume><fpage>2154</fpage><lpage>2164</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1611310</pub-id><pub-id pub-id-type="pmid">27717299</pub-id></element-citation></ref><ref id="B83-biomolecules-09-00679"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCann</surname><given-names>K.E.</given-names></name></person-group><article-title>Advances in the use of PARP inhibitors for BRCA1/2-associated breast cancer: Talazoparib</article-title><source>Future Oncol.</source><year>2019</year><volume>15</volume><fpage>1707</fpage><lpage>1715</lpage><pub-id pub-id-type="doi">10.2217/fon-2018-0751</pub-id><pub-id pub-id-type="pmid">30912451</pub-id></element-citation></ref><ref id="B84-biomolecules-09-00679"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coussens</surname><given-names>L.M.</given-names></name><name><surname>Werb</surname><given-names>Z.</given-names></name></person-group><article-title>Inflammation and cancer</article-title><source>Nature</source><year>2002</year><volume>420</volume><fpage>860</fpage><pub-id pub-id-type="doi">10.1038/nature01322</pub-id><?supplied-pmid 12490959?><pub-id pub-id-type="pmid">12490959</pub-id></element-citation></ref><ref id="B85-biomolecules-09-00679"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murata</surname><given-names>M.</given-names></name></person-group><article-title>Inflammation and cancer</article-title><source>Environ. Health Prev. Med.</source><year>2018</year><volume>23</volume><fpage>50</fpage><pub-id pub-id-type="doi">10.1186/s12199-018-0740-1</pub-id><?supplied-pmid 30340457?><pub-id pub-id-type="pmid">30340457</pub-id></element-citation></ref><ref id="B86-biomolecules-09-00679"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapche</surname><given-names>D.W.</given-names></name><name><surname>Lekane</surname><given-names>N.M.</given-names></name><name><surname>Kulabas</surname><given-names>S.S.</given-names></name><name><surname>Ipek</surname><given-names>H.</given-names></name><name><surname>Tok</surname><given-names>T.T.</given-names></name><name><surname>Ngadjui</surname><given-names>B.T.</given-names></name><name><surname>Demirtas</surname><given-names>I.</given-names></name><name><surname>Tumer</surname><given-names>T.B.</given-names></name></person-group><article-title>Aryl benzofuran derivatives from the stem bark of Calpocalyx dinklagei attenuate inflammation</article-title><source>Phytochemistry</source><year>2017</year><volume>141</volume><fpage>70</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2017.05.007</pub-id><?supplied-pmid 28577435?><pub-id pub-id-type="pmid">28577435</pub-id></element-citation></ref><ref id="B87-biomolecules-09-00679"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tumer</surname><given-names>T.B.</given-names></name><name><surname>Y&#x00131;lmaz</surname><given-names>B.</given-names></name><name><surname>Ozleyen</surname><given-names>A.</given-names></name><name><surname>Kurt</surname><given-names>B.</given-names></name><name><surname>Tok</surname><given-names>T.T.</given-names></name><name><surname>Taskin</surname><given-names>K.M.</given-names></name><name><surname>Kulabas</surname><given-names>S.S.</given-names></name></person-group><article-title>GR24, a synthetic analog of Strigolactones, alleviates inflammation and promotes Nrf2 cytoprotective response: In vitro and in silico evidences</article-title><source>Comput. Biol. Chem.</source><year>2018</year><volume>76</volume><fpage>179</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.compbiolchem.2018.07.014</pub-id><?supplied-pmid 30048925?><pub-id pub-id-type="pmid">30048925</pub-id></element-citation></ref><ref id="B88-biomolecules-09-00679"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crusz</surname><given-names>S.M.</given-names></name><name><surname>Balkwill</surname><given-names>F.R.</given-names></name></person-group><article-title>Inflammation and cancer: Advances and new agents</article-title><source>Nat. Rev. Clin. Oncol.</source><year>2015</year><volume>12</volume><fpage>584</fpage><pub-id pub-id-type="doi">10.1038/nrclinonc.2015.105</pub-id><pub-id pub-id-type="pmid">26122183</pub-id></element-citation></ref><ref id="B89-biomolecules-09-00679"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulabas</surname><given-names>S.</given-names></name><name><surname>Ipek</surname><given-names>H.</given-names></name><name><surname>Tufekci</surname><given-names>A.</given-names></name><name><surname>Arslan</surname><given-names>S.</given-names></name><name><surname>Demirtas</surname><given-names>I.</given-names></name><name><surname>Ekren</surname><given-names>R.</given-names></name><name><surname>Sezerman</surname><given-names>U.</given-names></name><name><surname>Tumer</surname><given-names>T.</given-names></name></person-group><article-title>Ameliorative potential of Lavandula stoechas in metabolic syndrome via multitarget interactions</article-title><source>J. Ethnopharmacol.</source><year>2018</year><volume>223</volume><fpage>88</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2018.04.043</pub-id><pub-id pub-id-type="pmid">29729383</pub-id></element-citation></ref><ref id="B90-biomolecules-09-00679"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCurdy</surname><given-names>A.R.</given-names></name><name><surname>Lacy</surname><given-names>M.Q.</given-names></name></person-group><article-title>Pomalidomide and its clinical potential for relapsed or refractory multiple myeloma: An update for the hematologist</article-title><source>Ther. Adv. Hematol.</source><year>2013</year><volume>4</volume><fpage>211</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1177/2040620713480155</pub-id><pub-id pub-id-type="pmid">23730498</pub-id></element-citation></ref><ref id="B91-biomolecules-09-00679"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morabito</surname><given-names>F.</given-names></name><name><surname>Skafi</surname><given-names>M.</given-names></name><name><surname>Recchia</surname><given-names>A.G.</given-names></name><name><surname>Kashkeesh</surname><given-names>A.</given-names></name><name><surname>Hindiyeh</surname><given-names>M.</given-names></name><name><surname>Sabatleen</surname><given-names>A.</given-names></name><name><surname>Morabito</surname><given-names>L.</given-names></name><name><surname>Alijanazreh</surname><given-names>H.</given-names></name><name><surname>Hamamreh</surname><given-names>Y.</given-names></name><name><surname>Gentile</surname><given-names>M.</given-names></name></person-group><article-title>Lenalidomide for the treatment of mantle cell lymphoma</article-title><source>Expert Opin. Pharmacother.</source><year>2019</year><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1080/14656566.2018.1561865</pub-id></element-citation></ref><ref id="B92-biomolecules-09-00679"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hideshima</surname><given-names>T.</given-names></name><name><surname>Raje</surname><given-names>N.</given-names></name><name><surname>Richardson</surname><given-names>P.G.</given-names></name><name><surname>Anderson</surname><given-names>K.C.</given-names></name></person-group><article-title>A review of lenalidomide in combination with dexamethasone for the treatment of multiple myeloma</article-title><source>Ther. Clin. Risk Manag.</source><year>2008</year><volume>4</volume><fpage>129</fpage><pub-id pub-id-type="doi">10.2147/TCRM.S1445</pub-id><pub-id pub-id-type="pmid">18728702</pub-id></element-citation></ref><ref id="B93-biomolecules-09-00679"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butti</surname><given-names>R.</given-names></name><name><surname>Das</surname><given-names>S.</given-names></name><name><surname>Gunasekaran</surname><given-names>V.P.</given-names></name><name><surname>Yadav</surname><given-names>A.S.</given-names></name><name><surname>Kumar</surname><given-names>D.</given-names></name><name><surname>Kundu</surname><given-names>G.C.</given-names></name></person-group><article-title>Receptor tyrosine kinases (RTKs) in breast cancer: Signaling, therapeutic implications and challenges</article-title><source>Mol. Cancer</source><year>2018</year><volume>17</volume><fpage>34</fpage><pub-id pub-id-type="doi">10.1186/s12943-018-0797-x</pub-id><pub-id pub-id-type="pmid">29455658</pub-id></element-citation></ref><ref id="B94-biomolecules-09-00679"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>Z.</given-names></name><name><surname>Lovly</surname><given-names>C.M.</given-names></name></person-group><article-title>Mechanisms of receptor tyrosine kinase activation in cancer</article-title><source>Mol. Cancer</source><year>2018</year><volume>17</volume><fpage>58</fpage><pub-id pub-id-type="doi">10.1186/s12943-018-0782-4</pub-id><?supplied-pmid 29455648?><pub-id pub-id-type="pmid">29455648</pub-id></element-citation></ref><ref id="B95-biomolecules-09-00679"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vlahovic</surname><given-names>G.</given-names></name><name><surname>Crawford</surname><given-names>J.</given-names></name></person-group><article-title>Activation of tyrosine kinases in cancer</article-title><source>Oncologist</source><year>2003</year><volume>8</volume><fpage>531</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1634/theoncologist.8-6-531</pub-id><?supplied-pmid 14657531?><pub-id pub-id-type="pmid">14657531</pub-id></element-citation></ref><ref id="B96-biomolecules-09-00679"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>K.</given-names></name><name><surname>Ito</surname><given-names>F.</given-names></name></person-group><article-title>Receptor tyrosine kinases and targeted cancer therapeutics</article-title><source>Biol. Pharm. Bull.</source><year>2011</year><volume>34</volume><fpage>1774</fpage><lpage>1780</lpage><pub-id pub-id-type="doi">10.1248/bpb.34.1774</pub-id><?supplied-pmid 22130229?><pub-id pub-id-type="pmid">22130229</pub-id></element-citation></ref><ref id="B97-biomolecules-09-00679"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishina</surname><given-names>T.</given-names></name><name><surname>Takahashi</surname><given-names>S.</given-names></name><name><surname>Iwasawa</surname><given-names>R.</given-names></name><name><surname>Noguchi</surname><given-names>H.</given-names></name><name><surname>Aoki</surname><given-names>M.</given-names></name><name><surname>Doi</surname><given-names>T.</given-names></name></person-group><article-title>Safety, pharmacokinetic, and pharmacodynamics of erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients with advanced or refractory solid tumors</article-title><source>Investig. New Drugs</source><year>2018</year><volume>36</volume><fpage>424</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1007/s10637-017-0514-4</pub-id><pub-id pub-id-type="pmid">28965185</pub-id></element-citation></ref><ref id="B98-biomolecules-09-00679"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haugsten</surname><given-names>E.M.</given-names></name><name><surname>Wiedlocha</surname><given-names>A.</given-names></name><name><surname>Olsnes</surname><given-names>S.</given-names></name><name><surname>Wesche</surname><given-names>J.</given-names></name></person-group><article-title>Roles of fibroblast growth factor receptors in carcinogenesis</article-title><source>Mol. Cancer Res.</source><year>2010</year><volume>8</volume><fpage>1439</fpage><lpage>1452</lpage><pub-id pub-id-type="doi">10.1158/1541-7786.MCR-10-0168</pub-id><?supplied-pmid 21047773?><pub-id pub-id-type="pmid">21047773</pub-id></element-citation></ref><ref id="B99-biomolecules-09-00679"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>L.J.</given-names></name></person-group><article-title>Lenvatinib: First global approval</article-title><source>Drugs</source><year>2015</year><volume>75</volume><fpage>553</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1007/s40265-015-0383-0</pub-id><pub-id pub-id-type="pmid">25795101</pub-id></element-citation></ref><ref id="B100-biomolecules-09-00679"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verheul</surname><given-names>H.M.</given-names></name><name><surname>Pinedo</surname><given-names>H.M.</given-names></name></person-group><article-title>The role of vascular endothelial growth factor (VEGF) in tumor angiogenesis and early clinical development of VEGFReceptor kinase inhibitors</article-title><source>Clin. Breast Cancer</source><year>2000</year><volume>1</volume><fpage>S80</fpage><lpage>S84</lpage><pub-id pub-id-type="doi">10.3816/CBC.2000.s.015</pub-id><pub-id pub-id-type="pmid">11970755</pub-id></element-citation></ref><ref id="B101-biomolecules-09-00679"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>R.J.</given-names></name><name><surname>Rixe</surname><given-names>O.</given-names></name></person-group><article-title>Axitinib&#x02014;a selective inhibitor of the vascular endothelial growth factor (VEGF) receptor</article-title><source>Target. Oncol.</source><year>2009</year><volume>4</volume><fpage>297</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1007/s11523-009-0126-9</pub-id><pub-id pub-id-type="pmid">19876699</pub-id></element-citation></ref><ref id="B102-biomolecules-09-00679"><label>102.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>DrugBank</collab></person-group><article-title>The Drug Database</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.drugbank.ca/">https://www.drugbank.ca/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2019-10-31">(accessed on 31 October 2019)</date-in-citation></element-citation></ref><ref id="B103-biomolecules-09-00679"><label>103.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dimitrov</surname><given-names>D.S.</given-names></name></person-group><article-title>Therapeutic proteins</article-title><source>Therapeutic Proteins</source><publisher-name>Springer</publisher-name><publisher-loc>Totowa, NJ, USA</publisher-loc><year>2012</year><fpage>1</fpage><lpage>26</lpage></element-citation></ref><ref id="B104-biomolecules-09-00679"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagass&#x000e9;</surname><given-names>H.D.</given-names></name><name><surname>Alexaki</surname><given-names>A.</given-names></name><name><surname>Simhadri</surname><given-names>V.L.</given-names></name><name><surname>Katagiri</surname><given-names>N.H.</given-names></name><name><surname>Jankowski</surname><given-names>W.</given-names></name><name><surname>Sauna</surname><given-names>Z.E.</given-names></name><name><surname>Kimchi-Sarfaty</surname><given-names>C.</given-names></name></person-group><article-title>Recent advances in (therapeutic protein) drug development</article-title><source>F1000Research</source><year>2017</year><volume>6</volume><fpage>113</fpage><pub-id pub-id-type="doi">10.12688/f1000research.9970.1</pub-id><pub-id pub-id-type="pmid">28232867</pub-id></element-citation></ref><ref id="B105-biomolecules-09-00679"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J.</given-names></name></person-group><article-title>Mammalian cell protein expression for biopharmaceutical production</article-title><source>Biotechnol. Adv.</source><year>2012</year><volume>30</volume><fpage>1158</fpage><lpage>1170</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2011.08.022</pub-id><pub-id pub-id-type="pmid">21968146</pub-id></element-citation></ref><ref id="B106-biomolecules-09-00679"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>W.</given-names></name><name><surname>Mahato</surname><given-names>R.</given-names></name><name><surname>Cheng</surname><given-names>K.</given-names></name></person-group><article-title>The role of HER2 in cancer therapy and targeted drug delivery</article-title><source>J. Control. Release</source><year>2010</year><volume>146</volume><fpage>264</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2010.04.009</pub-id><?supplied-pmid 20385184?><pub-id pub-id-type="pmid">20385184</pub-id></element-citation></ref><ref id="B107-biomolecules-09-00679"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunturu</surname><given-names>K.S.</given-names></name><name><surname>Woo</surname><given-names>Y.</given-names></name><name><surname>Beaubier</surname><given-names>N.</given-names></name><name><surname>Remotti</surname><given-names>H.E.</given-names></name><name><surname>Saif</surname><given-names>M.W.</given-names></name></person-group><article-title>Gastric cancer and trastuzumab: First biologic therapy in gastric cancer</article-title><source>Ther. Adv. Med Oncol.</source><year>2013</year><volume>5</volume><fpage>143</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1177/1758834012469429</pub-id><?supplied-pmid 23450234?><pub-id pub-id-type="pmid">23450234</pub-id></element-citation></ref><ref id="B108-biomolecules-09-00679"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casak</surname><given-names>S.J.</given-names></name><name><surname>Fashoyin-Aje</surname><given-names>I.</given-names></name><name><surname>Lemery</surname><given-names>S.J.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Jin</surname><given-names>R.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Zhao</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name></person-group><article-title>FDA approval summary: Ramucirumab for gastric cancer</article-title><source>Clin. Cancer Res.</source><year>2015</year><volume>21</volume><fpage>3372</fpage><lpage>3376</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-15-0600</pub-id><?supplied-pmid 26048277?><pub-id pub-id-type="pmid">26048277</pub-id></element-citation></ref><ref id="B109-biomolecules-09-00679"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vora</surname><given-names>C.</given-names></name><name><surname>Gupta</surname><given-names>S.</given-names></name></person-group><article-title>Targeted therapy in cervical cancer</article-title><source>Esmo Open</source><year>2019</year><volume>3</volume><fpage>e000462</fpage><pub-id pub-id-type="doi">10.1136/esmoopen-2018-000462</pub-id><?supplied-pmid 30997156?><pub-id pub-id-type="pmid">30997156</pub-id></element-citation></ref><ref id="B110-biomolecules-09-00679"><label>110.</label><element-citation publication-type="web"><article-title>The Nobel Prize in Physiology or Medicine</article-title><year>2018</year><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.nobelprize.org/prizes/medicine/2018/summary/">https://www.nobelprize.org/prizes/medicine/2018/summary/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2019-10-31">(accessed on 31 October 2019)</date-in-citation></element-citation></ref><ref id="B111-biomolecules-09-00679"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammerich</surname><given-names>L.</given-names></name><name><surname>Binder</surname><given-names>A.</given-names></name><name><surname>Brody</surname><given-names>J.D.</given-names></name></person-group><article-title>In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf</article-title><source>Mol. Oncol.</source><year>2015</year><volume>9</volume><fpage>1966</fpage><lpage>1981</lpage><pub-id pub-id-type="doi">10.1016/j.molonc.2015.10.016</pub-id><?supplied-pmid 26632446?><pub-id pub-id-type="pmid">26632446</pub-id></element-citation></ref><ref id="B112-biomolecules-09-00679"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>E.D.</given-names></name><name><surname>Hurwitz</surname><given-names>A.A.</given-names></name><name><surname>Foster</surname><given-names>B.A.</given-names></name><name><surname>Madias</surname><given-names>C.</given-names></name><name><surname>Feldhaus</surname><given-names>A.L.</given-names></name><name><surname>Greenberg</surname><given-names>N.M.</given-names></name><name><surname>Burg</surname><given-names>M.B.</given-names></name><name><surname>Allison</surname><given-names>J.P.</given-names></name></person-group><article-title>Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1997</year><volume>94</volume><fpage>8099</fpage><lpage>8103</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.15.8099</pub-id><pub-id pub-id-type="pmid">9223321</pub-id></element-citation></ref><ref id="B113-biomolecules-09-00679"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodi</surname><given-names>F.S.</given-names></name><name><surname>Mihm</surname><given-names>M.C.</given-names></name><name><surname>Soiffer</surname><given-names>R.J.</given-names></name><name><surname>Haluska</surname><given-names>F.G.</given-names></name><name><surname>Butler</surname><given-names>M.</given-names></name><name><surname>Seiden</surname><given-names>M.V.</given-names></name><name><surname>Davis</surname><given-names>T.</given-names></name><name><surname>Henry-Spires</surname><given-names>R.</given-names></name><name><surname>MacRae</surname><given-names>S.</given-names></name><name><surname>Willman</surname><given-names>A.</given-names></name></person-group><article-title>Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2003</year><volume>100</volume><fpage>4712</fpage><lpage>4717</lpage><pub-id pub-id-type="doi">10.1073/pnas.0830997100</pub-id><pub-id pub-id-type="pmid">12682289</pub-id></element-citation></ref><ref id="B114-biomolecules-09-00679"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leach</surname><given-names>D.R.</given-names></name><name><surname>Krummel</surname><given-names>M.F.</given-names></name><name><surname>Allison</surname><given-names>J.P.</given-names></name></person-group><article-title>Enhancement of antitumor immunity by CTLA-4 blockade</article-title><source>Science (N. Y.)</source><year>1996</year><volume>271</volume><fpage>1734</fpage><lpage>1736</lpage><pub-id pub-id-type="doi">10.1126/science.271.5256.1734</pub-id></element-citation></ref><ref id="B115-biomolecules-09-00679"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodi</surname><given-names>F.S.</given-names></name><name><surname>O&#x02019;Day</surname><given-names>S.J.</given-names></name><name><surname>McDermott</surname><given-names>D.F.</given-names></name><name><surname>Weber</surname><given-names>R.W.</given-names></name><name><surname>Sosman</surname><given-names>J.A.</given-names></name><name><surname>Haanen</surname><given-names>J.B.</given-names></name><name><surname>Gonzalez</surname><given-names>R.</given-names></name><name><surname>Robert</surname><given-names>C.</given-names></name><name><surname>Schadendorf</surname><given-names>D.</given-names></name><name><surname>Hassel</surname><given-names>J.C.</given-names></name></person-group><article-title>Improved survival with ipilimumab in patients with metastatic melanoma</article-title><source>N. Engl. J. Med.</source><year>2010</year><volume>363</volume><fpage>711</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1003466</pub-id><pub-id pub-id-type="pmid">20525992</pub-id></element-citation></ref><ref id="B116-biomolecules-09-00679"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>D.B.</given-names></name><name><surname>Peng</surname><given-names>C.</given-names></name><name><surname>Abramson</surname><given-names>R.G.</given-names></name><name><surname>Ye</surname><given-names>F.</given-names></name><name><surname>Zhao</surname><given-names>S.</given-names></name><name><surname>Wolchok</surname><given-names>J.D.</given-names></name><name><surname>Sosman</surname><given-names>J.A.</given-names></name><name><surname>Carvajal</surname><given-names>R.D.</given-names></name><name><surname>Ariyan</surname><given-names>C.E.</given-names></name></person-group><article-title>Clinical activity of ipilimumab in acral melanoma: A retrospective review</article-title><source>Oncologist</source><year>2015</year><volume>20</volume><fpage>648</fpage><lpage>652</lpage><pub-id pub-id-type="doi">10.1634/theoncologist.2014-0468</pub-id><pub-id pub-id-type="pmid">25964307</pub-id></element-citation></ref><ref id="B117-biomolecules-09-00679"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>G.J.</given-names></name><name><surname>Long</surname><given-names>A.J.</given-names></name><name><surname>Iwai</surname><given-names>Y.</given-names></name><name><surname>Bourque</surname><given-names>K.</given-names></name><name><surname>Chernova</surname><given-names>T.</given-names></name><name><surname>Nishimura</surname><given-names>H.</given-names></name><name><surname>Fitz</surname><given-names>L.J.</given-names></name><name><surname>Malenkovich</surname><given-names>N.</given-names></name><name><surname>Okazaki</surname><given-names>T.</given-names></name><name><surname>Byrne</surname><given-names>M.C.</given-names></name></person-group><article-title>Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation</article-title><source>J. Exp. Med.</source><year>2000</year><volume>192</volume><fpage>1027</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.1084/jem.192.7.1027</pub-id><?supplied-pmid 11015443?><pub-id pub-id-type="pmid">11015443</pub-id></element-citation></ref><ref id="B118-biomolecules-09-00679"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poole</surname><given-names>R.M.</given-names></name></person-group><article-title>Pembrolizumab: First global approval</article-title><source>Drugs</source><year>2014</year><volume>74</volume><fpage>1973</fpage><lpage>1981</lpage><pub-id pub-id-type="doi">10.1007/s40265-014-0314-5</pub-id><?supplied-pmid 25331768?><pub-id pub-id-type="pmid">25331768</pub-id></element-citation></ref><ref id="B119-biomolecules-09-00679"><label>119.</label><element-citation publication-type="gov"><article-title>FDA Approval</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-ipilimumab-msi-h-or-dmmr-metastatic-colorectal-cancer">https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-ipilimumab-msi-h-or-dmmr-metastatic-colorectal-cancer</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2019-10-31">(accessed on 31 October 2019)</date-in-citation></element-citation></ref><ref id="B120-biomolecules-09-00679"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massard</surname><given-names>C.</given-names></name><name><surname>Gordon</surname><given-names>M.S.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Rafii</surname><given-names>S.</given-names></name><name><surname>Wainberg</surname><given-names>Z.A.</given-names></name><name><surname>Luke</surname><given-names>J.</given-names></name><name><surname>Curiel</surname><given-names>T.J.</given-names></name><name><surname>Colon-Otero</surname><given-names>G.</given-names></name><name><surname>Hamid</surname><given-names>O.</given-names></name><name><surname>Sanborn</surname><given-names>R.E.</given-names></name></person-group><article-title>Safety and efficacy of durvalumab (MEDI4736), an anti&#x02013;programmed cell death ligand-1 immune checkpoint inhibitor, in patients with advanced urothelial bladder cancer</article-title><source>J. Clin. Oncol.</source><year>2016</year><volume>34</volume><fpage>3119</fpage><pub-id pub-id-type="doi">10.1200/JCO.2016.67.9761</pub-id><?supplied-pmid 27269937?><pub-id pub-id-type="pmid">27269937</pub-id></element-citation></ref><ref id="B121-biomolecules-09-00679"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markham</surname><given-names>A.</given-names></name></person-group><article-title>Atezolizumab: first global approval</article-title><source>Drugs</source><year>2016</year><volume>76</volume><fpage>1227</fpage><lpage>1232</lpage><pub-id pub-id-type="doi">10.1007/s40265-016-0618-8</pub-id><pub-id pub-id-type="pmid">27412122</pub-id></element-citation></ref><ref id="B122-biomolecules-09-00679"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diamantis</surname><given-names>N.</given-names></name><name><surname>Banerji</surname><given-names>U.</given-names></name></person-group><article-title>Antibody-drug conjugates&#x02014;an emerging class of cancer treatment</article-title><source>Br. J. Cancer</source><year>2016</year><volume>114</volume><fpage>362</fpage><pub-id pub-id-type="doi">10.1038/bjc.2015.435</pub-id><pub-id pub-id-type="pmid">26742008</pub-id></element-citation></ref><ref id="B123-biomolecules-09-00679"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchikama</surname><given-names>K.</given-names></name><name><surname>An</surname><given-names>Z.</given-names></name></person-group><article-title>Antibody-drug conjugates: Recent advances in conjugation and linker chemistries</article-title><source>Protein Cell</source><year>2018</year><volume>9</volume><fpage>33</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1007/s13238-016-0323-0</pub-id><pub-id pub-id-type="pmid">27743348</pub-id></element-citation></ref><ref id="B124-biomolecules-09-00679"><label>124.</label><element-citation publication-type="web"><article-title>FDA Approval History</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.centerwatch.com/drug-information/fda-approved-drugs/drug/1254/kadcyla-ado-trastuzumab-emtansine">https://www.centerwatch.com/drug-information/fda-approved-drugs/drug/1254/kadcyla-ado-trastuzumab-emtansine</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2019-10-31">(accessed on 31 October 2019)</date-in-citation></element-citation></ref><ref id="B125-biomolecules-09-00679"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>G.D.L.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Dugger</surname><given-names>D.L.</given-names></name><name><surname>Crocker</surname><given-names>L.M.</given-names></name><name><surname>Parsons</surname><given-names>K.L.</given-names></name><name><surname>Mai</surname><given-names>E.</given-names></name><name><surname>Bl&#x000e4;ttler</surname><given-names>W.A.</given-names></name><name><surname>Lambert</surname><given-names>J.M.</given-names></name><name><surname>Chari</surname><given-names>R.V.</given-names></name><name><surname>Lutz</surname><given-names>R.J.</given-names></name></person-group><article-title>Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody&#x02013;cytotoxic drug conjugate</article-title><source>Cancer Res.</source><year>2008</year><volume>68</volume><fpage>9280</fpage><lpage>9290</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-1776</pub-id><pub-id pub-id-type="pmid">19010901</pub-id></element-citation></ref><ref id="B126-biomolecules-09-00679"><label>126.</label><element-citation publication-type="web"><article-title>Asparlas Approval History</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.drugs.com/history/asparlas.html">https://www.drugs.com/history/asparlas.html</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2019-10-31">(accessed on 31 October 2019)</date-in-citation></element-citation></ref><ref id="B127-biomolecules-09-00679"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angiolillo</surname><given-names>A.L.</given-names></name><name><surname>Schore</surname><given-names>R.J.</given-names></name><name><surname>Devidas</surname><given-names>M.</given-names></name><name><surname>Borowitz</surname><given-names>M.J.</given-names></name><name><surname>Carroll</surname><given-names>A.J.</given-names></name><name><surname>Gastier-Foster</surname><given-names>J.M.</given-names></name><name><surname>Heerema</surname><given-names>N.A.</given-names></name><name><surname>Keilani</surname><given-names>T.</given-names></name><name><surname>Lane</surname><given-names>A.R.</given-names></name><name><surname>Loh</surname><given-names>M.L.</given-names></name></person-group><article-title>Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: Results from Children&#x02019;s Oncology Group Study AALL07P4</article-title><source>J. Clin. Oncol.</source><year>2014</year><volume>32</volume><fpage>3874</fpage><pub-id pub-id-type="doi">10.1200/JCO.2014.55.5763</pub-id><pub-id pub-id-type="pmid">25348002</pub-id></element-citation></ref><ref id="B128-biomolecules-09-00679"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>R.G.</given-names></name><name><surname>Murillo</surname><given-names>G.</given-names></name><name><surname>Naithani</surname><given-names>R.</given-names></name><name><surname>Peng</surname><given-names>X.</given-names></name></person-group><article-title>Cancer chemoprevention by natural products: How far have we come?</article-title><source>Pharm. Res.</source><year>2010</year><volume>27</volume><fpage>950</fpage><lpage>961</lpage><pub-id pub-id-type="doi">10.1007/s11095-010-0085-y</pub-id><pub-id pub-id-type="pmid">20238150</pub-id></element-citation></ref><ref id="B129-biomolecules-09-00679"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>W.Y.</given-names></name><name><surname>Cai</surname><given-names>Y.Z.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group><article-title>Natural phenolic compounds from medicinal herbs and dietary plants: Potential use for cancer prevention</article-title><source>Nutr. Cancer</source><year>2010</year><volume>62</volume><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1080/01635580903191585</pub-id><pub-id pub-id-type="pmid">20043255</pub-id></element-citation></ref><ref id="B130-biomolecules-09-00679"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desai</surname><given-names>A.G.</given-names></name><name><surname>Qazi</surname><given-names>G.N.</given-names></name><name><surname>Ganju</surname><given-names>R.K.</given-names></name><name><surname>El-Tamer</surname><given-names>M.</given-names></name><name><surname>Singh</surname><given-names>J.</given-names></name><name><surname>Saxena</surname><given-names>A.K.</given-names></name><name><surname>Bedi</surname><given-names>Y.S.</given-names></name><name><surname>Taneja</surname><given-names>S.C.</given-names></name><name><surname>Bhat</surname><given-names>H.K.</given-names></name></person-group><article-title>Medicinal plants and cancer chemoprevention</article-title><source>Curr. Drug Metab.</source><year>2008</year><volume>9</volume><fpage>581</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.2174/138920008785821657</pub-id><?supplied-pmid 18781909?><pub-id pub-id-type="pmid">18781909</pub-id></element-citation></ref><ref id="B131-biomolecules-09-00679"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagler</surname><given-names>R.M.</given-names></name></person-group><article-title>Saliva as a tool for oral cancer diagnosis and prognosis</article-title><source>Oral Oncol.</source><year>2009</year><volume>45</volume><fpage>1006</fpage><lpage>1010</lpage><pub-id pub-id-type="doi">10.1016/j.oraloncology.2009.07.005</pub-id><?supplied-pmid 19828359?><pub-id pub-id-type="pmid">19828359</pub-id></element-citation></ref><ref id="B132-biomolecules-09-00679"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>M.A.</given-names></name><name><surname>Amin</surname><given-names>A.R.</given-names></name><name><surname>Shin</surname><given-names>D.M.</given-names></name></person-group><article-title>Chemopreventive potential of natural compounds in head and neck cancer</article-title><source>Nutr. Cancer</source><year>2010</year><volume>62</volume><fpage>973</fpage><lpage>987</lpage><pub-id pub-id-type="doi">10.1080/01635581.2010.509538</pub-id><pub-id pub-id-type="pmid">20924973</pub-id></element-citation></ref><ref id="B133-biomolecules-09-00679"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>W.</given-names></name><name><surname>Tak</surname><given-names>J.</given-names></name><name><surname>Ryu</surname><given-names>J.K.</given-names></name><name><surname>Jung</surname><given-names>M.</given-names></name><name><surname>Yook</surname><given-names>J.I.</given-names></name><name><surname>Kim</surname><given-names>H.J.</given-names></name><name><surname>Cha</surname><given-names>I.H.</given-names></name></person-group><article-title>Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells</article-title><source>Head Neck</source><year>2007</year><volume>29</volume><fpage>335</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1002/hed.20524</pub-id><?supplied-pmid 17163469?><pub-id pub-id-type="pmid">17163469</pub-id></element-citation></ref><ref id="B134-biomolecules-09-00679"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datta</surname><given-names>R.</given-names></name><name><surname>Kojima</surname><given-names>H.</given-names></name><name><surname>Yoshida</surname><given-names>K.</given-names></name><name><surname>Kufe</surname><given-names>D.</given-names></name></person-group><article-title>Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis</article-title><source>J. Biol. Chem.</source><year>1997</year><volume>272</volume><fpage>20317</fpage><lpage>20320</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.33.20317</pub-id><pub-id pub-id-type="pmid">9252332</pub-id></element-citation></ref><ref id="B135-biomolecules-09-00679"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Amours</surname><given-names>D.</given-names></name><name><surname>Germain</surname><given-names>M.</given-names></name><name><surname>Orth</surname><given-names>K.</given-names></name><name><surname>Dixit</surname><given-names>V.M.</given-names></name><name><surname>Poirier</surname><given-names>G.G.</given-names></name></person-group><article-title>Proteolysis of poly(ADP-ribose) polymerase by caspase 3: Kinetics of cleavage of mono(ADP-ribosyl)ated and DNA-bound substrates</article-title><source>Radiat. Res.</source><year>1998</year><volume>150</volume><fpage>3</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.2307/3579638</pub-id><pub-id pub-id-type="pmid">9650595</pub-id></element-citation></ref><ref id="B136-biomolecules-09-00679"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujisawa</surname><given-names>S.</given-names></name><name><surname>Atsumi</surname><given-names>T.</given-names></name><name><surname>Satoh</surname><given-names>K.</given-names></name><name><surname>Kadoma</surname><given-names>Y.</given-names></name><name><surname>Ishihara</surname><given-names>M.</given-names></name><name><surname>Okada</surname><given-names>N.</given-names></name><name><surname>Nagasaki</surname><given-names>M.</given-names></name><name><surname>Yokoe</surname><given-names>I.</given-names></name><name><surname>Sakagami</surname><given-names>H.</given-names></name></person-group><article-title>Radical generation, radical-scavenging activity, and cytotoxicity of eugenol-related compounds</article-title><source>Vitr. Mol. Toxicol.</source><year>2000</year><volume>13</volume><fpage>269</fpage><lpage>280</lpage></element-citation></ref><ref id="B137-biomolecules-09-00679"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrasco</surname><given-names>A.H.</given-names></name><name><surname>Espinoza</surname><given-names>C.L.</given-names></name><name><surname>Cardile</surname><given-names>V.</given-names></name><name><surname>Gallardo</surname><given-names>C.</given-names></name><name><surname>Cardona</surname><given-names>W.</given-names></name><name><surname>Lombardo</surname><given-names>L.</given-names></name><name><surname>Catal&#x000e1;n</surname><given-names>M.K.</given-names></name><name><surname>Cuellar</surname><given-names>F.M.</given-names></name><name><surname>Russo</surname><given-names>A.</given-names></name></person-group><article-title>Eugenol and its synthetic analogues inhibit cell growth of human cancer cells (Part I)</article-title><source>J. Braz. Chem. Soc.</source><year>2008</year><volume>19</volume><fpage>543</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1590/S0103-50532008000300024</pub-id></element-citation></ref><ref id="B138-biomolecules-09-00679"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeng</surname><given-names>J.H.</given-names></name><name><surname>Hahn</surname><given-names>L.J.</given-names></name><name><surname>Lu</surname><given-names>F.J.</given-names></name><name><surname>Wang</surname><given-names>Y.J.</given-names></name><name><surname>Kuo</surname><given-names>M.Y.</given-names></name></person-group><article-title>Eugenol triggers different pathobiological effects on human oral mucosal fibroblasts</article-title><source>J. Dent. Res.</source><year>1994</year><volume>73</volume><fpage>1050</fpage><lpage>1055</lpage><pub-id pub-id-type="doi">10.1177/00220345940730050601</pub-id><pub-id pub-id-type="pmid">8006231</pub-id></element-citation></ref><ref id="B139-biomolecules-09-00679"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziech</surname><given-names>D.</given-names></name><name><surname>Anestopoulos</surname><given-names>I.</given-names></name><name><surname>Hanafi</surname><given-names>R.</given-names></name><name><surname>Voulgaridou</surname><given-names>G.P.</given-names></name><name><surname>Franco</surname><given-names>R.</given-names></name><name><surname>Georgakilas</surname><given-names>A.G.</given-names></name><name><surname>Pappa</surname><given-names>A.</given-names></name><name><surname>Panayiotidis</surname><given-names>M.I.</given-names></name></person-group><article-title>Pleiotrophic effects of natural products in ROS-induced carcinogenesis: The role of plant-derived natural products in oral cancer chemoprevention</article-title><source>Cancer Lett.</source><year>2012</year><volume>327</volume><fpage>16</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2012.02.025</pub-id><pub-id pub-id-type="pmid">22381695</pub-id></element-citation></ref><ref id="B140-biomolecules-09-00679"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>W.F.</given-names></name><name><surname>Tsai</surname><given-names>C.H.</given-names></name><name><surname>Yang</surname><given-names>S.F.</given-names></name><name><surname>Chang</surname><given-names>Y.C.</given-names></name></person-group><article-title>Elevated expression of NF-kappaB in oral submucous fibrosis--evidence for NF-kappaB induction by safrole in human buccal mucosal fibroblasts</article-title><source>Oral Oncol.</source><year>2007</year><volume>43</volume><fpage>557</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1016/j.oraloncology.2006.06.007</pub-id><?supplied-pmid 16996785?><pub-id pub-id-type="pmid">16996785</pub-id></element-citation></ref><ref id="B141-biomolecules-09-00679"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gopalakrishnan</surname><given-names>A.</given-names></name><name><surname>Tony Kong</surname><given-names>A.N.</given-names></name></person-group><article-title>Anticarcinogenesis by dietary phytochemicals: Cytoprotection by Nrf2 in normal cells and cytotoxicity by modulation of transcription factors NF-kappa B and AP-1 in abnormal cancer cells</article-title><source>Food Chem. Toxicol.</source><year>2008</year><volume>46</volume><fpage>1257</fpage><lpage>1270</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2007.09.082</pub-id><?supplied-pmid 17950513?><pub-id pub-id-type="pmid">17950513</pub-id></element-citation></ref><ref id="B142-biomolecules-09-00679"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H.L.</given-names></name><name><surname>Liu</surname><given-names>T.Y.</given-names></name><name><surname>Wu</surname><given-names>C.W.</given-names></name><name><surname>Chi</surname><given-names>C.W.</given-names></name></person-group><article-title>Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel</article-title><source>Br. J. Cancer</source><year>1999</year><volume>81</volume><fpage>416</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1038/sj.bjc.6690710</pub-id><?supplied-pmid 10507765?><pub-id pub-id-type="pmid">10507765</pub-id></element-citation></ref><ref id="B143-biomolecules-09-00679"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C.C.</given-names></name><name><surname>Yang</surname><given-names>J.S.</given-names></name><name><surname>Chen</surname><given-names>J.T.</given-names></name><name><surname>Fan</surname><given-names>S.</given-names></name><name><surname>Yu</surname><given-names>F.S.</given-names></name><name><surname>Yang</surname><given-names>J.L.</given-names></name><name><surname>Lu</surname><given-names>C.C.</given-names></name><name><surname>Kao</surname><given-names>M.C.</given-names></name><name><surname>Huang</surname><given-names>A.C.</given-names></name><name><surname>Lu</surname><given-names>H.F.</given-names></name><etal/></person-group><article-title>Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway</article-title><source>Anticancer Res.</source><year>2007</year><volume>27</volume><fpage>3371</fpage><lpage>3378</lpage><?supplied-pmid 17970083?><pub-id pub-id-type="pmid">17970083</pub-id></element-citation></ref><ref id="B144-biomolecules-09-00679"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>W.Z.</given-names></name><name><surname>Chou</surname><given-names>C.T.</given-names></name><name><surname>Lu</surname><given-names>T.</given-names></name><name><surname>Chi</surname><given-names>C.C.</given-names></name><name><surname>Tseng</surname><given-names>L.L.</given-names></name><name><surname>Pan</surname><given-names>C.C.</given-names></name><name><surname>Lin</surname><given-names>K.L.</given-names></name><name><surname>Kuo</surname><given-names>C.C.</given-names></name><name><surname>Jan</surname><given-names>C.R.</given-names></name></person-group><article-title>The mechanism of carvacrol-evoked [Ca<sup>2+</sup>]i rises and non-Ca<sup>2+</sup>-triggered cell death in OC2 human oral cancer cells</article-title><source>Toxicology</source><year>2013</year><volume>303</volume><fpage>152</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/j.tox.2012.10.026</pub-id><?supplied-pmid 23146755?><pub-id pub-id-type="pmid">23146755</pub-id></element-citation></ref><ref id="B145-biomolecules-09-00679"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sertel</surname><given-names>S.</given-names></name><name><surname>Eichhorn</surname><given-names>T.</given-names></name><name><surname>Plinkert</surname><given-names>P.K.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name></person-group><article-title>Cytotoxicity of Thymus vulgaris essential oil towards human oral cavity squamous cell carcinoma</article-title><source>Anticancer Res.</source><year>2011</year><volume>31</volume><fpage>81</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">21273584</pub-id></element-citation></ref><ref id="B146-biomolecules-09-00679"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sertel</surname><given-names>S.</given-names></name><name><surname>Eichhorn</surname><given-names>T.</given-names></name><name><surname>Plinkert</surname><given-names>P.K.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name></person-group><article-title>[Anticancer activity of Salvia officinalis essential oil against HNSCC cell line (UMSCC1)]</article-title><source>Hno</source><year>2011</year><volume>59</volume><fpage>1203</fpage><lpage>1208</lpage><pub-id pub-id-type="doi">10.1007/s00106-011-2274-3</pub-id><pub-id pub-id-type="pmid">21894557</pub-id></element-citation></ref><ref id="B147-biomolecules-09-00679"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sertel</surname><given-names>S.</given-names></name><name><surname>Eichhorn</surname><given-names>T.</given-names></name><name><surname>Plinkert</surname><given-names>P.K.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name></person-group><article-title>Chemical Composition and antiproliferative activity of essential oil from the leaves of a medicinal herb, Levisticum officinale, against UMSCC1 head and neck squamous carcinoma cells</article-title><source>Anticancer Res.</source><year>2011</year><volume>31</volume><fpage>185</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">21273597</pub-id></element-citation></ref><ref id="B148-biomolecules-09-00679"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manosroi</surname><given-names>J.</given-names></name><name><surname>Dhumtanom</surname><given-names>P.</given-names></name><name><surname>Manosroi</surname><given-names>A.</given-names></name></person-group><article-title>Anti-proliferative activity of essential oil extracted from Thai medicinal plants on KB and P388 cell lines</article-title><source>Cancer Lett.</source><year>2006</year><volume>235</volume><fpage>114</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2005.04.021</pub-id><pub-id pub-id-type="pmid">15979235</pub-id></element-citation></ref><ref id="B149-biomolecules-09-00679"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>J.D.</given-names></name><name><surname>Jeong</surname><given-names>M.R.</given-names></name><name><surname>Kim</surname><given-names>H.Y.</given-names></name><name><surname>Lee</surname><given-names>J.C.</given-names></name><name><surname>Lee</surname><given-names>K.Y.</given-names></name></person-group><article-title>MAPK activation is necessary to the apoptotic death of KB cells induced by the essential oil isolated from Artemisia iwayomogi</article-title><source>J. Ethnopharmacol.</source><year>2009</year><volume>123</volume><fpage>308</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2009.03.002</pub-id><pub-id pub-id-type="pmid">19429377</pub-id></element-citation></ref><ref id="B150-biomolecules-09-00679"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>J.D.</given-names></name><name><surname>Moon</surname><given-names>S.E.</given-names></name><name><surname>Kim</surname><given-names>H.Y.</given-names></name><name><surname>Cha</surname><given-names>I.H.</given-names></name><name><surname>Lee</surname><given-names>K.Y.</given-names></name></person-group><article-title>Essential oil of Artemisia capillaris induces apoptosis in KB cells via mitochondrial stress and caspase activation mediated by MAPK-stimulated signaling pathway</article-title><source>J. Food Sci.</source><year>2009</year><volume>74</volume><fpage>T75</fpage><lpage>T81</lpage><pub-id pub-id-type="doi">10.1111/j.1750-3841.2009.01355.x</pub-id><?supplied-pmid 20492133?><pub-id pub-id-type="pmid">20492133</pub-id></element-citation></ref><ref id="B151-biomolecules-09-00679"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keawsa-ard</surname><given-names>S.</given-names></name><name><surname>Liawruangrath</surname><given-names>B.</given-names></name><name><surname>Liawruangrath</surname><given-names>S.</given-names></name><name><surname>Teerawutgulrag</surname><given-names>A.</given-names></name><name><surname>Pyne</surname><given-names>S.G.</given-names></name></person-group><article-title>Chemical constituents and antioxidant and biological activities of the essential oil from leaves of Solanum spirale</article-title><source>Nat. Prod. Commun.</source><year>2012</year><volume>7</volume><fpage>955</fpage><lpage>958</lpage><pub-id pub-id-type="doi">10.1177/1934578X1200700740</pub-id><?supplied-pmid 22908592?><pub-id pub-id-type="pmid">22908592</pub-id></element-citation></ref><ref id="B152-biomolecules-09-00679"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edris</surname><given-names>A.E.</given-names></name></person-group><article-title>Anti-cancer properties of Nigella spp. essential oils and their major constituents, thymoquinone and beta-elemene</article-title><source>Curr. Clin. Pharm.</source><year>2009</year><volume>4</volume><fpage>43</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.2174/157488409787236137</pub-id></element-citation></ref><ref id="B153-biomolecules-09-00679"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pisseri</surname><given-names>F.</given-names></name><name><surname>Bertoli</surname><given-names>A.</given-names></name><name><surname>Pistelli</surname><given-names>L.</given-names></name></person-group><article-title>Essential oils in medicine: principles of therapy</article-title><source>Parassitologia</source><year>2008</year><volume>50</volume><fpage>89</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">18693566</pub-id></element-citation></ref><ref id="B154-biomolecules-09-00679"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seifried</surname><given-names>H.E.</given-names></name><name><surname>Anderson</surname><given-names>D.E.</given-names></name><name><surname>Fisher</surname><given-names>E.I.</given-names></name><name><surname>Milner</surname><given-names>J.A.</given-names></name></person-group><article-title>A review of the interaction among dietary antioxidants and reactive oxygen species</article-title><source>J. Nutr. Biochem.</source><year>2007</year><volume>18</volume><fpage>567</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2006.10.007</pub-id><pub-id pub-id-type="pmid">17360173</pub-id></element-citation></ref><ref id="B155-biomolecules-09-00679"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziech</surname><given-names>D.</given-names></name><name><surname>Franco</surname><given-names>R.</given-names></name><name><surname>Georgakilas</surname><given-names>A.G.</given-names></name><name><surname>Georgakila</surname><given-names>S.</given-names></name><name><surname>Malamou-Mitsi</surname><given-names>V.</given-names></name><name><surname>Schoneveld</surname><given-names>O.</given-names></name><name><surname>Pappa</surname><given-names>A.</given-names></name><name><surname>Panayiotidis</surname><given-names>M.I.</given-names></name></person-group><article-title>The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker development</article-title><source>Chem.-Biol. Interact.</source><year>2010</year><volume>188</volume><fpage>334</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2010.07.010</pub-id><pub-id pub-id-type="pmid">20637748</pub-id></element-citation></ref><ref id="B156-biomolecules-09-00679"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harish Kumar</surname><given-names>G.</given-names></name><name><surname>Vidya Priyadarsini</surname><given-names>R.</given-names></name><name><surname>Vinothini</surname><given-names>G.</given-names></name><name><surname>Vidjaya Letchoumy</surname><given-names>P.</given-names></name><name><surname>Nagini</surname><given-names>S.</given-names></name></person-group><article-title>The neem limonoids azadirachtin and nimbolide inhibit cell proliferation and induce apoptosis in an animal model of oral oncogenesis</article-title><source>Investig. New Drugs</source><year>2010</year><volume>28</volume><fpage>392</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1007/s10637-009-9263-3</pub-id><pub-id pub-id-type="pmid">19458912</pub-id></element-citation></ref><ref id="B157-biomolecules-09-00679"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hseu</surname><given-names>Y.C.</given-names></name><name><surname>Lee</surname><given-names>M.S.</given-names></name><name><surname>Wu</surname><given-names>C.R.</given-names></name><name><surname>Cho</surname><given-names>H.J.</given-names></name><name><surname>Lin</surname><given-names>K.Y.</given-names></name><name><surname>Lai</surname><given-names>G.H.</given-names></name><name><surname>Wang</surname><given-names>S.Y.</given-names></name><name><surname>Kuo</surname><given-names>Y.H.</given-names></name><name><surname>Kumar</surname><given-names>K.J.</given-names></name><name><surname>Yang</surname><given-names>H.L.</given-names></name></person-group><article-title>The chalcone flavokawain B induces G2/M cell-cycle arrest and apoptosis in human oral carcinoma HSC-3 cells through the intracellular ROS generation and downregulation of the Akt/p38 MAPK signaling pathway</article-title><source>J. Agric. Food Chem.</source><year>2012</year><volume>60</volume><fpage>2385</fpage><lpage>2397</lpage><pub-id pub-id-type="doi">10.1021/jf205053r</pub-id><pub-id pub-id-type="pmid">22324429</pub-id></element-citation></ref><ref id="B158-biomolecules-09-00679"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>M.</given-names></name><name><surname>Chung</surname><given-names>H.Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group><article-title>Deoxyelephantopin from Elephantopus scaber L. induces cell-cycle arrest and apoptosis in the human nasopharyngeal cancer CNE cells</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2011</year><volume>411</volume><fpage>342</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2011.06.144</pub-id><pub-id pub-id-type="pmid">21741953</pub-id></element-citation></ref><ref id="B159-biomolecules-09-00679"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>Z.</given-names></name><name><surname>Guo</surname><given-names>Y.T.</given-names></name><name><surname>Yi</surname><given-names>Y.J.</given-names></name><name><surname>Wang</surname><given-names>R.C.</given-names></name><name><surname>Hu</surname><given-names>Q.L.</given-names></name><name><surname>Xiong</surname><given-names>X.Y.</given-names></name></person-group><article-title>Ganoderma lucidum polysaccharides target a Fas/caspase dependent pathway to induce apoptosis in human colon cancer cells</article-title><source>Asian Pac. J. Cancer Prev.</source><year>2014</year><volume>15</volume><fpage>3981</fpage><lpage>3986</lpage><pub-id pub-id-type="doi">10.7314/APJCP.2014.15.9.3981</pub-id><pub-id pub-id-type="pmid">24935584</pub-id></element-citation></ref><ref id="B160-biomolecules-09-00679"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thyagarajan</surname><given-names>A.</given-names></name><name><surname>Jedinak</surname><given-names>A.</given-names></name><name><surname>Nguyen</surname><given-names>H.</given-names></name><name><surname>Terry</surname><given-names>C.</given-names></name><name><surname>Baldridge</surname><given-names>L.A.</given-names></name><name><surname>Jiang</surname><given-names>J.</given-names></name><name><surname>Sliva</surname><given-names>D.</given-names></name></person-group><article-title>Triterpenes from Ganoderma Lucidum induce autophagy in colon cancer through the inhibition of p38 mitogen-activated kinase (p38 MAPK)</article-title><source>Nutr. Cancer</source><year>2010</year><volume>62</volume><fpage>630</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1080/01635580903532390</pub-id><?supplied-pmid 20574924?><pub-id pub-id-type="pmid">20574924</pub-id></element-citation></ref><ref id="B161-biomolecules-09-00679"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romano</surname><given-names>B.</given-names></name><name><surname>Borrelli</surname><given-names>F.</given-names></name><name><surname>Pagano</surname><given-names>E.</given-names></name><name><surname>Cascio</surname><given-names>M.G.</given-names></name><name><surname>Pertwee</surname><given-names>R.G.</given-names></name><name><surname>Izzo</surname><given-names>A.A.</given-names></name></person-group><article-title>Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol</article-title><source>Phytomedicine</source><year>2014</year><volume>21</volume><fpage>631</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2013.11.006</pub-id><?supplied-pmid 24373545?><pub-id pub-id-type="pmid">24373545</pub-id></element-citation></ref><ref id="B162-biomolecules-09-00679"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name></person-group><article-title>Inhibition of proliferation and induction of apoptosis by genistein in colon cancer HT-29 cells</article-title><source>Cancer Lett.</source><year>2004</year><volume>215</volume><fpage>159</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2004.06.010</pub-id><?supplied-pmid 15488634?><pub-id pub-id-type="pmid">15488634</pub-id></element-citation></ref><ref id="B163-biomolecules-09-00679"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>S.X.</given-names></name><name><surname>Zhou</surname><given-names>Z.Q.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>Y.G.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>P.</given-names></name></person-group><article-title>Apoptotic effect of genistein on human colon cancer cells via inhibiting the nuclear factor-kappa B (NF-kappaB) pathway</article-title><source>Tumour Biol.</source><year>2014</year><volume>35</volume><fpage>11483</fpage><lpage>11488</lpage><pub-id pub-id-type="doi">10.1007/s13277-014-2487-7</pub-id><pub-id pub-id-type="pmid">25128065</pub-id></element-citation></ref><ref id="B164-biomolecules-09-00679"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>W.K.</given-names></name><name><surname>Ha</surname><given-names>A.W.</given-names></name><name><surname>Kim</surname><given-names>M.H.</given-names></name><name><surname>Chang</surname><given-names>M.J.</given-names></name></person-group><article-title>Anti-inflammatory effect of lycopene in SW480 human colorectal cancer cells</article-title><source>Nutr. Res. Pract.</source><year>2017</year><volume>11</volume><fpage>90</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.4162/nrp.2017.11.2.90</pub-id><?supplied-pmid 28386381?><pub-id pub-id-type="pmid">28386381</pub-id></element-citation></ref><ref id="B165-biomolecules-09-00679"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.H.</given-names></name><name><surname>Miao</surname><given-names>Y.X.</given-names></name><name><surname>Wang</surname><given-names>X.J.</given-names></name><name><surname>Yu</surname><given-names>Z.</given-names></name><name><surname>Geng</surname><given-names>M.Y.</given-names></name><name><surname>Han</surname><given-names>Y.T.</given-names></name><name><surname>Wang</surname><given-names>L.X.</given-names></name></person-group><article-title>Effects of Ginkgo biloba extract EGb761 on human colon adenocarcinoma cells</article-title><source>Cell. Physiol. Biochem.</source><year>2011</year><volume>27</volume><fpage>227</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1159/000327948</pub-id><pub-id pub-id-type="pmid">21471711</pub-id></element-citation></ref><ref id="B166-biomolecules-09-00679"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lefort</surname><given-names>E.C.</given-names></name><name><surname>Blay</surname><given-names>J.</given-names></name></person-group><article-title>The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cells</article-title><source>Clin. Exp. Metastasis</source><year>2011</year><volume>28</volume><fpage>337</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1007/s10585-010-9364-6</pub-id><pub-id pub-id-type="pmid">21298326</pub-id></element-citation></ref><ref id="B167-biomolecules-09-00679"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Psahoulia</surname><given-names>F.H.</given-names></name><name><surname>Drosopoulos</surname><given-names>K.G.</given-names></name><name><surname>Doubravska</surname><given-names>L.</given-names></name><name><surname>Andera</surname><given-names>L.</given-names></name><name><surname>Pintzas</surname><given-names>A.</given-names></name></person-group><article-title>Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts</article-title><source>Mol. Cancer Ther.</source><year>2007</year><volume>6</volume><fpage>2591</fpage><lpage>2599</lpage><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-07-0001</pub-id><pub-id pub-id-type="pmid">17876056</pub-id></element-citation></ref><ref id="B168-biomolecules-09-00679"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>R.</given-names></name><name><surname>Ward</surname><given-names>E.</given-names></name><name><surname>Brawley</surname><given-names>O.</given-names></name><name><surname>Jemal</surname><given-names>A.</given-names></name></person-group><article-title>Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths</article-title><source>CA Cancer J. Clin.</source><year>2011</year><volume>61</volume><fpage>212</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.3322/caac.20121</pub-id><pub-id pub-id-type="pmid">21685461</pub-id></element-citation></ref><ref id="B169-biomolecules-09-00679"><label>169.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>World Health Organization (WHO)</collab></person-group><article-title>Statistics on Brain Cancer</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://Www.Who.Int/Cancer/En/">http://Www.Who.Int/Cancer/En/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2018-12-31">(accessed on 31 December 2018)</date-in-citation></element-citation></ref><ref id="B170-biomolecules-09-00679"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salehi</surname><given-names>B.</given-names></name><name><surname>Fokou</surname><given-names>P.V.T.</given-names></name><name><surname>Yamthe</surname><given-names>L.R.T.</given-names></name><name><surname>Tali</surname><given-names>B.T.</given-names></name><name><surname>Adetunji</surname><given-names>C.O.</given-names></name><name><surname>Rahavian</surname><given-names>A.</given-names></name><name><surname>Mudau</surname><given-names>F.N.</given-names></name><name><surname>Martorell</surname><given-names>M.</given-names></name><name><surname>Setzer</surname><given-names>W.N.</given-names></name><name><surname>Rodrigues</surname><given-names>C.F.</given-names></name><etal/></person-group><article-title>Phytochemicals in Prostate Cancer: From Bioactive Molecules to Upcoming Therapeutic Agents</article-title><source>Nutrients</source><year>2019</year><volume>11</volume><elocation-id>1483</elocation-id><pub-id pub-id-type="doi">10.3390/nu11071483</pub-id></element-citation></ref><ref id="B171-biomolecules-09-00679"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berkovich</surname><given-names>L.</given-names></name><name><surname>Earon</surname><given-names>G.</given-names></name><name><surname>Ron</surname><given-names>I.</given-names></name><name><surname>Rimmon</surname><given-names>A.</given-names></name><name><surname>Vexler</surname><given-names>A.</given-names></name><name><surname>Lev-Ari</surname><given-names>S.</given-names></name></person-group><article-title>Moringa Oleifera aqueous leaf extract down-regulates nuclear factor-kappaB and increases cytotoxic effect of chemotherapy in pancreatic cancer cells</article-title><source>BMC Complement. Altern. Med.</source><year>2013</year><volume>13</volume><elocation-id>212</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-13-212</pub-id><?supplied-pmid 23957955?><pub-id pub-id-type="pmid">23957955</pub-id></element-citation></ref><ref id="B172-biomolecules-09-00679"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Win</surname><given-names>N.N.</given-names></name><name><surname>Awale</surname><given-names>S.</given-names></name><name><surname>Esumi</surname><given-names>H.</given-names></name><name><surname>Tezuka</surname><given-names>Y.</given-names></name><name><surname>Kadota</surname><given-names>S.</given-names></name></person-group><article-title>Bioactive secondary metabolites from Boesenbergia pandurata of Myanmar and their preferential cytotoxicity against human pancreatic cancer PANC-1 cell line in nutrient-deprived medium</article-title><source>J. Nat. Prod.</source><year>2007</year><volume>70</volume><fpage>1582</fpage><lpage>1587</lpage><pub-id pub-id-type="doi">10.1021/np070286m</pub-id><?supplied-pmid 17896818?><pub-id pub-id-type="pmid">17896818</pub-id></element-citation></ref><ref id="B173-biomolecules-09-00679"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hafeez</surname><given-names>B.B.</given-names></name><name><surname>Jamal</surname><given-names>M.S.</given-names></name><name><surname>Fischer</surname><given-names>J.W.</given-names></name><name><surname>Mustafa</surname><given-names>A.</given-names></name><name><surname>Verma</surname><given-names>A.K.</given-names></name></person-group><article-title>Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF-kappaB signaling pathways</article-title><source>Int. J. Cancer</source><year>2012</year><volume>131</volume><fpage>2175</fpage><lpage>2186</lpage><pub-id pub-id-type="doi">10.1002/ijc.27478</pub-id><?supplied-pmid 22322442?><pub-id pub-id-type="pmid">22322442</pub-id></element-citation></ref><ref id="B174-biomolecules-09-00679"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zalatnai</surname><given-names>A.</given-names></name><name><surname>Bocsi</surname><given-names>J.</given-names></name></person-group><article-title>Mimosine, a plant-derived amino acid induces apoptosis in human pancreatic cancer xenografts</article-title><source>Anticancer Res.</source><year>2003</year><volume>23</volume><fpage>4007</fpage><lpage>4009</lpage><pub-id pub-id-type="pmid">14666710</pub-id></element-citation></ref><ref id="B175-biomolecules-09-00679"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shankar</surname><given-names>S.</given-names></name><name><surname>Ganapathy</surname><given-names>S.</given-names></name><name><surname>Hingorani</surname><given-names>S.R.</given-names></name><name><surname>Srivastava</surname><given-names>R.K.</given-names></name></person-group><article-title>EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer</article-title><source>Front. Biosci.</source><year>2008</year><volume>13</volume><fpage>440</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.2741/2691</pub-id><pub-id pub-id-type="pmid">17981559</pub-id></element-citation></ref><ref id="B176-biomolecules-09-00679"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>L.L.</given-names></name><name><surname>George</surname><given-names>S.</given-names></name><name><surname>Ahmad</surname><given-names>I.</given-names></name><name><surname>Gosangari</surname><given-names>S.L.</given-names></name><name><surname>Abbasi</surname><given-names>A.</given-names></name><name><surname>Cunningham</surname><given-names>B.T.</given-names></name><name><surname>Watkin</surname><given-names>K.L.</given-names></name></person-group><article-title>Cytotoxicity effects of amoora rohituka and chittagonga on breast and pancreatic cancer cells</article-title><source>Evid. -Based Complement. Altern. Med.</source><year>2011</year><volume>2011</volume><elocation-id>86060</elocation-id><pub-id pub-id-type="doi">10.1155/2011/860605</pub-id></element-citation></ref><ref id="B177-biomolecules-09-00679"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awale</surname><given-names>S.</given-names></name><name><surname>Nakashima</surname><given-names>E.M.</given-names></name><name><surname>Kalauni</surname><given-names>S.K.</given-names></name><name><surname>Tezuka</surname><given-names>Y.</given-names></name><name><surname>Kurashima</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Esumi</surname><given-names>H.</given-names></name><name><surname>Kadota</surname><given-names>S.</given-names></name></person-group><article-title>Angelmarin, a novel anti-cancer agent able to eliminate the tolerance of cancer cells to nutrient starvation</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2006</year><volume>16</volume><fpage>581</fpage><lpage>583</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2005.10.046</pub-id><pub-id pub-id-type="pmid">16288865</pub-id></element-citation></ref><ref id="B178-biomolecules-09-00679"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rifai</surname><given-names>Y.</given-names></name><name><surname>Arai</surname><given-names>M.A.</given-names></name><name><surname>Koyano</surname><given-names>T.</given-names></name><name><surname>Kowithayakorn</surname><given-names>T.</given-names></name><name><surname>Ishibashi</surname><given-names>M.</given-names></name></person-group><article-title>Terpenoids and a flavonoid glycoside from Acacia pennata leaves as hedgehog/GLI-mediated transcriptional inhibitors</article-title><source>J. Nat. Prod.</source><year>2010</year><volume>73</volume><fpage>995</fpage><lpage>997</lpage><pub-id pub-id-type="doi">10.1021/np1000818</pub-id><pub-id pub-id-type="pmid">20450170</pub-id></element-citation></ref><ref id="B179-biomolecules-09-00679"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drag</surname><given-names>M.</given-names></name><name><surname>Surowiak</surname><given-names>P.</given-names></name><name><surname>Drag-Zalesinska</surname><given-names>M.</given-names></name><name><surname>Dietel</surname><given-names>M.</given-names></name><name><surname>Lage</surname><given-names>H.</given-names></name><name><surname>Oleksyszyn</surname><given-names>J.</given-names></name></person-group><article-title>Comparision of the cytotoxic effects of birch bark extract, betulin and betulinic acid towards human gastric carcinoma and pancreatic carcinoma drug-sensitive and drug-resistant cell lines</article-title><source>Molecules</source><year>2009</year><volume>14</volume><fpage>1639</fpage><lpage>1651</lpage><pub-id pub-id-type="doi">10.3390/molecules14041639</pub-id><pub-id pub-id-type="pmid">19396022</pub-id></element-citation></ref><ref id="B180-biomolecules-09-00679"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwanski</surname><given-names>G.B.</given-names></name><name><surname>Lee</surname><given-names>D.H.</given-names></name><name><surname>En-Gal</surname><given-names>S.</given-names></name><name><surname>Doan</surname><given-names>N.B.</given-names></name><name><surname>Castor</surname><given-names>B.</given-names></name><name><surname>Vogt</surname><given-names>M.</given-names></name><name><surname>Toh</surname><given-names>M.</given-names></name><name><surname>Bokemeyer</surname><given-names>C.</given-names></name><name><surname>Said</surname><given-names>J.W.</given-names></name><name><surname>Thoennissen</surname><given-names>N.H.</given-names></name><etal/></person-group><article-title>Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer</article-title><source>Br. J. Pharm.</source><year>2010</year><volume>160</volume><fpage>998</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1111/j.1476-5381.2010.00741.x</pub-id></element-citation></ref><ref id="B181-biomolecules-09-00679"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rausch</surname><given-names>V.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Kallifatidis</surname><given-names>G.</given-names></name><name><surname>Baumann</surname><given-names>B.</given-names></name><name><surname>Mattern</surname><given-names>J.</given-names></name><name><surname>Gladkich</surname><given-names>J.</given-names></name><name><surname>Wirth</surname><given-names>T.</given-names></name><name><surname>Schemmer</surname><given-names>P.</given-names></name><name><surname>Buchler</surname><given-names>M.W.</given-names></name><name><surname>Zoller</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics</article-title><source>Cancer Res.</source><year>2010</year><volume>70</volume><fpage>5004</fpage><lpage>5013</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-10-0066</pub-id><?supplied-pmid 20530687?><pub-id pub-id-type="pmid">20530687</pub-id></element-citation></ref><ref id="B182-biomolecules-09-00679"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>G.X.</given-names></name><name><surname>Ding</surname><given-names>X.L.</given-names></name><name><surname>Huang</surname><given-names>J.F.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>S.B.</given-names></name><name><surname>Cheng</surname><given-names>J.P.</given-names></name><name><surname>Wei</surname><given-names>Q.</given-names></name></person-group><article-title>Apoptosis of human pancreatic cancer cells induced by Triptolide</article-title><source>World J. Gastroenterol.</source><year>2008</year><volume>14</volume><fpage>1504</fpage><lpage>1509</lpage><pub-id pub-id-type="doi">10.3748/wjg.14.1504</pub-id><?supplied-pmid 18330938?><pub-id pub-id-type="pmid">18330938</pub-id></element-citation></ref><ref id="B183-biomolecules-09-00679"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anastyuk</surname><given-names>S.D.</given-names></name><name><surname>Shevchenko</surname><given-names>N.M.</given-names></name><name><surname>Ermakova</surname><given-names>S.P.</given-names></name><name><surname>Vishchuk</surname><given-names>O.S.</given-names></name><name><surname>Nazarenko</surname><given-names>E.L.</given-names></name><name><surname>Dmitrenok</surname><given-names>P.S.</given-names></name><name><surname>Zvyagintseva</surname><given-names>T.N.</given-names></name></person-group><article-title>Anticancer activity in vitro of a fucoidan from the brown alga Fucus evanescens and its low-molecular fragments, structurally characterized by tandem mass-spectrometry</article-title><source>Carbohydr. Polym.</source><year>2012</year><volume>87</volume><fpage>186</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2011.07.036</pub-id></element-citation></ref><ref id="B184-biomolecules-09-00679"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brohem</surname><given-names>C.A.</given-names></name><name><surname>Sawada</surname><given-names>T.C.</given-names></name><name><surname>Massaro</surname><given-names>R.R.</given-names></name><name><surname>Almeida</surname><given-names>R.L.</given-names></name><name><surname>Rivelli</surname><given-names>D.P.</given-names></name><name><surname>Ropke</surname><given-names>C.D.</given-names></name><name><surname>da Silva</surname><given-names>V.V.</given-names></name><name><surname>de Lima</surname><given-names>T.M.</given-names></name><name><surname>Curi</surname><given-names>R.</given-names></name><name><surname>Barros</surname><given-names>S.B.</given-names></name><etal/></person-group><article-title>Apoptosis induction by 4-nerolidylcatechol in melanoma cell lines</article-title><source>Toxicol. Vitr.</source><year>2009</year><volume>23</volume><fpage>111</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.tiv.2008.11.004</pub-id></element-citation></ref><ref id="B185-biomolecules-09-00679"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Lan</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>Q.</given-names></name><name><surname>Hua</surname><given-names>Z.</given-names></name></person-group><article-title>Galangin induces B16F10 melanoma cell apoptosis via mitochondrial pathway and sustained activation of p38 MAPK</article-title><source>Cytotechnology</source><year>2013</year><volume>65</volume><fpage>447</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1007/s10616-012-9499-1</pub-id><pub-id pub-id-type="pmid">23001390</pub-id></element-citation></ref><ref id="B186-biomolecules-09-00679"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teh</surname><given-names>S.S.</given-names></name><name><surname>Ee</surname><given-names>G.C.</given-names></name><name><surname>Mah</surname><given-names>S.H.</given-names></name><name><surname>Yong</surname><given-names>Y.K.</given-names></name><name><surname>Lim</surname><given-names>Y.M.</given-names></name><name><surname>Rahmani</surname><given-names>M.</given-names></name><name><surname>Ahmad</surname><given-names>Z.</given-names></name></person-group><article-title>In vitro cytotoxic, antioxidant, and antimicrobial activities of Mesua beccariana (Baill.) Kosterm., Mesua ferrea Linn., and Mesua congestiflora extracts</article-title><source>Biomed Res. Int.</source><year>2013</year><volume>2013</volume><elocation-id>517072</elocation-id><pub-id pub-id-type="doi">10.1155/2013/517072</pub-id><pub-id pub-id-type="pmid">24089682</pub-id></element-citation></ref><ref id="B187-biomolecules-09-00679"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elmasri</surname><given-names>W.A.</given-names></name><name><surname>Hegazy</surname><given-names>M.-E.F.</given-names></name><name><surname>Mechref</surname><given-names>Y.</given-names></name><name><surname>Par&#x000e9;</surname><given-names>P.W.</given-names></name></person-group><article-title>Cytotoxic saponin poliusaposide from Teucrium polium</article-title><source>Rsc Adv.</source><year>2015</year><volume>5</volume><fpage>27126</fpage><lpage>27133</lpage><pub-id pub-id-type="doi">10.1039/C5RA02713F</pub-id></element-citation></ref><ref id="B188-biomolecules-09-00679"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nayak</surname><given-names>D.</given-names></name><name><surname>Pradhan</surname><given-names>S.</given-names></name><name><surname>Ashe</surname><given-names>S.</given-names></name><name><surname>Rauta</surname><given-names>P.R.</given-names></name><name><surname>Nayak</surname><given-names>B.</given-names></name></person-group><article-title>Biologically synthesised silver nanoparticles from three diverse family of plant extracts and their anticancer activity against epidermoid A431 carcinoma</article-title><source>J. Colloid Interface Sci.</source><year>2015</year><volume>457</volume><fpage>329</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1016/j.jcis.2015.07.012</pub-id><pub-id pub-id-type="pmid">26196716</pub-id></element-citation></ref><ref id="B189-biomolecules-09-00679"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuppusamy</surname><given-names>P.</given-names></name><name><surname>Yusoff</surname><given-names>M.M.</given-names></name><name><surname>Maniam</surname><given-names>G.P.</given-names></name><name><surname>Govindan</surname><given-names>N.</given-names></name></person-group><article-title>A case study&#x02013;Regulation and functional mechanisms of cancer cells and control its activity using plants and their derivatives</article-title><source>J. Pharm. Res.</source><year>2013</year><volume>6</volume><fpage>884</fpage><lpage>892</lpage><pub-id pub-id-type="doi">10.1016/j.jopr.2013.08.002</pub-id></element-citation></ref><ref id="B190-biomolecules-09-00679"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balasubramanian</surname><given-names>R.</given-names></name><name><surname>Narayanan</surname><given-names>M.</given-names></name><name><surname>Kedalgovindaram</surname><given-names>L.</given-names></name><name><surname>Devarakonda Rama</surname><given-names>K.</given-names></name></person-group><article-title>Cytotoxic activity of flavone glycoside from the stem of Indigofera aspalathoides Vahl</article-title><source>J. Nat. Med.</source><year>2006</year><volume>61</volume><fpage>80</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1007/s11418-006-0026-6</pub-id></element-citation></ref><ref id="B191-biomolecules-09-00679"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tourino</surname><given-names>S.</given-names></name><name><surname>Selga</surname><given-names>A.</given-names></name><name><surname>Jimenez</surname><given-names>A.</given-names></name><name><surname>Julia</surname><given-names>L.</given-names></name><name><surname>Lozano</surname><given-names>C.</given-names></name><name><surname>Lizarraga</surname><given-names>D.</given-names></name><name><surname>Cascante</surname><given-names>M.</given-names></name><name><surname>Torres</surname><given-names>J.L.</given-names></name></person-group><article-title>Procyanidin fractions from pine (Pinus pinaster) bark: Radical scavenging power in solution, antioxidant activity in emulsion, and antiproliferative effect in melanoma cells</article-title><source>J. Agric. Food Chem.</source><year>2005</year><volume>53</volume><fpage>4728</fpage><lpage>4735</lpage><pub-id pub-id-type="doi">10.1021/jf050262q</pub-id><?supplied-pmid 15941307?><pub-id pub-id-type="pmid">15941307</pub-id></element-citation></ref><ref id="B192-biomolecules-09-00679"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname><given-names>Q.L.</given-names></name><name><surname>Tezuka</surname><given-names>Y.</given-names></name><name><surname>Banskota</surname><given-names>A.H.</given-names></name><name><surname>Tran</surname><given-names>Q.K.</given-names></name><name><surname>Saiki</surname><given-names>I.</given-names></name><name><surname>Kadota</surname><given-names>S.</given-names></name></person-group><article-title>New spirostanol steroids and steroidal saponins from roots and rhizomes of Dracaena angustifolia and their antiproliferative activity</article-title><source>J. Nat. Prod.</source><year>2001</year><volume>64</volume><fpage>1127</fpage><lpage>1132</lpage><pub-id pub-id-type="doi">10.1021/np0100385</pub-id><?supplied-pmid 11575942?><pub-id pub-id-type="pmid">11575942</pub-id></element-citation></ref><ref id="B193-biomolecules-09-00679"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>M.H.</given-names></name><name><surname>Huang</surname><given-names>Z.</given-names></name><name><surname>Kim</surname><given-names>D.J.</given-names></name><name><surname>Kim</surname><given-names>S.H.</given-names></name><name><surname>Kim</surname><given-names>M.O.</given-names></name><name><surname>Lee</surname><given-names>S.Y.</given-names></name><name><surname>Xie</surname><given-names>H.</given-names></name><name><surname>Park</surname><given-names>S.J.</given-names></name><name><surname>Kim</surname><given-names>J.Y.</given-names></name><name><surname>Kundu</surname><given-names>J.K.</given-names></name><etal/></person-group><article-title>Direct targeting of MEK1/2 and RSK2 by silybin induces cell-cycle arrest and inhibits melanoma cell growth</article-title><source>Cancer Prev. Res.</source><year>2013</year><volume>6</volume><fpage>455</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-12-0425</pub-id><?supplied-pmid 23447564?><pub-id pub-id-type="pmid">23447564</pub-id></element-citation></ref><ref id="B194-biomolecules-09-00679"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramasamy</surname><given-names>K.</given-names></name><name><surname>Agarwal</surname><given-names>R.</given-names></name></person-group><article-title>Multitargeted therapy of cancer by silymarin</article-title><source>Cancer Lett.</source><year>2008</year><volume>269</volume><fpage>352</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2008.03.053</pub-id><?supplied-pmid 18472213?><pub-id pub-id-type="pmid">18472213</pub-id></element-citation></ref><ref id="B195-biomolecules-09-00679"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>S.</given-names></name><name><surname>Das</surname><given-names>J.</given-names></name><name><surname>Paul</surname><given-names>A.</given-names></name><name><surname>Samadder</surname><given-names>A.</given-names></name><name><surname>Khuda-Bukhsh</surname><given-names>A.R.</given-names></name></person-group><article-title>Apigenin, a bioactive flavonoid from Lycopodium clavatum, stimulates nucleotide excision repair genes to protect skin keratinocytes from ultraviolet B-induced reactive oxygen species and DNA damage</article-title><source>J. Acupunct. Meridian Stud.</source><year>2013</year><volume>6</volume><fpage>252</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1016/j.jams.2013.07.002</pub-id><pub-id pub-id-type="pmid">24139463</pub-id></element-citation></ref><ref id="B196-biomolecules-09-00679"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loizzo</surname><given-names>M.R.</given-names></name><name><surname>Tundis</surname><given-names>R.</given-names></name><name><surname>Menichini</surname><given-names>F.</given-names></name><name><surname>Saab</surname><given-names>A.M.</given-names></name><name><surname>Statti</surname><given-names>G.A.</given-names></name><name><surname>Menichini</surname><given-names>F.</given-names></name></person-group><article-title>Cytotoxic activity of essential oils from labiatae and lauraceae families against in vitro human tumor models</article-title><source>Anticancer Res.</source><year>2007</year><volume>27</volume><fpage>3293</fpage><lpage>3299</lpage><pub-id pub-id-type="pmid">17970073</pub-id></element-citation></ref><ref id="B197-biomolecules-09-00679"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fouche</surname><given-names>G.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name><name><surname>Pillay</surname><given-names>P.</given-names></name><name><surname>Kolesnikova</surname><given-names>N.</given-names></name><name><surname>Maharaj</surname><given-names>V.J.</given-names></name><name><surname>Senabe</surname><given-names>J.</given-names></name></person-group><article-title>In vitro anticancer screening of South African plants</article-title><source>J. Ethnopharmacol.</source><year>2008</year><volume>119</volume><fpage>455</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2008.07.005</pub-id><pub-id pub-id-type="pmid">18678239</pub-id></element-citation></ref><ref id="B198-biomolecules-09-00679"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darmanin</surname><given-names>S.</given-names></name><name><surname>Wismayer</surname><given-names>P.S.</given-names></name><name><surname>Camilleri Podesta</surname><given-names>M.T.</given-names></name><name><surname>Micallef</surname><given-names>M.J.</given-names></name><name><surname>Buhagiar</surname><given-names>J.A.</given-names></name></person-group><article-title>An extract from Ricinus communis L. leaves possesses cytotoxic properties and induces apoptosis in SK-MEL-28 human melanoma cells</article-title><source>Nat. Prod. Res.</source><year>2009</year><volume>23</volume><fpage>561</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1080/14786410802228579</pub-id><pub-id pub-id-type="pmid">19384733</pub-id></element-citation></ref><ref id="B199-biomolecules-09-00679"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name><name><surname>Bhardwaj</surname><given-names>A.</given-names></name><name><surname>Aggarwal</surname><given-names>R.S.</given-names></name><name><surname>Seeram</surname><given-names>N.P.</given-names></name><name><surname>Shishodia</surname><given-names>S.</given-names></name><name><surname>Takada</surname><given-names>Y.</given-names></name></person-group><article-title>Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies</article-title><source>Anticancer Res.</source><year>2004</year><volume>24</volume><fpage>2783</fpage><lpage>2840</lpage><pub-id pub-id-type="pmid">15517885</pub-id></element-citation></ref><ref id="B200-biomolecules-09-00679"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niles</surname><given-names>R.M.</given-names></name><name><surname>McFarland</surname><given-names>M.</given-names></name><name><surname>Weimer</surname><given-names>M.B.</given-names></name><name><surname>Redkar</surname><given-names>A.</given-names></name><name><surname>Fu</surname><given-names>Y.M.</given-names></name><name><surname>Meadows</surname><given-names>G.G.</given-names></name></person-group><article-title>Resveratrol is a potent inducer of apoptosis in human melanoma cells</article-title><source>Cancer Lett.</source><year>2003</year><volume>190</volume><fpage>157</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/S0304-3835(02)00676-6</pub-id><pub-id pub-id-type="pmid">12565170</pub-id></element-citation></ref><ref id="B201-biomolecules-09-00679"><label>201.</label><element-citation publication-type="web"><article-title>World Cancer Research Fund International</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://Www.Wcrf.Org/">https://Www.Wcrf.Org/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2018-12-31">(accessed on 31 December 2018)</date-in-citation></element-citation></ref><ref id="B202-biomolecules-09-00679"><label>202.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Globocan</collab></person-group><source>Worldwide Incidence and Mortality of Cancer, 2002 [computer program]. Version 2.0</source><publisher-name>IARC CancerBase</publisher-name><publisher-loc>Lyon, France</publisher-loc><year>2002</year></element-citation></ref><ref id="B203-biomolecules-09-00679"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bezerra</surname><given-names>D.P.</given-names></name><name><surname>Marinho Filho</surname><given-names>J.D.</given-names></name><name><surname>Alves</surname><given-names>A.P.</given-names></name><name><surname>Pessoa</surname><given-names>C.</given-names></name><name><surname>de Moraes</surname><given-names>M.O.</given-names></name><name><surname>Pessoa</surname><given-names>O.D.</given-names></name><name><surname>Torres</surname><given-names>M.C.</given-names></name><name><surname>Silveira</surname><given-names>E.R.</given-names></name><name><surname>Viana</surname><given-names>F.A.</given-names></name><name><surname>Costa-Lotufo</surname><given-names>L.V.</given-names></name></person-group><article-title>Antitumor activity of the essential oil from the leaves of Croton regelianus and its component ascaridole</article-title><source>Chem. Biodivers.</source><year>2009</year><volume>6</volume><fpage>1224</fpage><lpage>1231</lpage><pub-id pub-id-type="doi">10.1002/cbdv.200800253</pub-id><?supplied-pmid 19697341?><pub-id pub-id-type="pmid">19697341</pub-id></element-citation></ref><ref id="B204-biomolecules-09-00679"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>el-Sawi</surname><given-names>S.A.</given-names></name><name><surname>Motawae</surname><given-names>H.M.</given-names></name><name><surname>Ali</surname><given-names>A.M.</given-names></name></person-group><article-title>Chemical composition, cytotoxic activity and antimicrobial activity of essential oils of leaves and berries of Juniperus phoenicea L. grown in Egypt</article-title><source>Afr. J. Tradit. Complement. Altern. Med.</source><year>2007</year><volume>4</volume><fpage>417</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.4314/ajtcam.v4i4.31236</pub-id><?supplied-pmid 20161910?><pub-id pub-id-type="pmid">20161910</pub-id></element-citation></ref><ref id="B205-biomolecules-09-00679"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheck</surname><given-names>A.C.</given-names></name><name><surname>Perry</surname><given-names>K.</given-names></name><name><surname>Hank</surname><given-names>N.C.</given-names></name><name><surname>Clark</surname><given-names>W.D.</given-names></name></person-group><article-title>Anticancer activity of extracts derived from the mature roots of Scutellaria baicalensis on human malignant brain tumor cells</article-title><source>BMC Complement. Altern. Med.</source><year>2006</year><volume>6</volume><elocation-id>27</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-6-27</pub-id><?supplied-pmid 16914050?><pub-id pub-id-type="pmid">16914050</pub-id></element-citation></ref><ref id="B206-biomolecules-09-00679"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>N.M.</given-names></name><name><surname>Lin</surname><given-names>S.Z.</given-names></name><name><surname>Lee</surname><given-names>C.C.</given-names></name><name><surname>Chen</surname><given-names>S.P.</given-names></name><name><surname>Su</surname><given-names>H.C.</given-names></name><name><surname>Chang</surname><given-names>W.L.</given-names></name><name><surname>Harn</surname><given-names>H.J.</given-names></name></person-group><article-title>The antitumor effects of Angelica sinensis on malignant brain tumors in vitro and in vivo</article-title><source>Clin. Cancer Res.</source><year>2005</year><volume>11</volume><fpage>3475</fpage><lpage>3484</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-04-1827</pub-id><?supplied-pmid 15867250?><pub-id pub-id-type="pmid">15867250</pub-id></element-citation></ref><ref id="B207-biomolecules-09-00679"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okokon</surname><given-names>J.E.</given-names></name><name><surname>Dar</surname><given-names>A.</given-names></name><name><surname>Choudhary</surname><given-names>M.I.</given-names></name></person-group><article-title>Immunomodulatory, cytotoxic and antileishmanial activity of phytoconstituents of Croton zambesicus</article-title><source>Phytopharm. J.</source><year>2013</year><volume>4</volume><fpage>31</fpage><lpage>40</lpage></element-citation></ref><ref id="B208-biomolecules-09-00679"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X.S.</given-names></name><name><surname>Xie</surname><given-names>T.</given-names></name><name><surname>Lin</surname><given-names>J.</given-names></name><name><surname>Fan</surname><given-names>H.Z.</given-names></name><name><surname>Huang-Fu</surname><given-names>H.J.</given-names></name><name><surname>Ni</surname><given-names>L.F.</given-names></name><name><surname>Yan</surname><given-names>H.F.</given-names></name></person-group><article-title>An investigation of the ability of elemene to pass through the blood-brain barrier and its effect on brain carcinomas</article-title><source>J. Pharm. Pharmacol.</source><year>2009</year><volume>61</volume><fpage>1653</fpage><lpage>1656</lpage><pub-id pub-id-type="doi">10.1211/jpp.61.12.0010</pub-id><pub-id pub-id-type="pmid">19958588</pub-id></element-citation></ref><ref id="B209-biomolecules-09-00679"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferriola</surname><given-names>P.C.</given-names></name><name><surname>Cody</surname><given-names>V.</given-names></name><name><surname>Middleton</surname><given-names>E.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships</article-title><source>Biochem. Pharm.</source><year>1989</year><volume>38</volume><fpage>1617</fpage><lpage>1624</lpage><pub-id pub-id-type="doi">10.1016/0006-2952(89)90309-2</pub-id><pub-id pub-id-type="pmid">2730676</pub-id></element-citation></ref><ref id="B210-biomolecules-09-00679"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dimitric Markovic</surname><given-names>J.M.</given-names></name><name><surname>Pejin</surname><given-names>B.</given-names></name><name><surname>Milenkovic</surname><given-names>D.</given-names></name><name><surname>Amic</surname><given-names>D.</given-names></name><name><surname>Begovic</surname><given-names>N.</given-names></name><name><surname>Mojovic</surname><given-names>M.</given-names></name><name><surname>Markovic</surname><given-names>Z.S.</given-names></name></person-group><article-title>Antiradical activity of delphinidin, pelargonidin and malvin towards hydroxyl and nitric oxide radicals: The energy requirements calculations as a prediction of the possible antiradical mechanisms</article-title><source>Food Chem.</source><year>2017</year><volume>218</volume><fpage>440</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2016.09.106</pub-id><pub-id pub-id-type="pmid">27719933</pub-id></element-citation></ref><ref id="B211-biomolecules-09-00679"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puli</surname><given-names>S.</given-names></name><name><surname>Jain</surname><given-names>A.</given-names></name><name><surname>Lai</surname><given-names>J.C.</given-names></name><name><surname>Bhushan</surname><given-names>A.</given-names></name></person-group><article-title>Effect of combination treatment of rapamycin and isoflavones on mTOR pathway in human glioblastoma (U87) cells</article-title><source>Neurochem. Res.</source><year>2010</year><volume>35</volume><fpage>986</fpage><lpage>993</lpage><pub-id pub-id-type="doi">10.1007/s11064-010-0142-2</pub-id><pub-id pub-id-type="pmid">20177775</pub-id></element-citation></ref><ref id="B212-biomolecules-09-00679"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>N.M.</given-names></name><name><surname>Chen</surname><given-names>Y.L.</given-names></name><name><surname>Lee</surname><given-names>C.C.</given-names></name><name><surname>Lin</surname><given-names>P.C.</given-names></name><name><surname>Cheng</surname><given-names>Y.L.</given-names></name><name><surname>Chang</surname><given-names>W.L.</given-names></name><name><surname>Lin</surname><given-names>S.Z.</given-names></name><name><surname>Harn</surname><given-names>H.J.</given-names></name></person-group><article-title>The natural compound n-butylidenephthalide derived from Angelica sinensis inhibits malignant brain tumor growth in vitro and in vivo</article-title><source>J. Neurochem.</source><year>2006</year><volume>99</volume><fpage>1251</fpage><lpage>1262</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2006.04151.x</pub-id><pub-id pub-id-type="pmid">16987298</pub-id></element-citation></ref><ref id="B213-biomolecules-09-00679"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeon</surname><given-names>H.Y.</given-names></name><name><surname>Park</surname><given-names>C.G.</given-names></name><name><surname>Ham</surname><given-names>S.W.</given-names></name><name><surname>Choi</surname><given-names>S.H.</given-names></name><name><surname>Lee</surname><given-names>S.Y.</given-names></name><name><surname>Kim</surname><given-names>J.Y.</given-names></name><name><surname>Seo</surname><given-names>S.</given-names></name><name><surname>Jin</surname><given-names>X.</given-names></name><name><surname>Kim</surname><given-names>J.K.</given-names></name><name><surname>Eun</surname><given-names>K.</given-names></name><etal/></person-group><article-title>BRM270, a Compound from Natural Plant Extracts, Inhibits Glioblastoma Stem Cell Properties and Glioblastoma Recurrence</article-title><source>J. Med. Food</source><year>2017</year><volume>20</volume><fpage>838</fpage><lpage>845</lpage><pub-id pub-id-type="doi">10.1089/jmf.2017.3929</pub-id><?supplied-pmid 28792781?><pub-id pub-id-type="pmid">28792781</pub-id></element-citation></ref><ref id="B214-biomolecules-09-00679"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>A.</given-names></name><name><surname>Banik</surname><given-names>N.L.</given-names></name><name><surname>Ray</surname><given-names>S.K.</given-names></name></person-group><article-title>N-(4-Hydroxyphenyl) retinamide induced both differentiation and apoptosis in human glioblastoma T98G and U87MG cells</article-title><source>Brain Res.</source><year>2008</year><volume>1227</volume><fpage>207</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2008.06.045</pub-id><?supplied-pmid 18602901?><pub-id pub-id-type="pmid">18602901</pub-id></element-citation></ref><ref id="B215-biomolecules-09-00679"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>S.X.</given-names></name><name><surname>Ma</surname><given-names>J.W.</given-names></name><name><surname>Li</surname><given-names>H.Y.</given-names></name><name><surname>Ye</surname><given-names>J.C.</given-names></name><name><surname>Xie</surname><given-names>S.M.</given-names></name><name><surname>Du</surname><given-names>B.</given-names></name><name><surname>Zhong</surname><given-names>X.Y.</given-names></name></person-group><article-title>EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition</article-title><source>J. Neuro-Oncol.</source><year>2015</year><volume>121</volume><fpage>41</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1007/s11060-014-1604-1</pub-id><?supplied-pmid 25173233?><pub-id pub-id-type="pmid">25173233</pub-id></element-citation></ref><ref id="B216-biomolecules-09-00679"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galanti</surname><given-names>G.</given-names></name><name><surname>Fisher</surname><given-names>T.</given-names></name><name><surname>Kventsel</surname><given-names>I.</given-names></name><name><surname>Shoham</surname><given-names>J.</given-names></name><name><surname>Gallily</surname><given-names>R.</given-names></name><name><surname>Mechoulam</surname><given-names>R.</given-names></name><name><surname>Lavie</surname><given-names>G.</given-names></name><name><surname>Amariglio</surname><given-names>N.</given-names></name><name><surname>Rechavi</surname><given-names>G.</given-names></name><name><surname>Toren</surname><given-names>A.</given-names></name></person-group><article-title>Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells</article-title><source>Acta Oncol.</source><year>2008</year><volume>47</volume><fpage>1062</fpage><lpage>1070</lpage><pub-id pub-id-type="doi">10.1080/02841860701678787</pub-id><?supplied-pmid 17934890?><pub-id pub-id-type="pmid">17934890</pub-id></element-citation></ref><ref id="B217-biomolecules-09-00679"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcu</surname><given-names>J.P.</given-names></name><name><surname>Christian</surname><given-names>R.T.</given-names></name><name><surname>Lau</surname><given-names>D.</given-names></name><name><surname>Zielinski</surname><given-names>A.J.</given-names></name><name><surname>Horowitz</surname><given-names>M.P.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Pakdel</surname><given-names>A.</given-names></name><name><surname>Allison</surname><given-names>J.</given-names></name><name><surname>Limbad</surname><given-names>C.</given-names></name><name><surname>Moore</surname><given-names>D.H.</given-names></name><etal/></person-group><article-title>Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival</article-title><source>Mol. Cancer Ther.</source><year>2010</year><volume>9</volume><fpage>180</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-09-0407</pub-id><pub-id pub-id-type="pmid">20053780</pub-id></element-citation></ref><ref id="B218-biomolecules-09-00679"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>C.H.</given-names></name><name><surname>Pan</surname><given-names>S.L.</given-names></name><name><surname>Guh</surname><given-names>J.H.</given-names></name><name><surname>Chang</surname><given-names>Y.L.</given-names></name><name><surname>Pai</surname><given-names>H.C.</given-names></name><name><surname>Lin</surname><given-names>C.H.</given-names></name><name><surname>Teng</surname><given-names>C.M.</given-names></name></person-group><article-title>Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo</article-title><source>Carcinogenesis</source><year>2005</year><volume>26</volume><fpage>968</fpage><lpage>975</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgi041</pub-id><pub-id pub-id-type="pmid">15705600</pub-id></element-citation></ref><ref id="B219-biomolecules-09-00679"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>T.J.</given-names></name><name><surname>Leem</surname><given-names>J.</given-names></name><name><surname>Choi</surname><given-names>K.S.</given-names></name><name><surname>Park</surname><given-names>J.W.</given-names></name><name><surname>Kwon</surname><given-names>T.K.</given-names></name></person-group><article-title>Sanguinarine-induced apoptosis: Generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL</article-title><source>J. Cell. Biochem.</source><year>2008</year><volume>104</volume><fpage>895</fpage><lpage>907</lpage><pub-id pub-id-type="doi">10.1002/jcb.21672</pub-id><pub-id pub-id-type="pmid">18189268</pub-id></element-citation></ref><ref id="B220-biomolecules-09-00679"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gautam</surname><given-names>N.</given-names></name><name><surname>Mantha</surname><given-names>A.K.</given-names></name><name><surname>Mittal</surname><given-names>S.</given-names></name></person-group><article-title>Essential oils and their constituents as anticancer agents: A mechanistic view</article-title><source>Biomed Res. Int.</source><year>2014</year><volume>2014</volume><fpage>154106</fpage><pub-id pub-id-type="doi">10.1155/2014/154106</pub-id><pub-id pub-id-type="pmid">25003106</pub-id></element-citation></ref><ref id="B221-biomolecules-09-00679"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Tan</surname><given-names>G.</given-names></name><name><surname>Jiang</surname><given-names>X.</given-names></name><name><surname>Qiao</surname><given-names>H.</given-names></name><name><surname>Pan</surname><given-names>S.</given-names></name><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Kanwar</surname><given-names>J.R.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name></person-group><article-title>Therapeutic effects of matrine on primary and metastatic breast cancer</article-title><source>Am. J. Chin. Med.</source><year>2010</year><volume>38</volume><fpage>1115</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.1142/S0192415X10008512</pub-id><pub-id pub-id-type="pmid">21061465</pub-id></element-citation></ref><ref id="B222-biomolecules-09-00679"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>L.H.</given-names></name><name><surname>Fu</surname><given-names>Q.H.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Jiang</surname><given-names>K.</given-names></name><name><surname>Guo</surname><given-names>Q.M.</given-names></name><name><surname>Chen</surname><given-names>Q.Y.</given-names></name><name><surname>Yan</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>Q.Q.</given-names></name><name><surname>Shen</surname><given-names>J.G.</given-names></name></person-group><article-title>Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model</article-title><source>Acta Pharmacol. Sin.</source><year>2012</year><volume>33</volume><fpage>523</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1038/aps.2011.209</pub-id><pub-id pub-id-type="pmid">22388073</pub-id></element-citation></ref><ref id="B223-biomolecules-09-00679"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zu</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Liang</surname><given-names>L.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>N.</given-names></name></person-group><article-title>Activities of ten essential oils towards Propionibacterium acnes and PC-3, A-549 and MCF-7 cancer cells</article-title><source>Molecules</source><year>2010</year><volume>15</volume><fpage>3200</fpage><lpage>3210</lpage><pub-id pub-id-type="doi">10.3390/molecules15053200</pub-id><?supplied-pmid 20657472?><pub-id pub-id-type="pmid">20657472</pub-id></element-citation></ref><ref id="B224-biomolecules-09-00679"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suhail</surname><given-names>M.M.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Cao</surname><given-names>A.</given-names></name><name><surname>Mondalek</surname><given-names>F.G.</given-names></name><name><surname>Fung</surname><given-names>K.M.</given-names></name><name><surname>Shih</surname><given-names>P.T.</given-names></name><name><surname>Fang</surname><given-names>Y.T.</given-names></name><name><surname>Woolley</surname><given-names>C.</given-names></name><name><surname>Young</surname><given-names>G.</given-names></name><name><surname>Lin</surname><given-names>H.K.</given-names></name></person-group><article-title>Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells</article-title><source>BMC Complement. Altern. Med.</source><year>2011</year><volume>11</volume><elocation-id>129</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-11-129</pub-id><?supplied-pmid 22171782?><pub-id pub-id-type="pmid">22171782</pub-id></element-citation></ref><ref id="B225-biomolecules-09-00679"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fawzy</surname><given-names>G.A.</given-names></name><name><surname>Al Ati</surname><given-names>H.Y.</given-names></name><name><surname>El Gamal</surname><given-names>A.A.</given-names></name></person-group><article-title>Chemical composition and biological evaluation of essential oils of Pulicaria jaubertii</article-title><source>Pharmacogn. Mag.</source><year>2013</year><volume>9</volume><fpage>28</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.4103/0973-1296.108133</pub-id><?supplied-pmid 23661990?><pub-id pub-id-type="pmid">23661990</pub-id></element-citation></ref><ref id="B226-biomolecules-09-00679"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owolabi</surname><given-names>M.S.</given-names></name><name><surname>Ogundajo</surname><given-names>A.L.</given-names></name><name><surname>Dosoky</surname><given-names>N.S.</given-names></name><name><surname>Setzer</surname><given-names>W.N.</given-names></name></person-group><article-title>The cytotoxic activity of Annona muricata leaf oil from Badagary, Nigeria</article-title><source>AJEONP</source><year>2013</year><volume>1</volume><fpage>1</fpage><lpage>13</lpage></element-citation></ref><ref id="B227-biomolecules-09-00679"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afoulous</surname><given-names>S.</given-names></name><name><surname>Ferhout</surname><given-names>H.</given-names></name><name><surname>Raoelison</surname><given-names>E.G.</given-names></name><name><surname>Valentin</surname><given-names>A.</given-names></name><name><surname>Moukarzel</surname><given-names>B.</given-names></name><name><surname>Couderc</surname><given-names>F.</given-names></name><name><surname>Bouajila</surname><given-names>J.</given-names></name></person-group><article-title>Chemical composition and anticancer, antiinflammatory, antioxidant and antimalarial activities of leaves essential oil of Cedrelopsis grevei</article-title><source>Food Chem. Toxicol.</source><year>2013</year><volume>56</volume><fpage>352</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2013.02.008</pub-id><?supplied-pmid 23459148?><pub-id pub-id-type="pmid">23459148</pub-id></element-citation></ref><ref id="B228-biomolecules-09-00679"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahabipour</surname><given-names>S.</given-names></name><name><surname>Firuzi</surname><given-names>O.</given-names></name><name><surname>Asadollahi</surname><given-names>M.</given-names></name><name><surname>Miri</surname><given-names>M.</given-names></name><name><surname>Javidnia</surname><given-names>K.</given-names></name></person-group><article-title>Essential Oil Composition and Cytotoxic Activity of Libanotis transcaucasica Schischk. from Iran</article-title><source>Nat. Prod. Chem. Res.</source><year>2013</year><volume>1</volume><fpage>1</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.4172/2329-6836.1000108</pub-id></element-citation></ref><ref id="B229-biomolecules-09-00679"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharopov</surname><given-names>F.S.</given-names></name><name><surname>Wink</surname><given-names>M.</given-names></name><name><surname>Khalifaev</surname><given-names>D.R.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Dosoky</surname><given-names>N.S.</given-names></name><name><surname>Setzer</surname><given-names>W.N.</given-names></name></person-group><article-title>Composition and bioactivity of the essential oil of Melissa officinalis L. growing wild in Tajikistan</article-title><source>Int. J. Tradit. Nat. Med.</source><year>2013</year><volume>2</volume><fpage>86</fpage><lpage>96</lpage></element-citation></ref><ref id="B230-biomolecules-09-00679"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Hadri</surname><given-names>A.</given-names></name><name><surname>del Rio</surname><given-names>M.G.</given-names></name><name><surname>Sanz</surname><given-names>J.</given-names></name><name><surname>Coloma</surname><given-names>A.G.</given-names></name><name><surname>Idaomar</surname><given-names>M.</given-names></name><name><surname>Ozonas</surname><given-names>B.R.</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>J.B.</given-names></name><name><surname>Reus</surname><given-names>M.I.S.</given-names></name></person-group><article-title>Cytotoxic activity of &#x003b1;-humulene and transcaryophyllene from Salvia officinalis in animal and human tumor cells</article-title><source>R. Acad. Nac. Farm.</source><year>2010</year><volume>76</volume><fpage>343</fpage><lpage>356</lpage></element-citation></ref><ref id="B231-biomolecules-09-00679"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>C.</given-names></name><name><surname>Ge</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Feng</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Wei</surname><given-names>T.</given-names></name></person-group><article-title>Composition and potential anticancer activities of essential oils obtained from myrrh and frankincense</article-title><source>Oncol. Lett.</source><year>2013</year><volume>6</volume><fpage>1140</fpage><lpage>1146</lpage><pub-id pub-id-type="doi">10.3892/ol.2013.1520</pub-id><pub-id pub-id-type="pmid">24137478</pub-id></element-citation></ref><ref id="B232-biomolecules-09-00679"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>A.I.</given-names></name><name><surname>Anwar</surname><given-names>F.</given-names></name><name><surname>Chatha</surname><given-names>S.A.S.</given-names></name><name><surname>Latif</surname><given-names>S.</given-names></name><name><surname>Sherazi</surname><given-names>S.T.H.</given-names></name><name><surname>Ahmad</surname><given-names>A.</given-names></name><name><surname>Worthington</surname><given-names>J.</given-names></name><name><surname>Sarker</surname><given-names>S.D.</given-names></name></person-group><article-title>Chemical composition and bioactivity studies of the essential oils from two Thymus species from the Pakistani flora</article-title><source>Lwt Food Sci. Technol.</source><year>2013</year><volume>50</volume><fpage>185</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/j.lwt.2012.06.003</pub-id></element-citation></ref><ref id="B233-biomolecules-09-00679"><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva</surname><given-names>E.B.</given-names></name><name><surname>Matsuo</surname><given-names>A.L.</given-names></name><name><surname>Figueiredo</surname><given-names>C.R.</given-names></name><name><surname>Chaves</surname><given-names>M.H.</given-names></name><name><surname>Sartorelli</surname><given-names>P.</given-names></name><name><surname>Lago</surname><given-names>J.H.</given-names></name></person-group><article-title>Chemical constituents and cytotoxic evaluation of essential oils from leaves of Porcelia macrocarpa (Annonaceae)</article-title><source>Nat. Prod. Commun.</source><year>2013</year><volume>8</volume><fpage>277</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1177/1934578X1300800237</pub-id><?supplied-pmid 23513748?><pub-id pub-id-type="pmid">23513748</pub-id></element-citation></ref><ref id="B234-biomolecules-09-00679"><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arunasree</surname><given-names>K.M.</given-names></name></person-group><article-title>Anti-proliferative effects of carvacrol on a human metastatic breast cancer cell line, MDA-MB 231</article-title><source>Phytomedicine</source><year>2010</year><volume>17</volume><fpage>581</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2009.12.008</pub-id><?supplied-pmid 20096548?><pub-id pub-id-type="pmid">20096548</pub-id></element-citation></ref><ref id="B235-biomolecules-09-00679"><label>235.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaouki</surname><given-names>W.</given-names></name><name><surname>Leger</surname><given-names>D.Y.</given-names></name><name><surname>Liagre</surname><given-names>B.</given-names></name><name><surname>Beneytout</surname><given-names>J.L.</given-names></name><name><surname>Hmamouchi</surname><given-names>M.</given-names></name></person-group><article-title>Citral inhibits cell proliferation and induces apoptosis and cell cycle arrest in MCF-7 cells</article-title><source>Fundam. Clin. Pharmacol.</source><year>2009</year><volume>23</volume><fpage>549</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.1111/j.1472-8206.2009.00738.x</pub-id><?supplied-pmid 19656204?><pub-id pub-id-type="pmid">19656204</pub-id></element-citation></ref><ref id="B236-biomolecules-09-00679"><label>236.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santha</surname><given-names>S.</given-names></name><name><surname>Bommareddy</surname><given-names>A.</given-names></name><name><surname>Rule</surname><given-names>B.</given-names></name><name><surname>Guillermo</surname><given-names>R.</given-names></name><name><surname>Kaushik</surname><given-names>R.S.</given-names></name><name><surname>Young</surname><given-names>A.</given-names></name><name><surname>Dwivedi</surname><given-names>C.</given-names></name></person-group><article-title>Antineoplastic effects of alpha-santalol on estrogen receptor-positive and estrogen receptor-negative breast cancer cells through cell cycle arrest at G2/M phase and induction of apoptosis</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e56982</elocation-id><pub-id pub-id-type="doi">10.1371/annotation/c732480c-eb97-4eff-acb6-300797f4efa9</pub-id><pub-id pub-id-type="pmid">23451128</pub-id></element-citation></ref><ref id="B237-biomolecules-09-00679"><label>237.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>P.B.</given-names></name><name><surname>Thakkar</surname><given-names>V.R.</given-names></name><name><surname>Patel</surname><given-names>J.S.</given-names></name></person-group><article-title>Cellular effect of curcumin and citral combination on breast cancer cells: Induction of apoptosis and cell cycle arrest</article-title><source>J. Breast Cancer</source><year>2015</year><volume>18</volume><fpage>225</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.4048/jbc.2015.18.3.225</pub-id><?supplied-pmid 26472972?><pub-id pub-id-type="pmid">26472972</pub-id></element-citation></ref><ref id="B238-biomolecules-09-00679"><label>238.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabrielli</surname><given-names>B.</given-names></name><name><surname>Brooks</surname><given-names>K.</given-names></name><name><surname>Pavey</surname><given-names>S.</given-names></name></person-group><article-title>Defective cell cycle checkpoints as targets for anti-cancer therapies</article-title><source>Front. Pharmacol.</source><year>2012</year><volume>3</volume><fpage>9</fpage><pub-id pub-id-type="doi">10.3389/fphar.2012.00009</pub-id><pub-id pub-id-type="pmid">22347187</pub-id></element-citation></ref><ref id="B239-biomolecules-09-00679"><label>239.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>A.I.</given-names></name><name><surname>Anwar</surname><given-names>F.</given-names></name><name><surname>Chatha</surname><given-names>S.A.</given-names></name><name><surname>Jabbar</surname><given-names>A.</given-names></name><name><surname>Mahboob</surname><given-names>S.</given-names></name><name><surname>Nigam</surname><given-names>P.S.</given-names></name></person-group><article-title>Rosmarinus officinalis essential oil: Antiproliferative, antioxidant and antibacterial activities</article-title><source>Braz. J. Microbiol.</source><year>2010</year><volume>41</volume><fpage>1070</fpage><lpage>1078</lpage><pub-id pub-id-type="doi">10.1590/S1517-83822010000400027</pub-id><pub-id pub-id-type="pmid">24031588</pub-id></element-citation></ref><ref id="B240-biomolecules-09-00679"><label>240.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.L.</given-names></name><name><surname>Yeung</surname><given-names>C.M.</given-names></name><name><surname>Chiu</surname><given-names>L.C.</given-names></name><name><surname>Cen</surname><given-names>Y.Z.</given-names></name><name><surname>Ooi</surname><given-names>V.E.</given-names></name></person-group><article-title>Chemical composition and antiproliferative activity of essential oil from the leaves of a medicinal herb, Schefflera heptaphylla</article-title><source>Phytother. Res.</source><year>2009</year><volume>23</volume><fpage>140</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1002/ptr.2567</pub-id><pub-id pub-id-type="pmid">18814213</pub-id></element-citation></ref><ref id="B241-biomolecules-09-00679"><label>241.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashour</surname><given-names>H.M.</given-names></name></person-group><article-title>Antibacterial, antifungal, and anticancer activities of volatile oils and extracts from stems, leaves, and flowers of Eucalyptus sideroxylon and Eucalyptus torquata</article-title><source>Cancer Biol. Ther.</source><year>2008</year><volume>7</volume><fpage>399</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.4161/cbt.7.3.5367</pub-id><pub-id pub-id-type="pmid">18075306</pub-id></element-citation></ref><ref id="B242-biomolecules-09-00679"><label>242.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sireesha</surname><given-names>D.</given-names></name><name><surname>Reddy</surname><given-names>B.S.</given-names></name><name><surname>Reginald</surname><given-names>B.A.</given-names></name><name><surname>Samatha</surname><given-names>M.</given-names></name><name><surname>Kamal</surname><given-names>F.</given-names></name></person-group><article-title>Effect of amygdalin on oral cancer cell line: An in vitro study</article-title><source>J. Oral Maxillofac. Pathol.</source><year>2019</year><volume>23</volume><fpage>104</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.4103/jomfp.JOMFP_281_18</pub-id><pub-id pub-id-type="pmid">31110425</pub-id></element-citation></ref><ref id="B243-biomolecules-09-00679"><label>243.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>J.R.</given-names></name><name><surname>Park</surname><given-names>J.S.</given-names></name><name><surname>Park</surname><given-names>Y.K.</given-names></name><name><surname>Chae</surname><given-names>Y.Z.</given-names></name><name><surname>Lee</surname><given-names>G.H.</given-names></name><name><surname>Park</surname><given-names>G.Y.</given-names></name><name><surname>Jang</surname><given-names>B.C.</given-names></name></person-group><article-title>Pinus densiflora leaf essential oil induces apoptosis via ROS generation and activation of caspases in YD-8 human oral cancer cells</article-title><source>Int. J. Oncol.</source><year>2012</year><volume>40</volume><fpage>1238</fpage><lpage>1245</lpage><pub-id pub-id-type="doi">10.3892/ijo.2011.1263</pub-id><?supplied-pmid 22086183?><pub-id pub-id-type="pmid">22086183</pub-id></element-citation></ref><ref id="B244-biomolecules-09-00679"><label>244.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>W.L.</given-names></name><name><surname>Cheng</surname><given-names>F.C.</given-names></name><name><surname>Wang</surname><given-names>S.P.</given-names></name><name><surname>Chou</surname><given-names>S.T.</given-names></name><name><surname>Shih</surname><given-names>Y.</given-names></name></person-group><article-title>Cinnamomum cassia essential oil and its major constituent cinnamaldehyde induced cell cycle arrest and apoptosis in human oral squamous cell carcinoma HSC-3 cells</article-title><source>Environ. Toxicol.</source><year>2017</year><volume>32</volume><fpage>456</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1002/tox.22250</pub-id><?supplied-pmid 26919256?><pub-id pub-id-type="pmid">26919256</pub-id></element-citation></ref><ref id="B245-biomolecules-09-00679"><label>245.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>J.D.</given-names></name><name><surname>Kim</surname><given-names>J.Y.</given-names></name></person-group><article-title>Essential oil from Cryptomeria japonica induces apoptosis in human oral epidermoid carcinoma cells via mitochondrial stress and activation of caspases</article-title><source>Molecules</source><year>2012</year><volume>17</volume><fpage>3890</fpage><lpage>3901</lpage><pub-id pub-id-type="doi">10.3390/molecules17043890</pub-id><?supplied-pmid 22466850?><pub-id pub-id-type="pmid">22466850</pub-id></element-citation></ref><ref id="B246-biomolecules-09-00679"><label>246.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saleh</surname><given-names>A.I.</given-names></name><name><surname>Mohamed</surname><given-names>I.</given-names></name><name><surname>Mohamed</surname><given-names>A.A.</given-names></name><name><surname>Abdelkader</surname><given-names>M.</given-names></name><name><surname>Yalcin</surname><given-names>H.C.</given-names></name><name><surname>Aboulkassim</surname><given-names>T.</given-names></name><name><surname>Batist</surname><given-names>G.</given-names></name><name><surname>Yasmeen</surname><given-names>A.</given-names></name><name><surname>Moustafa</surname><given-names>A.A.</given-names></name></person-group><article-title>Elaeagnus angustifolia Plant Extract Inhibits Angiogenesis and Downgrades Cell Invasion of Human Oral Cancer Cells via Erk1/Erk2 Inactivation</article-title><source>Nutr. Cancer</source><year>2018</year><volume>70</volume><fpage>297</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1080/01635581.2018.1412472</pub-id><?supplied-pmid 29300111?><pub-id pub-id-type="pmid">29300111</pub-id></element-citation></ref><ref id="B247-biomolecules-09-00679"><label>247.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Y.C.</given-names></name><name><surname>Hsu</surname><given-names>K.P.</given-names></name><name><surname>Wang</surname><given-names>E.I.</given-names></name><name><surname>Ho</surname><given-names>C.L.</given-names></name></person-group><article-title>Composition and in vitro anticancer activities of the leaf essential oil of Neolitsea variabillima from Taiwan</article-title><source>Nat. Prod. Commun.</source><year>2013</year><volume>8</volume><fpage>531</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1177/1934578X1300800432</pub-id><pub-id pub-id-type="pmid">23738472</pub-id></element-citation></ref><ref id="B248-biomolecules-09-00679"><label>248.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Cha</surname><given-names>I.H.</given-names></name><name><surname>Nam</surname><given-names>W.</given-names></name></person-group><article-title>Chios mastic gum extracts as a potent antitumor agent that inhibits growth and induces apoptosis of oral cancer cells</article-title><source>Asian Pac. J. Cancer Prev.</source><year>2011</year><volume>12</volume><fpage>1877</fpage><lpage>1880</lpage><pub-id pub-id-type="pmid">22126583</pub-id></element-citation></ref><ref id="B249-biomolecules-09-00679"><label>249.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname><given-names>S.M.</given-names></name><name><surname>Yun</surname><given-names>S.J.</given-names></name><name><surname>Kook</surname><given-names>J.K.</given-names></name><name><surname>Kim</surname><given-names>H.J.</given-names></name><name><surname>Choi</surname><given-names>M.S.</given-names></name><name><surname>Park</surname><given-names>B.R.</given-names></name><name><surname>Kim</surname><given-names>S.G.</given-names></name><name><surname>Kim</surname><given-names>B.O.</given-names></name><name><surname>Lee</surname><given-names>S.Y.</given-names></name><name><surname>Ahn</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Anticancer activity of Saussurea lappa extract by apoptotic pathway in KB human oral cancer cells</article-title><source>Pharm. Biol.</source><year>2013</year><volume>51</volume><fpage>1372</fpage><lpage>1377</lpage><pub-id pub-id-type="doi">10.3109/13880209.2013.792847</pub-id><pub-id pub-id-type="pmid">23855888</pub-id></element-citation></ref><ref id="B250-biomolecules-09-00679"><label>250.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fekrazad</surname><given-names>R.</given-names></name><name><surname>Afzali</surname><given-names>M.</given-names></name><name><surname>Pasban-Aliabadi</surname><given-names>H.</given-names></name><name><surname>Esmaeili-Mahani</surname><given-names>S.</given-names></name><name><surname>Aminizadeh</surname><given-names>M.</given-names></name><name><surname>Mostafavi</surname><given-names>A.</given-names></name></person-group><article-title>Cytotoxic Effect of Thymus caramanicus Jalas on Human Oral Epidermoid Carcinoma KB Cells</article-title><source>Braz. Dent. J.</source><year>2017</year><volume>28</volume><fpage>72</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1590/0103-6440201700737</pub-id><pub-id pub-id-type="pmid">28301021</pub-id></element-citation></ref><ref id="B251-biomolecules-09-00679"><label>251.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nedel</surname><given-names>F.</given-names></name><name><surname>Begnini</surname><given-names>K.</given-names></name><name><surname>Carvalho</surname><given-names>P.H.</given-names></name><name><surname>Lund</surname><given-names>R.G.</given-names></name><name><surname>Beira</surname><given-names>F.T.</given-names></name><name><surname>Del Pino</surname><given-names>F.A.</given-names></name></person-group><article-title>Antiproliferative activity of flower hexane extract obtained from Mentha spicata associated with Mentha rotundifolia against the MCF7, KB, and NIH/3T3 cell lines</article-title><source>J. Med. Food</source><year>2012</year><volume>15</volume><fpage>955</fpage><lpage>958</lpage><pub-id pub-id-type="doi">10.1089/jmf.2011.0340</pub-id><pub-id pub-id-type="pmid">23066647</pub-id></element-citation></ref><ref id="B252-biomolecules-09-00679"><label>252.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fathilah</surname><given-names>A.R.</given-names></name><name><surname>Sujata</surname><given-names>R.</given-names></name><name><surname>Norhanom</surname><given-names>A.W.</given-names></name><name><surname>Adenan</surname><given-names>M.I.</given-names></name></person-group><article-title>Antiproliferative activity of aqueous extract of <italic>Piper betle</italic> L. and <italic>Psidium guajava</italic> L. on KB and HeLa cell lines</article-title><source>J. Med. Plants Res.</source><year>2010</year><volume>4</volume><fpage>987</fpage><lpage>990</lpage></element-citation></ref><ref id="B253-biomolecules-09-00679"><label>253.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>L.-H.</given-names></name><name><surname>Khadka</surname><given-names>S.</given-names></name><name><surname>Shin</surname><given-names>J.-A.</given-names></name><name><surname>Jung</surname><given-names>J.-Y.</given-names></name><name><surname>Ryu</surname><given-names>M.-H.</given-names></name><name><surname>Yu</surname><given-names>H.-J.</given-names></name><name><surname>Lee</surname><given-names>H.N.</given-names></name><name><surname>Jang</surname><given-names>B.</given-names></name><name><surname>Yang</surname><given-names>I.-H.</given-names></name><name><surname>Won</surname><given-names>D.-H.</given-names></name><etal/></person-group><article-title>Nitidine chloride acts as an apoptosis inducer in human oral cancer cells and a nude mouse xenograft model via inhibition of STAT3</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>91306</fpage><lpage>91315</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.20444</pub-id><?supplied-pmid 29207645?><pub-id pub-id-type="pmid">29207645</pub-id></element-citation></ref><ref id="B254-biomolecules-09-00679"><label>254.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>C.</given-names></name><name><surname>Dong</surname><given-names>W.</given-names></name></person-group><article-title>Aloe-Emodin Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Colorectal Cancer Cells</article-title><source>Med. Sci. Monit.</source><year>2018</year><volume>24</volume><fpage>6331</fpage><lpage>6339</lpage><pub-id pub-id-type="doi">10.12659/MSM.908400</pub-id><?supplied-pmid 30199885?><pub-id pub-id-type="pmid">30199885</pub-id></element-citation></ref><ref id="B255-biomolecules-09-00679"><label>255.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pejin</surname><given-names>B.</given-names></name><name><surname>Iodice</surname><given-names>C.</given-names></name><name><surname>Bogdanovi&#x00107;</surname><given-names>G.</given-names></name><name><surname>Koji&#x00107;</surname><given-names>V.</given-names></name><name><surname>Te&#x00161;evi&#x00107;</surname><given-names>V.</given-names></name></person-group><article-title>Stictic acid inhibits cell growth of human colon adenocarcinoma HT-29 cells</article-title><source>Arab. J. Chem.</source><year>2017</year><volume>10</volume><fpage>S1240</fpage><lpage>S1242</lpage><pub-id pub-id-type="doi">10.1016/j.arabjc.2013.03.003</pub-id></element-citation></ref><ref id="B256-biomolecules-09-00679"><label>256.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carnesecchi</surname><given-names>S.</given-names></name><name><surname>Bras-Goncalves</surname><given-names>R.</given-names></name><name><surname>Bradaia</surname><given-names>A.</given-names></name><name><surname>Zeisel</surname><given-names>M.</given-names></name><name><surname>Gosse</surname><given-names>F.</given-names></name><name><surname>Poupon</surname><given-names>M.F.</given-names></name><name><surname>Raul</surname><given-names>F.</given-names></name></person-group><article-title>Geraniol, a component of plant essential oils, modulates DNA synthesis and potentiates 5-fluorouracil efficacy on human colon tumor xenografts</article-title><source>Cancer Lett.</source><year>2004</year><volume>215</volume><fpage>53</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2004.06.019</pub-id><?supplied-pmid 15374632?><pub-id pub-id-type="pmid">15374632</pub-id></element-citation></ref><ref id="B257-biomolecules-09-00679"><label>257.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okada</surname><given-names>T.</given-names></name><name><surname>Sawada</surname><given-names>T.</given-names></name><name><surname>Osawa</surname><given-names>T.</given-names></name><name><surname>Adachi</surname><given-names>M.</given-names></name><name><surname>Kubota</surname><given-names>K.</given-names></name></person-group><article-title>MK615 inhibits pancreatic cancer cell growth by dual inhibition of Aurora A and B kinases</article-title><source>World J. Gastroenterol.</source><year>2008</year><volume>14</volume><fpage>1378</fpage><lpage>1382</lpage><pub-id pub-id-type="doi">10.3748/wjg.14.1378</pub-id><?supplied-pmid 18322951?><pub-id pub-id-type="pmid">18322951</pub-id></element-citation></ref><ref id="B258-biomolecules-09-00679"><label>258.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melstrom</surname><given-names>L.G.</given-names></name><name><surname>Salabat</surname><given-names>M.R.</given-names></name><name><surname>Ding</surname><given-names>X.Z.</given-names></name><name><surname>Milam</surname><given-names>B.M.</given-names></name><name><surname>Strouch</surname><given-names>M.</given-names></name><name><surname>Pelling</surname><given-names>J.C.</given-names></name><name><surname>Bentrem</surname><given-names>D.J.</given-names></name></person-group><article-title>Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells</article-title><source>Pancreas</source><year>2008</year><volume>37</volume><fpage>426</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1097/MPA.0b013e3181735ccb</pub-id><pub-id pub-id-type="pmid">18953257</pub-id></element-citation></ref><ref id="B259-biomolecules-09-00679"><label>259.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wicker</surname><given-names>C.A.</given-names></name><name><surname>Sahu</surname><given-names>R.P.</given-names></name><name><surname>Kulkarni-Datar</surname><given-names>K.</given-names></name><name><surname>Srivastava</surname><given-names>S.K.</given-names></name><name><surname>Brown</surname><given-names>T.L.</given-names></name></person-group><article-title>BITC Sensitizes Pancreatic Adenocarcinomas to TRAIL-induced Apoptosis</article-title><source>Cancer Growth Metastasis</source><year>2010</year><volume>2009</volume><fpage>45</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.4137/CGM.S3982</pub-id><pub-id pub-id-type="pmid">20559452</pub-id></element-citation></ref><ref id="B260-biomolecules-09-00679"><label>260.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bence</surname><given-names>A.K.</given-names></name><name><surname>Adams</surname><given-names>V.R.</given-names></name><name><surname>Crooks</surname><given-names>P.A.</given-names></name></person-group><article-title>L-Canavanine as a radiosensitization agent for human pancreatic cancer cells</article-title><source>Mol. Cell. Biochem.</source><year>2003</year><volume>244</volume><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1023/A:1022435202066</pub-id><pub-id pub-id-type="pmid">12701807</pub-id></element-citation></ref><ref id="B261-biomolecules-09-00679"><label>261.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.H.</given-names></name><name><surname>Ryu</surname><given-names>J.K.</given-names></name><name><surname>Lee</surname><given-names>K.Y.</given-names></name><name><surname>Woo</surname><given-names>S.M.</given-names></name><name><surname>Park</surname><given-names>J.K.</given-names></name><name><surname>Yoo</surname><given-names>J.W.</given-names></name><name><surname>Kim</surname><given-names>Y.T.</given-names></name><name><surname>Yoon</surname><given-names>Y.B.</given-names></name></person-group><article-title>Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer</article-title><source>Cancer Lett.</source><year>2008</year><volume>259</volume><fpage>39</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2007.09.015</pub-id><pub-id pub-id-type="pmid">17967505</pub-id></element-citation></ref><ref id="B262-biomolecules-09-00679"><label>262.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name></person-group><article-title>The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2</article-title><source>Food Funct.</source><year>2018</year><volume>9</volume><fpage>3018</fpage><lpage>3027</lpage><pub-id pub-id-type="doi">10.1039/C8FO00033F</pub-id><pub-id pub-id-type="pmid">29770817</pub-id></element-citation></ref><ref id="B263-biomolecules-09-00679"><label>263.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>S.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Ding</surname><given-names>G.</given-names></name><name><surname>Cao</surname><given-names>L.</given-names></name></person-group><article-title>Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways</article-title><source>Cell Death Dis.</source><year>2019</year><volume>10</volume><fpage>142</fpage><pub-id pub-id-type="doi">10.1038/s41419-019-1366-y</pub-id><?supplied-pmid 30760707?><pub-id pub-id-type="pmid">30760707</pub-id></element-citation></ref><ref id="B264-biomolecules-09-00679"><label>264.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoca</surname><given-names>M.</given-names></name><name><surname>Becer</surname><given-names>E.</given-names></name><name><surname>Kabadayi</surname><given-names>H.</given-names></name><name><surname>Yucecan</surname><given-names>S.</given-names></name><name><surname>Vatansever</surname><given-names>H.S.</given-names></name></person-group><article-title>The Effect of Resveratrol and Quercetin on Epithelial-Mesenchymal Transition in Pancreatic Cancer Stem Cell</article-title><source>Nutr. Cancer</source><year>2019</year><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1080/01635581.2019.1670853</pub-id><?supplied-pmid 31595775?><pub-id pub-id-type="pmid">31595775</pub-id></element-citation></ref><ref id="B265-biomolecules-09-00679"><label>265.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tourino</surname><given-names>S.</given-names></name><name><surname>Lizarraga</surname><given-names>D.</given-names></name><name><surname>Carreras</surname><given-names>A.</given-names></name><name><surname>Lorenzo</surname><given-names>S.</given-names></name><name><surname>Ugartondo</surname><given-names>V.</given-names></name><name><surname>Mitjans</surname><given-names>M.</given-names></name><name><surname>Vinardell</surname><given-names>M.P.</given-names></name><name><surname>Julia</surname><given-names>L.</given-names></name><name><surname>Cascante</surname><given-names>M.</given-names></name><name><surname>Torres</surname><given-names>J.L.</given-names></name></person-group><article-title>Highly galloylated tannin fractions from witch hazel (Hamamelis virginiana) bark: Electron transfer capacity, in vitro antioxidant activity, and effects on skin-related cells</article-title><source>Chem. Res. Toxicol.</source><year>2008</year><volume>21</volume><fpage>696</fpage><lpage>704</lpage><pub-id pub-id-type="doi">10.1021/tx700425n</pub-id><?supplied-pmid 18311930?><pub-id pub-id-type="pmid">18311930</pub-id></element-citation></ref><ref id="B266-biomolecules-09-00679"><label>266.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowan</surname><given-names>J.</given-names></name><name><surname>Shadab</surname><given-names>M.</given-names></name><name><surname>Nadkarni</surname><given-names>D.H.</given-names></name><name><surname>Kc</surname><given-names>K.</given-names></name><name><surname>Velu</surname><given-names>S.E.</given-names></name></person-group><article-title>A novel marine natural product derived pyrroloiminoquinone with potent activity against skin cancer cells</article-title><source>Mar. drugs</source><year>2019</year><volume>17</volume><elocation-id>443</elocation-id><pub-id pub-id-type="doi">10.3390/md17080443</pub-id></element-citation></ref><ref id="B267-biomolecules-09-00679"><label>267.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kremer</surname><given-names>J.L.</given-names></name><name><surname>Melo</surname><given-names>G.P.</given-names></name><name><surname>Marinello</surname><given-names>P.C.</given-names></name><name><surname>Bordini</surname><given-names>H.P.</given-names></name><name><surname>Rossaneis</surname><given-names>A.C.</given-names></name><name><surname>Sabio</surname><given-names>L.R.</given-names></name><name><surname>Cecchini</surname><given-names>R.</given-names></name><name><surname>Cecchini</surname><given-names>A.L.</given-names></name><name><surname>Verri</surname><given-names>W.A.</given-names><suffix>Jr.</suffix></name><name><surname>Luiz</surname><given-names>R.C.</given-names></name></person-group><article-title>Citral prevents UVB-induced skin carcinogenesis in hairless mice</article-title><source>J. Photochem. Photobiol. B Biol.</source><year>2019</year><volume>198</volume><fpage>111565</fpage><pub-id pub-id-type="doi">10.1016/j.jphotobiol.2019.111565</pub-id></element-citation></ref><ref id="B268-biomolecules-09-00679"><label>268.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arcella</surname><given-names>A.</given-names></name><name><surname>Oliva</surname><given-names>M.A.</given-names></name><name><surname>Sanchez</surname><given-names>M.</given-names></name><name><surname>Staffieri</surname><given-names>S.</given-names></name><name><surname>Esposito</surname><given-names>V.</given-names></name><name><surname>Giangaspero</surname><given-names>F.</given-names></name><name><surname>Cantore</surname><given-names>G.</given-names></name></person-group><article-title>Effects of hispolon on glioblastoma cell growth</article-title><source>Environ. Toxicol.</source><year>2017</year><volume>32</volume><fpage>2113</fpage><lpage>2123</lpage><pub-id pub-id-type="doi">10.1002/tox.22419</pub-id><pub-id pub-id-type="pmid">28618133</pub-id></element-citation></ref><ref id="B269-biomolecules-09-00679"><label>269.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arcella</surname><given-names>A.</given-names></name><name><surname>Oliva</surname><given-names>M.A.</given-names></name><name><surname>Staffieri</surname><given-names>S.</given-names></name><name><surname>Sanchez</surname><given-names>M.</given-names></name><name><surname>Madonna</surname><given-names>M.</given-names></name><name><surname>Riozzi</surname><given-names>B.</given-names></name><name><surname>Esposito</surname><given-names>V.</given-names></name><name><surname>Giangaspero</surname><given-names>F.</given-names></name><name><surname>Frati</surname><given-names>L.</given-names></name></person-group><article-title>Effects of aloe emodin on U87MG glioblastoma cell growth: In vitro and in vivo study</article-title><source>Environ. Toxicol.</source><year>2018</year><volume>33</volume><fpage>1160</fpage><lpage>1167</lpage><pub-id pub-id-type="doi">10.1002/tox.22622</pub-id><pub-id pub-id-type="pmid">30218594</pub-id></element-citation></ref><ref id="B270-biomolecules-09-00679"><label>270.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>J.</given-names></name><name><surname>Qiu</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Liang</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>F.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Tian</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Cardamonin inhibits breast cancer growth by repressing HIF-1alpha-dependent metabolic reprogramming</article-title><source>J. Exp. Clin. Cancer Res.</source><year>2019</year><volume>38</volume><fpage>377</fpage><pub-id pub-id-type="doi">10.1186/s13046-019-1351-4</pub-id><pub-id pub-id-type="pmid">31455352</pub-id></element-citation></ref><ref id="B271-biomolecules-09-00679"><label>271.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zheng</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Fu</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>N.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Lao</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name></person-group><article-title>The natural compound neobractatin inhibits tumor metastasis by upregulating the RNA-binding-protein MBNL2</article-title><source>Cell Death Dis.</source><year>2019</year><volume>10</volume><fpage>554</fpage><pub-id pub-id-type="doi">10.1038/s41419-019-1789-5</pub-id><pub-id pub-id-type="pmid">31320607</pub-id></element-citation></ref><ref id="B272-biomolecules-09-00679"><label>272.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Periasamy</surname><given-names>V.S.</given-names></name><name><surname>Athinarayanan</surname><given-names>J.</given-names></name><name><surname>Alshatwi</surname><given-names>A.A.</given-names></name></person-group><article-title>Anticancer activity of an ultrasonic nanoemulsion formulation of Nigella sativa L. essential oil on human breast cancer cells</article-title><source>Ultrason. Sonochem.</source><year>2016</year><volume>31</volume><fpage>449</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1016/j.ultsonch.2016.01.035</pub-id><pub-id pub-id-type="pmid">26964971</pub-id></element-citation></ref><ref id="B273-biomolecules-09-00679"><label>273.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>S.C.</given-names></name><name><surname>Vasconcellos</surname><given-names>F.A.</given-names></name><name><surname>Lenard&#x000e3;o</surname><given-names>E.J.</given-names></name><name><surname>do Amaral</surname><given-names>R.C.</given-names></name><name><surname>Jacob</surname><given-names>R.G.</given-names></name><name><surname>Leite</surname><given-names>F.L.</given-names></name></person-group><article-title>Evaluation of potential use of Cymbopogon sp. essential oils,(R)-citronellal and N-citronellylamine in cancer chemotherapy</article-title><source>Int. J. Appl. Res. Nat. Prod.</source><year>2013</year><volume>6</volume><fpage>11</fpage><lpage>15</lpage></element-citation></ref><ref id="B274-biomolecules-09-00679"><label>274.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>J.Q.</given-names></name><name><surname>Lei</surname><given-names>J.C.</given-names></name><name><surname>Zhang</surname><given-names>X.Q.</given-names></name><name><surname>Yu</surname><given-names>H.D.</given-names></name><name><surname>Tian</surname><given-names>D.Z.</given-names></name><name><surname>Liao</surname><given-names>Z.X.</given-names></name><name><surname>Zou</surname><given-names>G.L.</given-names></name></person-group><article-title>Anticancer, antioxidant and antimicrobial activities of the essential oil of Lycopus lucidus Turcz. var. hirtus Regel</article-title><source>Food Chem.</source><year>2011</year><volume>126</volume><fpage>1593</fpage><lpage>1598</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2010.12.027</pub-id><?supplied-pmid 25213932?><pub-id pub-id-type="pmid">25213932</pub-id></element-citation></ref><ref id="B275-biomolecules-09-00679"><label>275.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dwivedi</surname><given-names>V.</given-names></name><name><surname>Shrivastava</surname><given-names>R.</given-names></name><name><surname>Hussain</surname><given-names>S.</given-names></name><name><surname>Ganguly</surname><given-names>C.</given-names></name><name><surname>Bharadwaj</surname><given-names>M.</given-names></name></person-group><article-title>Comparative anticancer potential of clove (Syzygium aromaticum)&#x02014;An Indian spice&#x02014;Against cancer cell lines of various anatomical origin</article-title><source>Asian Pac. J. Cancer Prev.</source><year>2011</year><volume>12</volume><fpage>1989</fpage><lpage>1993</lpage><?supplied-pmid 22292639?><pub-id pub-id-type="pmid">22292639</pub-id></element-citation></ref><ref id="B276-biomolecules-09-00679"><label>276.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Kalaldeh</surname><given-names>J.Z.</given-names></name><name><surname>Abu-Dahab</surname><given-names>R.</given-names></name><name><surname>Afifi</surname><given-names>F.U.</given-names></name></person-group><article-title>Volatile oil composition and antiproliferative activity of Laurus nobilis, Origanum syriacum, Origanum vulgare, and Salvia triloba against human breast adenocarcinoma cells</article-title><source>Nutr. Res.</source><year>2010</year><volume>30</volume><fpage>271</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1016/j.nutres.2010.04.001</pub-id><?supplied-pmid 20534330?><pub-id pub-id-type="pmid">20534330</pub-id></element-citation></ref><ref id="B277-biomolecules-09-00679"><label>277.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bendaoud</surname><given-names>H.</given-names></name><name><surname>Romdhane</surname><given-names>M.</given-names></name><name><surname>Souchard</surname><given-names>J.P.</given-names></name><name><surname>Cazaux</surname><given-names>S.</given-names></name><name><surname>Bouajila</surname><given-names>J.</given-names></name></person-group><article-title>Chemical composition and anticancer and antioxidant activities of Schinus molle L. and Schinus terebinthifolius Raddi berries essential oils</article-title><source>J. Food Sci.</source><year>2010</year><volume>75</volume><fpage>C466</fpage><lpage>C472</lpage><pub-id pub-id-type="doi">10.1111/j.1750-3841.2010.01711.x</pub-id><pub-id pub-id-type="pmid">20722898</pub-id></element-citation></ref><ref id="B278-biomolecules-09-00679"><label>278.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaz</surname><given-names>C.</given-names></name><name><surname>Quesada</surname><given-names>S.</given-names></name><name><surname>Brenes</surname><given-names>O.</given-names></name><name><surname>Aguilar</surname><given-names>G.</given-names></name><name><surname>Ciccio</surname><given-names>J.F.</given-names></name></person-group><article-title>Chemical composition of Schinus molle essential oil and its cytotoxic activity on tumour cell lines</article-title><source>Nat. Prod. Res.</source><year>2008</year><volume>22</volume><fpage>1521</fpage><lpage>1534</lpage><pub-id pub-id-type="doi">10.1080/14786410701848154</pub-id><pub-id pub-id-type="pmid">19023816</pub-id></element-citation></ref><ref id="B279-biomolecules-09-00679"><label>279.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>J.</given-names></name><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Liao</surname><given-names>Z.</given-names></name></person-group><article-title>Composition, cytotoxicity and antimicrobial activity of essential oil from Dictamnus dasycarpus</article-title><source>Food Chem.</source><year>2008</year><volume>107</volume><fpage>1205</fpage><lpage>1209</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2007.09.050</pub-id></element-citation></ref><ref id="B280-biomolecules-09-00679"><label>280.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apel</surname><given-names>M.A.</given-names></name><name><surname>Lima</surname><given-names>M.E.L.</given-names></name><name><surname>Souza</surname><given-names>A.</given-names></name><name><surname>Cordeiro</surname><given-names>I.</given-names></name><name><surname>Young</surname><given-names>M.C.M.</given-names></name><name><surname>Sobral</surname><given-names>M.E.</given-names></name><name><surname>Suffredini</surname><given-names>I.B.</given-names></name><name><surname>Moreno</surname><given-names>P.R.H.</given-names></name></person-group><article-title>Screening of the biological activity from essential oils of native species from the Atlantic rain forest (S&#x000e3;o Paulo&#x02013;Brazil)</article-title><source>Pharmacologyonline</source><year>2006</year><volume>3</volume><fpage>376</fpage><lpage>383</lpage></element-citation></ref><ref id="B281-biomolecules-09-00679"><label>281.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monajemi</surname><given-names>R.</given-names></name><name><surname>Oryan</surname><given-names>S.</given-names></name><name><surname>Haeri-Roohani</surname><given-names>A.</given-names></name><name><surname>Ghannadi</surname><given-names>A.</given-names></name><name><surname>Jafarian</surname><given-names>A.</given-names></name></person-group><article-title>Cytotoxic Effects of Essential Oils of Some Iranian Citrus Peels</article-title><source>Iran. J. Pharm. Res.</source><year>2010</year><volume>4</volume><fpage>183</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.22037/ijpr.2010.635</pub-id></element-citation></ref><ref id="B282-biomolecules-09-00679"><label>282.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goren</surname><given-names>A.</given-names></name><name><surname>Topcu</surname><given-names>G.</given-names></name><name><surname>Bilsel</surname><given-names>G.</given-names></name><name><surname>Bilsel</surname><given-names>M.</given-names></name><name><surname>Aydogmus</surname><given-names>Z.</given-names></name><name><surname>Pezzuto</surname><given-names>J.M.</given-names></name></person-group><article-title>The chemical constituents and biological activity of essential oil of Lavandula stoechas ssp. stoechas</article-title><source>Z. Fur Nat.</source><year>2002</year><volume>57</volume><fpage>797</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1515/znc-2002-9-1007</pub-id></element-citation></ref><ref id="B283-biomolecules-09-00679"><label>283.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manikandan</surname><given-names>P.</given-names></name><name><surname>Vinothini</surname><given-names>G.</given-names></name><name><surname>Vidya Priyadarsini</surname><given-names>R.</given-names></name><name><surname>Prathiba</surname><given-names>D.</given-names></name><name><surname>Nagini</surname><given-names>S.</given-names></name></person-group><article-title>Eugenol inhibits cell proliferation via NF-kappaB suppression in a rat model of gastric carcinogenesis induced by MNNG</article-title><source>Investig. New Drugs</source><year>2011</year><volume>29</volume><fpage>110</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1007/s10637-009-9345-2</pub-id><?supplied-pmid 19851710?><pub-id pub-id-type="pmid">19851710</pub-id></element-citation></ref><ref id="B284-biomolecules-09-00679"><label>284.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sajjadi</surname><given-names>M.</given-names></name><name><surname>Karimi</surname><given-names>E.</given-names></name></person-group><article-title>Galbanic acid: Induced antiproliferation in estrogen receptor-negative breast cancer cells and enhanced cellular redox state in the human dermal fibroblasts</article-title><source>J. Biochem. Mol. Toxicol.</source><year>2019</year><elocation-id>e22402</elocation-id><pub-id pub-id-type="doi">10.1002/jbt.22402</pub-id><?supplied-pmid 31576639?><pub-id pub-id-type="pmid">31576639</pub-id></element-citation></ref><ref id="B285-biomolecules-09-00679"><label>285.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kakarala</surname><given-names>M.</given-names></name><name><surname>Brenner</surname><given-names>D.E.</given-names></name><name><surname>Korkaya</surname><given-names>H.</given-names></name><name><surname>Cheng</surname><given-names>C.</given-names></name><name><surname>Tazi</surname><given-names>K.</given-names></name><name><surname>Ginestier</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Dontu</surname><given-names>G.</given-names></name><name><surname>Wicha</surname><given-names>M.S.</given-names></name></person-group><article-title>Targeting breast stem cells with the cancer preventive compounds curcumin and piperine</article-title><source>Breast Cancer Res. Treat.</source><year>2010</year><volume>122</volume><fpage>777</fpage><lpage>785</lpage><pub-id pub-id-type="doi">10.1007/s10549-009-0612-x</pub-id><?supplied-pmid 19898931?><pub-id pub-id-type="pmid">19898931</pub-id></element-citation></ref><ref id="B286-biomolecules-09-00679"><label>286.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pejin</surname><given-names>B.</given-names></name><name><surname>Kojic</surname><given-names>V.</given-names></name><name><surname>Bogdanovic</surname><given-names>G.</given-names></name></person-group><article-title>An insight into the cytotoxic activity of phytol at in vitro conditions</article-title><source>Nat. Prod. Res.</source><year>2014</year><volume>28</volume><fpage>2053</fpage><lpage>2056</lpage><pub-id pub-id-type="doi">10.1080/14786419.2014.921686</pub-id><?supplied-pmid 24896297?><pub-id pub-id-type="pmid">24896297</pub-id></element-citation></ref><ref id="B287-biomolecules-09-00679"><label>287.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>K.</given-names></name><name><surname>Yagasaki</surname><given-names>K.</given-names></name><name><surname>Wu</surname><given-names>E.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name></person-group><article-title>Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-kappaB signaling</article-title><source>Cytotechnology</source><year>2009</year><volume>59</volume><fpage>219</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1007/s10616-009-9225-9</pub-id><pub-id pub-id-type="pmid">19760125</pub-id></element-citation></ref><ref id="B288-biomolecules-09-00679"><label>288.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>Y.H.</given-names></name><name><surname>Choi</surname><given-names>W.Y.</given-names></name><name><surname>Hong</surname><given-names>S.H.</given-names></name><name><surname>Kim</surname><given-names>S.O.</given-names></name><name><surname>Kim</surname><given-names>G.Y.</given-names></name><name><surname>Lee</surname><given-names>W.H.</given-names></name><name><surname>Yoo</surname><given-names>Y.H.</given-names></name></person-group><article-title>Anti-invasive activity of sanguinarine through modulation of tight junctions and matrix metalloproteinase activities in MDA-MB-231 human breast carcinoma cells</article-title><source>Chem.-Biol. Interact.</source><year>2009</year><volume>179</volume><fpage>185</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2008.11.009</pub-id><pub-id pub-id-type="pmid">19063874</pub-id></element-citation></ref><ref id="B289-biomolecules-09-00679"><label>289.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>L.W.</given-names></name><name><surname>Zhang</surname><given-names>Y.M.</given-names></name><name><surname>Liang</surname><given-names>Y.J.</given-names></name><name><surname>Yang</surname><given-names>X.P.</given-names></name><name><surname>Pan</surname><given-names>Q.C.</given-names></name></person-group><article-title>The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells</article-title><source>Eur. J. Cancer</source><year>2002</year><volume>38</volume><fpage>418</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1016/S0959-8049(01)00356-2</pub-id><pub-id pub-id-type="pmid">11818209</pub-id></element-citation></ref><ref id="B290-biomolecules-09-00679"><label>290.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Xie</surname><given-names>W.</given-names></name><name><surname>Xie</surname><given-names>C.</given-names></name><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Liang</surname><given-names>Z.</given-names></name><name><surname>Deng</surname><given-names>F.</given-names></name><name><surname>Zhu</surname><given-names>M.</given-names></name><name><surname>Zhu</surname><given-names>W.</given-names></name><name><surname>Wu</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Curcumin modulates miR-19/PTEN/AKT/p53 axis to suppress bisphenol A-induced MCF-7 breast cancer cell proliferation</article-title><source>Phytother. Res.</source><year>2014</year><volume>28</volume><fpage>1553</fpage><lpage>1560</lpage><pub-id pub-id-type="doi">10.1002/ptr.5167</pub-id><pub-id pub-id-type="pmid">24831732</pub-id></element-citation></ref><ref id="B291-biomolecules-09-00679"><label>291.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bimonte</surname><given-names>S.</given-names></name><name><surname>Barbieri</surname><given-names>A.</given-names></name><name><surname>Palma</surname><given-names>G.</given-names></name><name><surname>Rea</surname><given-names>D.</given-names></name><name><surname>Luciano</surname><given-names>A.</given-names></name><name><surname>D&#x02019;Aiuto</surname><given-names>M.</given-names></name><name><surname>Arra</surname><given-names>C.</given-names></name><name><surname>Izzo</surname><given-names>F.</given-names></name></person-group><article-title>Dissecting the role of curcumin in tumour growth and angiogenesis in mouse model of human breast cancer</article-title><source>Biomed Res. Int.</source><year>2015</year><volume>2015</volume><fpage>878134</fpage><pub-id pub-id-type="doi">10.1155/2015/878134</pub-id><pub-id pub-id-type="pmid">25879038</pub-id></element-citation></ref><ref id="B292-biomolecules-09-00679"><label>292.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name><name><surname>Shishodia</surname><given-names>S.</given-names></name><name><surname>Takada</surname><given-names>Y.</given-names></name><name><surname>Banerjee</surname><given-names>S.</given-names></name><name><surname>Newman</surname><given-names>R.A.</given-names></name><name><surname>Bueso-Ramos</surname><given-names>C.E.</given-names></name><name><surname>Price</surname><given-names>J.E.</given-names></name></person-group><article-title>Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice</article-title><source>Clin. Cancer Res.</source><year>2005</year><volume>11</volume><fpage>7490</fpage><lpage>7498</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-05-1192</pub-id><pub-id pub-id-type="pmid">16243823</pub-id></element-citation></ref><ref id="B293-biomolecules-09-00679"><label>293.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>Z.D.</given-names></name><name><surname>Liu</surname><given-names>X.P.</given-names></name><name><surname>Zhao</surname><given-names>W.J.</given-names></name><name><surname>Dong</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>F.N.</given-names></name><name><surname>Wang</surname><given-names>H.B.</given-names></name><name><surname>Kong</surname><given-names>B.</given-names></name></person-group><article-title>Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo</article-title><source>Int. J. Clin. Exp. Pathol.</source><year>2014</year><volume>7</volume><fpage>2818</fpage><lpage>2824</lpage><?supplied-pmid 25031701?><pub-id pub-id-type="pmid">25031701</pub-id></element-citation></ref><ref id="B294-biomolecules-09-00679"><label>294.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>H.</given-names></name><name><surname>Ullah</surname><given-names>H.</given-names></name><name><surname>Martorell</surname><given-names>M.</given-names></name><name><surname>Esteban Valdes</surname><given-names>S.</given-names></name><name><surname>Belwal</surname><given-names>T.</given-names></name><name><surname>Tejada</surname><given-names>S.</given-names></name><name><surname>Sureda</surname><given-names>A.</given-names></name><name><surname>Kamal</surname><given-names>M.A.</given-names></name></person-group><article-title>Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects</article-title><source>Semin. Cancer Biol.</source><year>2019</year><pub-id pub-id-type="doi">10.1016/j.semcancer.2019.07.023</pub-id><?supplied-pmid 31374244?><pub-id pub-id-type="pmid">31374244</pub-id></element-citation></ref><ref id="B295-biomolecules-09-00679"><label>295.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pezzani</surname><given-names>R.</given-names></name><name><surname>Salehi</surname><given-names>B.</given-names></name><name><surname>Vitalini</surname><given-names>S.</given-names></name><name><surname>Iriti</surname><given-names>M.</given-names></name><name><surname>Zuniga</surname><given-names>F.A.</given-names></name><name><surname>Sharifi-Rad</surname><given-names>J.</given-names></name><name><surname>Martorell</surname><given-names>M.</given-names></name><name><surname>Martins</surname><given-names>N.</given-names></name></person-group><article-title>Synergistic effects of plant derivatives and conventional chemotherapeutic agents: An update on the cancer perspective</article-title><source>Medicina</source><year>2019</year><volume>55</volume><elocation-id>110</elocation-id><pub-id pub-id-type="doi">10.3390/medicina55040110</pub-id><?supplied-pmid 30999703?><pub-id pub-id-type="pmid">30999703</pub-id></element-citation></ref><ref id="B296-biomolecules-09-00679"><label>296.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitra</surname><given-names>A.K.</given-names></name><name><surname>Agrahari</surname><given-names>V.</given-names></name><name><surname>Mandal</surname><given-names>A.</given-names></name><name><surname>Cholkar</surname><given-names>K.</given-names></name><name><surname>Natarajan</surname><given-names>C.</given-names></name><name><surname>Shah</surname><given-names>S.</given-names></name><name><surname>Joseph</surname><given-names>M.</given-names></name><name><surname>Trinh</surname><given-names>H.M.</given-names></name><name><surname>Vaishya</surname><given-names>R.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Novel delivery approaches for cancer therapeutics</article-title><source>J. Control. Release</source><year>2015</year><volume>219</volume><fpage>248</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2015.09.067</pub-id><?supplied-pmid 26456750?><pub-id pub-id-type="pmid">26456750</pub-id></element-citation></ref><ref id="B297-biomolecules-09-00679"><label>297.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunnumakkara</surname><given-names>A.B.</given-names></name><name><surname>Bordoloi</surname><given-names>D.</given-names></name><name><surname>Sailo</surname><given-names>B.L.</given-names></name><name><surname>Roy</surname><given-names>N.K.</given-names></name><name><surname>Thakur</surname><given-names>K.K.</given-names></name><name><surname>Banik</surname><given-names>K.</given-names></name><name><surname>Shakibaei</surname><given-names>M.</given-names></name><name><surname>Gupta</surname><given-names>S.C.</given-names></name><name><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Cancer drug development: The missing links</article-title><source>Exp. Biol. Med.</source><year>2019</year><volume>244</volume><fpage>663</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1177/1535370219839163</pub-id></element-citation></ref><ref id="B298-biomolecules-09-00679"><label>298.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoonjan</surname><given-names>M.</given-names></name><name><surname>Jadhav</surname><given-names>V.</given-names></name><name><surname>Bhatt</surname><given-names>P.</given-names></name></person-group><article-title>Arsenic trioxide: insights into its evolution to an anticancer agent</article-title><source>J. Biol. Inorg. Chem.</source><year>2018</year><volume>23</volume><fpage>313</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1007/s00775-018-1537-9</pub-id><pub-id pub-id-type="pmid">29396610</pub-id></element-citation></ref><ref id="B299-biomolecules-09-00679"><label>299.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slezakova</surname><given-names>S.</given-names></name><name><surname>Ruda-Kucerova</surname><given-names>J.</given-names></name></person-group><article-title>Anticancer activity of artemisinin and its derivatives</article-title><source>Anticancer Res.</source><year>2017</year><volume>37</volume><fpage>5995</fpage><lpage>6003</lpage><pub-id pub-id-type="doi">10.21873/anticanres.12046</pub-id><pub-id pub-id-type="pmid">29061778</pub-id></element-citation></ref><ref id="B300-biomolecules-09-00679"><label>300.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Arfuso</surname><given-names>F.</given-names></name><name><surname>Chinnathambi</surname><given-names>A.</given-names></name><name><surname>Zayed</surname><given-names>M.E.</given-names></name><name><surname>Alharbi</surname><given-names>S.A.</given-names></name><name><surname>Kumar</surname><given-names>A.P.</given-names></name><name><surname>Ahn</surname><given-names>K.S.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name></person-group><article-title>Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy</article-title><source>Exp. Biol. Med.</source><year>2015</year><volume>240</volume><fpage>760</fpage><lpage>773</lpage><pub-id pub-id-type="doi">10.1177/1535370215579167</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="biomolecules-09-00679-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Classification of the antitumor drugs according to their action mechanism and timeline showing their history.</p></caption><graphic xlink:href="biomolecules-09-00679-g001"/></fig><fig id="biomolecules-09-00679-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Chemical structures of cabazitaxel, paclitaxel and docetaxel.</p></caption><graphic xlink:href="biomolecules-09-00679-g002"/></fig><fig id="biomolecules-09-00679-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Chemical structures of eribulin and halichondrin B.</p></caption><graphic xlink:href="biomolecules-09-00679-g003"/></fig><fig id="biomolecules-09-00679-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Chemical structure of vincristine and formulation of VinCRIStine sulfate liposome injection (Marqibo).</p></caption><graphic xlink:href="biomolecules-09-00679-g004"/></fig><fig id="biomolecules-09-00679-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Chemical structures of rucaparib, niraparib, and talazoparib.</p></caption><graphic xlink:href="biomolecules-09-00679-g005"/></fig><fig id="biomolecules-09-00679-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>The structure of pomalidomide and lenalidomide.</p></caption><graphic xlink:href="biomolecules-09-00679-g006"/></fig><fig id="biomolecules-09-00679-f007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Chemical structures of erdafitinib and lenvatin.</p></caption><graphic xlink:href="biomolecules-09-00679-g007"/></fig><table-wrap id="biomolecules-09-00679-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">biomolecules-09-00679-t001_Table 1</object-id><label>Table 1</label><caption><p>Natural antitumor drugs and synthetic analogs.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Antitumor Drug</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Chemical Structure</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Natural Source/Analog</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Paclitaxel</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="biomolecules-09-00679-i001.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Taxus brevifolia</italic> Nutt.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Docetaxel</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="biomolecules-09-00679-i002.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Paclitaxel analog</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cabazitaxel</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="biomolecules-09-00679-i003.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Paclitaxel analog</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Camptothecin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="biomolecules-09-00679-i004.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Camptotheca acuminata</italic> Decne.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Belotecan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="biomolecules-09-00679-i005.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Camptothecin analog</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Topotecan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="biomolecules-09-00679-i006.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Camptothecin analog</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Irinotecan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="biomolecules-09-00679-i007.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Camptothecin analog</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vinblastine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="biomolecules-09-00679-i008.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Vinca rosea</italic> L.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vincristine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="biomolecules-09-00679-i009.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Vinca rosea</italic> L.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vindesine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="biomolecules-09-00679-i010.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vincristine analog</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vinorelbine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="biomolecules-09-00679-i011.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vincristine analog</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Podophyllotoxin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="biomolecules-09-00679-i012.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Podophyllum</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Etoposide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="biomolecules-09-00679-i013.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Podophyllotoxin analog</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Teniposide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="biomolecules-09-00679-i014.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Podophyllotoxin analog</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bleomycin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="biomolecules-09-00679-i015.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Streptomyces verticillus</italic>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dactinomycin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="biomolecules-09-00679-i016.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Streptomyces</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Doxorubicin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="biomolecules-09-00679-i017.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Streptomyces peucetius</italic> var. caesius</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Daunorubicin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="biomolecules-09-00679-i018.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Streptomyces</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Epirubicin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="biomolecules-09-00679-i019.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Doxorubicin analog</td></tr></tbody></table></table-wrap><table-wrap id="biomolecules-09-00679-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">biomolecules-09-00679-t002_Table 2</object-id><label>Table 2</label><caption><p>Small molecules. Some data were drawn from DrugBank [<xref rid="B102-biomolecules-09-00679" ref-type="bibr">102</xref>].</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ingredient Name<break/>Product Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Chemical Classification</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Associated Conditions</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanism of Action</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Target(s)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">FDA Approval</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Cabazitaxel Jevtana</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Organic compound<break/>Taxanes and derivatives<break/>Diterpenoids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Refractory, metastatic prostate cancer<break/>Effective against docetaxel-sensitive and insensitive tumors</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tubulin-based antimitotic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tubulin alpha-4A chain<break/>Tubulin beta-1 chain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">June 2010</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Eribulin Halaven</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Organic compound<break/>Furopyrans</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Metastatic liposarcoma<break/>Refractory, metastatic breast cancer<break/>Unresectable liposarcoma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tubulin-based antimitotic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Apoptosis regulator Bcl-2<break/>Tubulin beta-1 chain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">November 2010</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>VinCRIStine sulfate LIPOSOME Marqibo</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vinca alkaloids formulated in liposomes (sphingomyelin and cholesterol based)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Relapsed Philadelphia chromosome-negative (Ph-) acute lymphoblastic<break/>leukemia<break/>Malignant lymphoma<break/>Hodgkin&#x02019;s disease</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tubulin-based antimitotic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tubulin beta chain<break/>Tubulin alpha-4A chain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">August 2012</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Rucaparib Rubraca</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Organic compound<break/>Indoles and derivatives<break/>Indoles</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Advanced ovarian cancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PARPs inhibitor leading to DNA damage, apoptosis, and cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poly(ADP-ribose) polymerase 1<break/>Poly(ADP-ribose) polymerase 2<break/>Poly(ADP-ribose) polymerase 3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">December 2016</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Niraparib Zejula</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Organic compound<break/>Indoles and derivatives<break/>Indoles</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ovarian epithelial cancer<break/>Fallopian Tube Cancer<break/>Primary Peritoneal Cancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PARPs inhibitor leading to DNA damage, apoptosis, and cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poly(ADP-ribose) polymerase 1<break/>Poly(ADP-ribose) polymerase 2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">March 2017</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Talazoparib Talzenna</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Organic compound<break/>Quinolines and derivatives<break/>Phenylquinolines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Locally advanced breast cancer Metastatic breast cancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PARPs inhibitor leading to DNA damage, apoptosis, and cell death</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poly(ADP-ribose) polymerase 1<break/>Poly(ADP-ribose) polymerase 2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">October 2018</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Pomalidomide Pomalyst</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Organic compound<break/>Isoindoles and derivatives<break/>Isoindolines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Refractory multiple myeloma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x00130;nhibition of the proliferation and stimulation of apoptosis. Inhibition of the production of proinflammatory cytokines.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein cereblon<break/>Tumor necrosis factor<break/>Prostaglandin G/H synthase 2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">February 2013</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Lenalidomide Revlimid</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Organic compound<break/>Soindoles and derivatives<break/>Isoindolines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chronic Lymphocytic Leukemia<break/>Mantle Cell Lymphoma<break/>Multiple Myeloma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of the release of proinflammatory cytokines and increasing the secretion of anti-inflammatory cytokines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protein cereblon<break/>Tumor necrosis factor ligand superfamily member 11<break/>Prostaglandin G/H synthase 2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">June 2013</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Erdafitinib Balversa</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Organic compound<break/>Organic nitrogen compounds<break/>Amines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Locally advanced urothelial carcinoma<break/>Metastatic urothelial carcinoma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of the enzymatic activity of expressed FGFR1, FGFR2, FGFR3, and FGFR4.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fibroblast growth factor receptor 1<break/>Fibroblast growth factor receptor 2<break/>Fibroblast growth factor receptor 3<break/>Fibroblast growth factor receptor 4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">April 2019</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Lenvatinib Lenvima</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Organic compounds<break/>Quinolines and derivatives<break/>Quinoline carboxamides</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Advanced renal cell carcinoma<break/>Locally recurrent radioactive iodine-refractory thyroid cancer<break/>Metastatic radioactive iodine-refractory thyroid cancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x00130;nhibition of the receptor tyrosine kinases leading to suppression of angiogenesis, tumor growth, and cancer progression.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vascular endothelial growth factor receptor 1/2/3<break/>Fibroblast growth factor receptor 1/2/3/4<break/>Platelet derived growth factor receptor alpha</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">August 2015</td></tr></tbody></table></table-wrap><table-wrap id="biomolecules-09-00679-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">biomolecules-09-00679-t003_Table 3</object-id><label>Table 3</label><caption><p>Activity anticancer of medicinal plants phytochemical compounds on oral cancer.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plants</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Extracts/Molecules</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Biological Approach (In Vitro/In Vivo)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Lines Tested</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Key Finding/Mechanisms</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Artemisinin and<break/>its derivatives</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">YD-10B cell line</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B133-biomolecules-09-00679" ref-type="bibr">133</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Amonds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Amygdalin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KB cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">cytotoxic and antiproliferative activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B242-biomolecules-09-00679" ref-type="bibr">242</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eugenol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HSC-2 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B136-biomolecules-09-00679" ref-type="bibr">136</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cloves oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eugenol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KB cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B137-biomolecules-09-00679" ref-type="bibr">137</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eugenol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human oral mucosal fibroblasts</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B138-biomolecules-09-00679" ref-type="bibr">138</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Piper betle</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Safrole</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human<break/>buccal mucosal fibroblasts (BMFs)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B140-biomolecules-09-00679" ref-type="bibr">140</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Berberine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OC2 and KB cells</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Block cell cycle responses</p></list-item><list-item><label>-</label><p>Cytotoxic effect</p></list-item></list>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B143-biomolecules-09-00679" ref-type="bibr">143</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Thymus vulgaris</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UMSCC1 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B145-biomolecules-09-00679" ref-type="bibr">145</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Azadirachta indica</italic> A.Juss.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Limonoids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hamster buccal pouch (HBP) carcinogenesis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of cell proliferation and induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B156-biomolecules-09-00679" ref-type="bibr">156</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Alpinia pricei</italic> Hayata</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chalcone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HSC-3 cells</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>G2/M arrest</p></list-item><list-item><label>-</label><p>induction of apoptosis</p></list-item></list>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B157-biomolecules-09-00679" ref-type="bibr">157</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Pinus densiflora</italic> Siebold &#x00026; Zucc.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">YD-8 cells</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Inhibition of proliferation and survival</p></list-item><list-item><label>-</label><p>Induction of apoptosis</p></list-item></list>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B243-biomolecules-09-00679" ref-type="bibr">243</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Artemisia capillaris</italic> Thunb.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KB cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B150-biomolecules-09-00679" ref-type="bibr">150</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cinnamomum cassia</italic> (L.) J.Presl</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cinnamaldehyde Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HSC-3 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell cycle arrest and apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B244-biomolecules-09-00679" ref-type="bibr">244</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cryptomeria japonica</italic> (Thunb. ex L.f.) D.Don</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KB cells</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Induction of apoptosis</p></list-item><list-item><label>-</label><p>Activation of Caspases</p></list-item></list>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B245-biomolecules-09-00679" ref-type="bibr">245</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Solanum spirale</italic> Roxb.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KB cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B151-biomolecules-09-00679" ref-type="bibr">151</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Sal</italic>via <italic>officinalis</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UMSCC1 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B146-biomolecules-09-00679" ref-type="bibr">146</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Levisticum officinale</italic> W.D.J.Koch</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UMSCC1 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B147-biomolecules-09-00679" ref-type="bibr">147</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Elaeagnus angustifolia</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SCC25 cells</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Inhibits of angiogenesis</p></list-item><list-item><label>-</label><p>Induction of differentiation to an epithelial phenotype</p></list-item></list>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B246-biomolecules-09-00679" ref-type="bibr">246</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Neolitsea variabillima</italic> (Hayata) Kaneh. &#x00026; Sasaki</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OEC-M1 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B247-biomolecules-09-00679" ref-type="bibr">247</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carvacrol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OC2 cells</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Induction of apoptosis</p></list-item><list-item><label>-</label><p>Activation of caspase-3</p></list-item></list>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B144-biomolecules-09-00679" ref-type="bibr">144</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chios mastic gum extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">YD-10B cells</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Inhibition of growth</p></list-item><list-item><label>-</label><p>Induction of apoptosis</p></list-item></list>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B248-biomolecules-09-00679" ref-type="bibr">248</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Saussurea costus</italic> (Falc.) Lipsch.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methanol extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KB cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B249-biomolecules-09-00679" ref-type="bibr">249</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Thymus caramanicus</italic> Jalas</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydro-ethanolic extractEssential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KB cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B250-biomolecules-09-00679" ref-type="bibr">250</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Artemisia gmelinii</italic> Weber ex Stechm.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KB cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B149-biomolecules-09-00679" ref-type="bibr">149</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Mentha spicata</italic> L.<break/>Associated with <italic>Mentha &#x000d7; rotundifolia</italic> (L.) Huds.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hexane Extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KB cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-neoplastic activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B251-biomolecules-09-00679" ref-type="bibr">251</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Piper betle</italic> L. and <italic>Psidium guajava</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KB cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B252-biomolecules-09-00679" ref-type="bibr">252</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Zanthoxylum nitidum</italic> (Roxb.) DC.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nitidine chloride</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro and in vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HSC-3 and HSC-4 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Decreased cell viability via apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B253-biomolecules-09-00679" ref-type="bibr">253</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="biomolecules-09-00679-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">biomolecules-09-00679-t004_Table 4</object-id><label>Table 4</label><caption><p>Activity anticancer of medicinal plants phytochemical compounds on gastrointestinal cancer.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Molecules </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Biological Approach (in vitro/in vivo)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell lines tested </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Key Finding/mechanisms</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Ganoderma</italic>
<break/>
<italic>lucidum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCT116</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induced apoptosis in HCT116 and increased caspase-8, caspase-3, and Fas</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B159-biomolecules-09-00679" ref-type="bibr">159</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aloe-Emodin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SW-620 and HT-29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppress cell proliferation in a dose-dependent manner and induced ROS production</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B254-biomolecules-09-00679" ref-type="bibr">254</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Triterpenes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HT-29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppresses the proliferation, inhibits tumor growth in the colon carcinoma xenograft model</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B160-biomolecules-09-00679" ref-type="bibr">160</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cannabidiol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HCT116 mice xenograft</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced pre-neoplastic lesions and azoxymethane-induced polyps</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B161-biomolecules-09-00679" ref-type="bibr">161</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Genistein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HT-29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Proapoptotic effect: increases expression of Bax or p21 proteins; inhibits NF-kB and topoisomerase II, in combination with cisplatin inhibits cell growth; and induces apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B162-biomolecules-09-00679" ref-type="bibr">162</xref>,<xref rid="B163-biomolecules-09-00679" ref-type="bibr">163</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stictic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HT-29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moderate anticancer activity and low growth inhibition on nonmalignant cells (MRC-5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B255-biomolecules-09-00679" ref-type="bibr">255</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Apigenin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HT-29 and HRT-18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increases activity of CD26, more in combination with irinotecan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B166-biomolecules-09-00679" ref-type="bibr">166</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Quercetin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SW-620, HT-29, Caco-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sensitizes cells against TRAIL, causing apoptosis, generating of ROS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B167-biomolecules-09-00679" ref-type="bibr">167</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Geraniol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Caco-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased apoptosis combined with 5-FU</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B256-biomolecules-09-00679" ref-type="bibr">256</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lycopene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SW480</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acts anti-inflammatory suppresses the expression of PCNA and b-catechins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B164-biomolecules-09-00679" ref-type="bibr">164</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ginkgo biloba</italic> L. extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HT29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits progression of the tumor, increases caspase-3 activity, elevates p53 expression, and decreases<break/>expression of Bcl-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B165-biomolecules-09-00679" ref-type="bibr">165</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="biomolecules-09-00679-t005" orientation="portrait" position="float"><object-id pub-id-type="pii">biomolecules-09-00679-t005_Table 5</object-id><label>Table 5</label><caption><p>Activity anticancer of medicinal plants phytochemical compounds on pancreatic cancer.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plants</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Extracts/Molecules</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Biological Approach (In Vitro/In Vivo)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Lines Tested </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Key Finding/Mechanisms</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Plumbago zeylanica</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plumbagin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Panc-1, BxPC3, and ASPC1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induced apoptosis and inhibited the cell viability of PC cells<break/>Inhibited the cell invasion of PC cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B173-biomolecules-09-00679" ref-type="bibr">173</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Plumbago zeylanica</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plumbagin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of both tumor weight and volume</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B173-biomolecules-09-00679" ref-type="bibr">173</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Moringa oleifera</italic> Lam.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Panc-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited the growth of all pancreatic cell lines <break/>Enhanced the cytotoxic effect of cisplatin on Panc-1 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B171-biomolecules-09-00679" ref-type="bibr">171</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mimosine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Xenografts</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited of the cell cycle giving rise to growth arrest in G1-phase</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B174-biomolecules-09-00679" ref-type="bibr">174</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Epigallocatechin-3-gallate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cells in a xenograft model system.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited the cell growth and induced apoptosis in human pancreatic cancer cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B175-biomolecules-09-00679" ref-type="bibr">175</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MK615</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Panc-1, PK-1, and PK45H</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased the population of cells in G2/M phase<break/>Inhibited the expression of Aurora A and B kinases</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B257-biomolecules-09-00679" ref-type="bibr">257</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Acacia pennata</italic> (L.) Willd.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Panc-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induced a cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B178-biomolecules-09-00679" ref-type="bibr">178</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chittagonga CH<sub>2</sub>Cl<sub>2</sub></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Panc-1, Mia-PaCa2, and Capan1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B176-biomolecules-09-00679" ref-type="bibr">176</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Angelica pubescens</italic> Maxim.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Angelmarin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Panc-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B177-biomolecules-09-00679" ref-type="bibr">177</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Betulinic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EPP85-181P</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B179-biomolecules-09-00679" ref-type="bibr">179</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Boesenbergia rotunda</italic> (L.) Mansf</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chloroform</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Panc-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B172-biomolecules-09-00679" ref-type="bibr">172</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cucurbitacin B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited significantly the tumor growth of pancreatic cancer xenografts</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B180-biomolecules-09-00679" ref-type="bibr">180</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inositol hexaphosphate (IP6)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mia-PaCa et Panc-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Decreased the cellular growth and increased apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B22-biomolecules-09-00679" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Apigenin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CD18 et S2-013</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Decreased glucose uptake and downregulated the GLUT-1 glucose transporter in human pancreatic cancer cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B258-biomolecules-09-00679" ref-type="bibr">258</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cruciferous vegetables</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sorafenib</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited of angiogenesis Induced of apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B181-biomolecules-09-00679" ref-type="bibr">181</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Benzyl isothiocyanate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BxPC3, Mia-PaCa2 and Panc-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited of cell cycle <break/>Activated of apoptotic pathways</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B259-biomolecules-09-00679" ref-type="bibr">259</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L-canavanine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Panc-1 and Mia-PaCa2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synergistic effect with radiation may have clinical potential in the treatment of pancreatic cancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B260-biomolecules-09-00679" ref-type="bibr">260</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Apigenin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MiaPaca-2, AsPC-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induced of apoptosis </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B261-biomolecules-09-00679" ref-type="bibr">261</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Tripterygium wilfordii</italic> Hook. f.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Triptolide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SW1990</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited the growth of human pancreatic cancer<break/>Apoptotic activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B182-biomolecules-09-00679" ref-type="bibr">182</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Luteolin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SW1990</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induced apoptosis by targeting Bcl-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B262-biomolecules-09-00679" ref-type="bibr">262</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fisetetin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Panc-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased autophagy via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B263-biomolecules-09-00679" ref-type="bibr">263</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resveratrol and quercetin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Panc-1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resveratrol and quercetin affected metastasis in pancreatic cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B264-biomolecules-09-00679" ref-type="bibr">264</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="biomolecules-09-00679-t006" orientation="portrait" position="float"><object-id pub-id-type="pii">biomolecules-09-00679-t006_Table 6</object-id><label>Table 6</label><caption><p>Activity anticancer of medicinal plants phytochemical compounds on skin cancer.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plants</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Extracts/Molecules</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Biological Approach (In Vitro/In Vivo)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Lines Tested </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Key Finding/Mechanisms</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Piper umbellatum</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4-nerolidylcatechol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SK-MEL-2, SK-MEL-103, SK-MEL-147</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G-1 phase arrest, inhibit the effect of matrix metalloproteinase MMP-2 and MMP-9 activity, loss of membrane integrity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B184-biomolecules-09-00679" ref-type="bibr">184</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Indigofera aspalathoides</italic> DC.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flavone glycoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Melanoma (LOX IMVI, MALME-3M, SK-MEL-2, SK-MEL-28, SK-MEL-5, UACC-257, UACC-62)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Important cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B190-biomolecules-09-00679" ref-type="bibr">190</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Fucus evanescens</italic> C.Agardh</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fucoidans</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SK-MEL-28 and SK-MEL-5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited colony formation and cell proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B183-biomolecules-09-00679" ref-type="bibr">183</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Alpinia officinarum</italic> Hance</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Galangin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B16F10 cell line (murine melanoma cell)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced the mitochondrial membrane potential</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B185-biomolecules-09-00679" ref-type="bibr">185</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Hamamelis virginiana</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyphenols</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SK-MEL-28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pro-oxidant effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B265-biomolecules-09-00679" ref-type="bibr">265</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Satureja thymbra</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Linalool</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Amelanotic melanoma C32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited tumor cell growth (Mechanism Still unknown)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B196-biomolecules-09-00679" ref-type="bibr">196</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Mesua ferrea</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-polar extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Melanoma SK-MEL-28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B186-biomolecules-09-00679" ref-type="bibr">186</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Euphorbia lagascae</italic> Spreng.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Polyphenol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Melanoma SK-MEL-28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Initiated G2/M arrest by downregulating expression of cyclins A, E, and B1.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B187-biomolecules-09-00679" ref-type="bibr">187</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Pinus pinaster</italic> Aiton</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Procyanidins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SK-MEL-28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B191-biomolecules-09-00679" ref-type="bibr">191</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Vitis vinifera</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resveratrol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Melanoma (A-375, A-431, SK-MEL-28)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enhanced the phosphorylation of ERK1/2. <break/>Induced an arresting of the cell cycle at G1-phase.<break/>Induced the downregulating of the protein expression of Cyclin D1, D2, and E and also cdk2, cdk4, and cdk6.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B199-biomolecules-09-00679" ref-type="bibr">199</xref>,<xref rid="B200-biomolecules-09-00679" ref-type="bibr">200</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Dracaena angustifolia</italic> (Medik.) Roxb.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Saponins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B-16 melanoma cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B192-biomolecules-09-00679" ref-type="bibr">192</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Schkuhria pinnata</italic> (Lam.) Kuntze ex Thell.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sesquiterpene lactones</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Melanoma UACC-62</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B197-biomolecules-09-00679" ref-type="bibr">197</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Silybum marianum</italic> (L.) Gaertn.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silybin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human melanoma SK-MEL-5, SK-MEL-28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited the expression of Cyclin D1 and caused the cell cycle arrest at G-1 phase.<break/>Downregulated the expression of NF-kB, Ap-1 and STAT3.<break/>Inhibited the phosphorylation of ERK1/2 and RSK2. <break/>Inhibited the activity of MEK1 and MEK2.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B193-biomolecules-09-00679" ref-type="bibr">193</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Silybum marianum</italic> (L.) Gaertn.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Silymarin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human malignant melanoma A375-S2 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased the expression of cell surface ligand death receptors such as Fas and Fas ligand helped the activation and cleavage of procaspase-8 that cause cell death by apoptosis.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B194-biomolecules-09-00679" ref-type="bibr">194</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Ricinus communis</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Terpenoids (monoterpenoids: 1,8-cineole,<break/>camphor and pinene, and sesquiterpenoid:<break/>caryophyllene)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SK-MEL-28 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induced apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B198-biomolecules-09-00679" ref-type="bibr">198</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Nigella sativa</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thymoquinone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Skin cancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B189-biomolecules-09-00679" ref-type="bibr">189</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Moringa oleifera</italic> Lam.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Extract (silver nanoparticle)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A-431 epedermoid carcinoma cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B188-biomolecules-09-00679" ref-type="bibr">188</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Lycopodium clavatum</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Apigenin (flavonoid)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human keratinocyte cell line HaCaT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited the formation of ROS, interfered with NF-kB and p38MAPK signaling pathways</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B195-biomolecules-09-00679" ref-type="bibr">195</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pyrroloiminoquinone compounds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SCC13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited cancer cell migration and invasion</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B266-biomolecules-09-00679" ref-type="bibr">266</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Citral</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited UVB-induced skin carcinogenesis by reducing levels of oxidative stress and proinflammatory cytokines, increasing apoptotic rate in the skin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B267-biomolecules-09-00679" ref-type="bibr">267</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="biomolecules-09-00679-t007" orientation="portrait" position="float"><object-id pub-id-type="pii">biomolecules-09-00679-t007_Table 7</object-id><label>Table 7</label><caption><p>Activity anticancer of medicinal plants phytochemical compounds on brain cancer.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plants</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Extracts/Molecules</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Biological Approach (In Vitro/In Vivo)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Lines Tested </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Key Finding/Mechanisms</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Croton regelianus</italic> M&#x000fc;ll.Arg.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SF-295</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B203-biomolecules-09-00679" ref-type="bibr">203</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Juniperus phoenicea</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">U251</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effects</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B204-biomolecules-09-00679" ref-type="bibr">204</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carvone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Primary rat neuron and<break/>neuroblastoma (N2a) cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased in antioxidant level in primary cells with little<break/>potential in treatment of brain tumor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B207-biomolecules-09-00679" ref-type="bibr">207</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-Elemene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G-422 tumor cells in mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited brain carcinomas</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B208-biomolecules-09-00679" ref-type="bibr">208</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flavonoid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rat brain PKC.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited the kinase</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B209-biomolecules-09-00679" ref-type="bibr">209</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Angelica sinensis</italic> (Oliv.) Diels</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chloroform</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glioblastoma multiforme (GBM)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Changed the cell cycle distribution, and induced apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B206-biomolecules-09-00679" ref-type="bibr">206</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Angelica sinensis</italic> (Oliv.) Diels</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chloroform</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced the volume of tumor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B206-biomolecules-09-00679" ref-type="bibr">206</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> BRM270</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> GBM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induced of apoptosis and inhibited cell growth</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B213-biomolecules-09-00679" ref-type="bibr">213</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> BRM270</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induced of apoptosis and inhibited cell growth</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B213-biomolecules-09-00679" ref-type="bibr">213</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Isoflavones</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GBM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">By its combination with rapamycin, its isoflavones decreased the phosphorylation of Akt and eIF4E proteins, and rendered U87 cells more sensitive to rapamycin treatment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B211-biomolecules-09-00679" ref-type="bibr">211</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retinoids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T98G</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induced of apoptosis with activation of caspase-8 and cleavage of Bid to truncated Bid (tBid)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B214-biomolecules-09-00679" ref-type="bibr">214</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Retinoids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">U87MG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induced apoptosis with activation of caspase-8 and cleavage of Bid to truncated Bid (tBid)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B214-biomolecules-09-00679" ref-type="bibr">214</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Epigallocatechin gallate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">U87</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induced apoptosis via<break/>downregulation of p-Akt and Bcl-2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B215-biomolecules-09-00679" ref-type="bibr">215</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>delta</italic>-9-Tetrahydrocannabinol (&#x00394;<sup>9</sup>-THC)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GBM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Decreased cell viability</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B216-biomolecules-09-00679" ref-type="bibr">216</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>delta</italic>-9-tetrahydrocannabinol (&#x00394;<sup>9</sup>-THC)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">U251 and SF126</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acted synergistically to inhibit cell proliferation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B217-biomolecules-09-00679" ref-type="bibr">217</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>n</italic>-Butylidenephthalide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GBM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Decreased the cell proliferation, and induced apoptotic pathways</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B212-biomolecules-09-00679" ref-type="bibr">212</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>n</italic>-Butylidenephthalide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppressed the growth of malignant brain tumor cells without inducing cytotoxicity on fibroblast</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B212-biomolecules-09-00679" ref-type="bibr">212</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Scutellaria baicalensis Georgi</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethanolic extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GBM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited the cellular growth</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B205-biomolecules-09-00679" ref-type="bibr">205</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Phellinus linteus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hispolon</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">U87MG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits cell viability, induced G2/M cell cycle arrest and apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B268-biomolecules-09-00679" ref-type="bibr">268</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aloe-Emodin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro and in vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">U87MG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited the cellular growth</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B269-biomolecules-09-00679" ref-type="bibr">269</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="biomolecules-09-00679-t008" orientation="portrait" position="float"><object-id pub-id-type="pii">biomolecules-09-00679-t008_Table 8</object-id><label>Table 8</label><caption><p>Activity anticancer of medicinal plants phytochemical compounds on breast cancer.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plants</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Extracts/Molecules</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Biological Approach (In Vitro/In Vivo)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Lines Tested </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Key Finding/Mechanisms</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alpiniae katsumadai</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cardamonin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDA-MB-231 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of the HIF-1&#x003b1; pathway and modulated cancer cell metabolism</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B270-biomolecules-09-00679" ref-type="bibr">270</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Garcinia bracteata</italic> C.Y.Wu ex Y.H.Li</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neobractatin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDA-MB-231 and MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prevention of metastasis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B271-biomolecules-09-00679" ref-type="bibr">271</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Tetradium ruticarpum</italic><break/>(A.Juss.) T.G.Hartley</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Evodiamine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro and in vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NCI/ADR-RES cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of the proliferation of NCI / ADR-RES cells of human breast cancer resistant to adriamycin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B218-biomolecules-09-00679" ref-type="bibr">218</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Sanguinaria canadensis</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sanguinarine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>MDA-231 cells</p></list-item><list-item><label>-</label><p>MDA-435S cells</p></list-item></list>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Analyzing changes in expression levels with various antiapoptotic proteins.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B219-biomolecules-09-00679" ref-type="bibr">219</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Sophora flavescens</italic> Aiton</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Matrine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro and in vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells and mouse 4T1 breast cancer cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduced viability of both types of cells and induction of apoptosis in MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B221-biomolecules-09-00679" ref-type="bibr">221</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Piper nigrum</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Piperine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro and in vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4T1 cells</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Induction of apoptosis of 4T1 cells</p></list-item><list-item><label>-</label><p>suppression of primary tumor growth 4T1</p></list-item></list>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B222-biomolecules-09-00679" ref-type="bibr">222</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Curcuma longa</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7, MDA-MB-231, BT-474</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of tumor regression induced by cyclophosphamide.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B22-biomolecules-09-00679" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Carvacrol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDA-MB-231</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis in cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B234-biomolecules-09-00679" ref-type="bibr">234</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Boswellia sacra</italic> Flueck.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T47D, MCF-7, MDA-MB-231</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppression of cellular network formation and disruption of spheroid development of breast cancer cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B224-biomolecules-09-00679" ref-type="bibr">224</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Nigella sativa</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis in cancer cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B272-biomolecules-09-00679" ref-type="bibr">272</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Pulicaria jaubertii</italic> E.Gamal-Eldin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B225-biomolecules-09-00679" ref-type="bibr">225</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Commiphora pyracanthoides</italic> Engl.<break/><italic>Boswellia carterii</italic> Balf.f.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis in cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B231-biomolecules-09-00679" ref-type="bibr">231</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cymbopogon citratus</italic> (DC.) Stapf<break/><italic>Cymbopogon nardus</italic> (L.) Rendle</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B273-biomolecules-09-00679" ref-type="bibr">273</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Thymus linearis</italic> Benth.<break/><italic>Thymus serpyllum</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antiproliferative activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B232-biomolecules-09-00679" ref-type="bibr">232</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Porcelia macrocarpa</italic> R.E.Fr.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SKBr cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B233-biomolecules-09-00679" ref-type="bibr">233</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Annona muricata</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B226-biomolecules-09-00679" ref-type="bibr">226</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Cedrelopsis grevei</italic> Baill. &#x00026; Courchet</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B227-biomolecules-09-00679" ref-type="bibr">227</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Seseli transcaucasicum</italic> Pimenov &#x00026; Sdobnina</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B228-biomolecules-09-00679" ref-type="bibr">228</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Melissa officinalis</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B229-biomolecules-09-00679" ref-type="bibr">229</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Lycopus lucidus</italic> Turcz. var. hirtus Regel</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDA-MB-435S and ZR-75-30 cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B274-biomolecules-09-00679" ref-type="bibr">274</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Syzygium aromaticum</italic> (L.) Merr. &#x00026; L.M.Perry</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aqueous extract, ethanolic extract, oil extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 and MDA-MB-231</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B275-biomolecules-09-00679" ref-type="bibr">275</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Sal</italic>via <italic>officinalis</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B230-biomolecules-09-00679" ref-type="bibr">230</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Mentha spicata</italic> L.<break/><italic>Zingiber officinale</italic> Roscoe<break/><italic>Citrus limon</italic> (L.) Osbeck<break/><italic>Jasminum grandiflorum</italic> L.<break/><italic>Matricaria chamomilla</italic> L.<break/><italic>Thymus vulgaris</italic> L.<break/><italic>Rosa &#x000d7; damascena</italic> Herrm.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B223-biomolecules-09-00679" ref-type="bibr">223</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Laurus nobilis</italic> L.<break/><italic>Origanum syriacum</italic> L.<break/><italic>Origanum vulgare</italic> L.<break/><italic>Sal</italic>via <italic>fruticosa</italic> Mill.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Volatile oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B276-biomolecules-09-00679" ref-type="bibr">276</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Schinus molle</italic> L.<break/><italic>Schinus terebinthifolia</italic> Raddi</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B277-biomolecules-09-00679" ref-type="bibr">277</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Rosmarinus officinalis</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antiproliferative activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B239-biomolecules-09-00679" ref-type="bibr">239</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Schefflera heptaphylla</italic> (L.) Frodin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antiproliferative activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B240-biomolecules-09-00679" ref-type="bibr">240</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Eucalyptus sideroxylon</italic> A.Cunn. ex Woolls<break/><italic>Eucalyptus torquata</italic> Luehm.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil, methanolic extract, aqueous extract</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antiproliferative activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B241-biomolecules-09-00679" ref-type="bibr">241</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Schinus molle</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EMT6 cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B278-biomolecules-09-00679" ref-type="bibr">278</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Dictamnus albus</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7, ZR-75-30 and<break/>MDA-MB-435S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antiproliferative activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B279-biomolecules-09-00679" ref-type="bibr">279</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Sal</italic>via <italic>officinalis</italic> L.<break/><italic>Sideritis perfoliata</italic> L.<break/><italic>Satureja thymbra</italic> L.<break/><italic>Laurus nobilis</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B196-biomolecules-09-00679" ref-type="bibr">196</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Juniperus phoenicea</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B204-biomolecules-09-00679" ref-type="bibr">204</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Magnolia ovata</italic> (A.St.-Hil.) Spreng.<break/><italic>Symphyopappus itatiayensis</italic> (Hieron.) R.M.King &#x00026; H.Rob.<break/><italic>Myrciaria floribunda</italic> (H.West ex Willd.) O.Berg<break/><italic>Psidium cattleianum</italic> Afzel. ex Sabine<break/><italic>Nectandra megapotamica</italic> (Spreng.) Mez</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B280-biomolecules-09-00679" ref-type="bibr">280</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Citrus limon</italic> (L.) Osbeck</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B281-biomolecules-09-00679" ref-type="bibr">281</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>Lavandula stoechas</italic> L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Essential oil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BC1 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B282-biomolecules-09-00679" ref-type="bibr">282</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Citral</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cycle arrest in G2/M<break/>phase and apoptosis induction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B235-biomolecules-09-00679" ref-type="bibr">235</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Eugenol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition and apoptosis induction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B283-biomolecules-09-00679" ref-type="bibr">283</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Galbanic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 and<break/>MDA-MB-231 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibited proliferation and induced apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B284-biomolecules-09-00679" ref-type="bibr">284</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-Santalol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 and<break/>MDA-MB-231 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G2/M phase cell cycle arrest and apoptosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B236-biomolecules-09-00679" ref-type="bibr">236</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Piperine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of self-renewal of breast stem cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B285-biomolecules-09-00679" ref-type="bibr">285</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phytol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">in vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic activity in a dose-dependent manner</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B286-biomolecules-09-00679" ref-type="bibr">286</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Matrine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDA-MB-231 cell line</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of proliferation and invasion of cancer cells via the EGF/VEGF-VEGFR1-Akt-NF-&#x003ba;B signaling pathway.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B287-biomolecules-09-00679" ref-type="bibr">287</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sanguinarine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDA-MB-231 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of cell growth and migration of MDA-MB-231 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B288-biomolecules-09-00679" ref-type="bibr">288</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tetrandrine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7/adr cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">inhibition of cell growth in MCF-7 and MCF-7/adr cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B289-biomolecules-09-00679" ref-type="bibr">289</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of proliferative effects of bisphenol A on MCF-7 cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B290-biomolecules-09-00679" ref-type="bibr">290</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin and citral,</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 and MDA-MB-231 cell lines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis and cell cycle arrest at G0/G1 phase in breast cancer cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B237-biomolecules-09-00679" ref-type="bibr">237</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro and in vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDA-MB-231 cells</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>In vitro: regulation of proliferation and apoptosis in cells</p></list-item><list-item><label>-</label><p>In vivo: inhibition of tumor growth and angiogenesis</p></list-item></list>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B291-biomolecules-09-00679" ref-type="bibr">291</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDA-MB-435 cells</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Suppress the expression of antiapoptotic, proliferative and metastatic proteins</p></list-item><list-item><label>-</label><p>Strengthen apoptosis.</p></list-item></list>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B292-biomolecules-09-00679" ref-type="bibr">292</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Curcumin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro and in vivo</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 and MDA-MB-231</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="simple"><list-item><label>-</label><p>Induction of apoptosis</p></list-item><list-item><label>-</label><p>inhibition of tumor growth</p></list-item></list>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B293-biomolecules-09-00679" ref-type="bibr">293</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>